0001493152-22-023055.txt : 20220815 0001493152-22-023055.hdr.sgml : 20220815 20220815181828 ACCESSION NUMBER: 0001493152-22-023055 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 65 CONFORMED PERIOD OF REPORT: 20220430 FILED AS OF DATE: 20220815 DATE AS OF CHANGE: 20220815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPARTA COMMERCIAL SERVICES, INC. CENTRAL INDEX KEY: 0000318299 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 300298178 FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-09483 FILM NUMBER: 221167600 BUSINESS ADDRESS: STREET 1: 555 FIFTH AVENUE STREET 2: 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2122392666 MAIL ADDRESS: STREET 1: 555 FIFTH AVENUE STREET 2: 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: TOMAHAWK INDUSTRIES INC DATE OF NAME CHANGE: 20001120 FORMER COMPANY: FORMER CONFORMED NAME: TOMAHAWK OIL & MINERALS INC DATE OF NAME CHANGE: 19831216 10-K 1 form10-k.htm
0000318299 false FY 0000318299 2021-05-01 2022-04-30 0000318299 2022-04-30 0000318299 2022-08-15 0000318299 2021-04-30 0000318299 SRCO:SeriesAConvertiblePreferredStockMember 2022-04-30 0000318299 SRCO:SeriesAConvertiblePreferredStockMember 2021-04-30 0000318299 SRCO:SeriesBRedeemablePreferredStockMember 2022-04-30 0000318299 SRCO:SeriesBRedeemablePreferredStockMember 2021-04-30 0000318299 SRCO:SeriesCRedeemableConvertiblePreferredStockMember 2022-04-30 0000318299 SRCO:SeriesCRedeemableConvertiblePreferredStockMember 2021-04-30 0000318299 SRCO:SeriesDRedeemableConvertiblePreferredStockMember 2022-04-30 0000318299 SRCO:SeriesDRedeemableConvertiblePreferredStockMember 2021-04-30 0000318299 2020-05-01 2021-04-30 0000318299 SRCO:InformationTechnologyMember 2021-05-01 2022-04-30 0000318299 SRCO:InformationTechnologyMember 2020-05-01 2021-04-30 0000318299 SRCO:NewWorldHealthBrandsMember 2021-05-01 2022-04-30 0000318299 SRCO:NewWorldHealthBrandsMember 2020-05-01 2021-04-30 0000318299 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-04-30 0000318299 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-04-30 0000318299 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2021-04-30 0000318299 us-gaap:CommonStockMember 2021-04-30 0000318299 SRCO:CommonStockToBeIssuedMember 2021-04-30 0000318299 us-gaap:AdditionalPaidInCapitalMember 2021-04-30 0000318299 us-gaap:RetainedEarningsMember 2021-04-30 0000318299 us-gaap:NoncontrollingInterestMember 2021-04-30 0000318299 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-05-01 2022-04-30 0000318299 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-05-01 2022-04-30 0000318299 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2021-05-01 2022-04-30 0000318299 us-gaap:CommonStockMember 2021-05-01 2022-04-30 0000318299 SRCO:CommonStockToBeIssuedMember 2021-05-01 2022-04-30 0000318299 us-gaap:AdditionalPaidInCapitalMember 2021-05-01 2022-04-30 0000318299 us-gaap:RetainedEarningsMember 2021-05-01 2022-04-30 0000318299 us-gaap:NoncontrollingInterestMember 2021-05-01 2022-04-30 0000318299 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-04-30 0000318299 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-04-30 0000318299 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-04-30 0000318299 us-gaap:CommonStockMember 2022-04-30 0000318299 SRCO:CommonStockToBeIssuedMember 2022-04-30 0000318299 us-gaap:AdditionalPaidInCapitalMember 2022-04-30 0000318299 us-gaap:RetainedEarningsMember 2022-04-30 0000318299 us-gaap:NoncontrollingInterestMember 2022-04-30 0000318299 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-04-30 0000318299 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-04-30 0000318299 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2020-04-30 0000318299 us-gaap:CommonStockMember 2020-04-30 0000318299 SRCO:CommonStockToBeIssuedMember 2020-04-30 0000318299 us-gaap:AdditionalPaidInCapitalMember 2020-04-30 0000318299 us-gaap:RetainedEarningsMember 2020-04-30 0000318299 us-gaap:NoncontrollingInterestMember 2020-04-30 0000318299 2020-04-30 0000318299 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-05-01 2021-04-30 0000318299 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-05-01 2021-04-30 0000318299 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2020-05-01 2021-04-30 0000318299 us-gaap:CommonStockMember 2020-05-01 2021-04-30 0000318299 SRCO:CommonStockToBeIssuedMember 2020-05-01 2021-04-30 0000318299 us-gaap:AdditionalPaidInCapitalMember 2020-05-01 2021-04-30 0000318299 us-gaap:RetainedEarningsMember 2020-05-01 2021-04-30 0000318299 us-gaap:NoncontrollingInterestMember 2020-05-01 2021-04-30 0000318299 us-gaap:LeaseholdImprovementsMember 2021-05-01 2022-04-30 0000318299 us-gaap:FurnitureAndFixturesMember 2021-05-01 2022-04-30 0000318299 SRCO:WebsiteCostsMember 2021-05-01 2022-04-30 0000318299 us-gaap:ComputerEquipmentMember 2021-05-01 2022-04-30 0000318299 SRCO:SharesToBeIssuedMember 2021-05-01 2022-04-30 0000318299 SRCO:SharesToBeIssuedMember 2020-05-01 2021-04-30 0000318299 SRCO:NotesConvertibleAtHoldersOptionMember 2022-04-30 0000318299 SRCO:NotesConvertibleAtHoldersOptionMember 2021-04-30 0000318299 SRCO:NotesConvertibleAtCompanysOptionMember 2022-04-30 0000318299 SRCO:NotesConvertibleAtCompanysOptionMember 2021-04-30 0000318299 SRCO:NonConvertibleNotesPayableMember 2022-04-30 0000318299 SRCO:NonConvertibleNotesPayableMember 2021-04-30 0000318299 srt:MinimumMember 2021-05-01 2022-04-30 0000318299 srt:MaximumMember 2021-05-01 2022-04-30 0000318299 2019-05-01 2020-04-30 0000318299 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2022-04-30 0000318299 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2021-04-30 0000318299 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2022-04-30 0000318299 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2021-04-30 0000318299 us-gaap:MeasurementInputPriceVolatilityMember 2022-04-30 0000318299 us-gaap:MeasurementInputPriceVolatilityMember 2021-04-30 0000318299 SRCO:MeasurementInputDividendPayoutMember 2022-04-30 0000318299 SRCO:MeasurementInputDividendPayoutMember 2021-04-30 0000318299 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2021-05-01 2022-04-30 0000318299 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2020-05-01 2021-04-30 0000318299 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember 2021-05-01 2022-04-30 0000318299 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember 2020-05-01 2021-04-30 0000318299 2020-07-25 2020-07-30 0000318299 SRCO:PostSplitMember 2022-04-30 0000318299 SRCO:PostSplitMember 2021-04-30 0000318299 us-gaap:SeriesCPreferredStockMember 2022-04-30 0000318299 SRCO:CommonStockOneMember 2021-05-01 2022-04-30 0000318299 us-gaap:SeriesCPreferredStockMember 2021-05-01 2022-04-30 0000318299 us-gaap:SeriesDPreferredStockMember 2021-05-01 2022-04-30 0000318299 us-gaap:CommonStockMember SRCO:FourteenAccreditedInvestorsMember 2021-05-01 2022-04-30 0000318299 us-gaap:CommonStockMember SRCO:ThreeAccreditedInvestorsMember 2021-05-01 2022-04-30 0000318299 SRCO:HavensStockOptionAgreementMember us-gaap:CommonStockMember 2021-05-01 2022-04-30 0000318299 SRCO:AhmanStockOptionAgreementMember us-gaap:CommonStockMember 2021-05-01 2022-04-30 0000318299 us-gaap:CommonStockMember SRCO:TwoIndependentDirectorMember 2022-01-02 2022-01-03 0000318299 us-gaap:CommonStockMember SRCO:TwoIndependentDirectorMember 2022-01-03 0000318299 SRCO:ChiefExecutiveOfficerAndVicePresidentMember us-gaap:CommonStockMember 2022-01-02 2022-01-03 0000318299 SRCO:ChiefExecutiveOfficerAndVicePresidentMember us-gaap:CommonStockMember 2022-01-03 0000318299 SRCO:FourEmployeesMember us-gaap:CommonStockMember 2022-01-02 2022-01-03 0000318299 SRCO:FourEmployeesMember us-gaap:CommonStockMember 2022-01-03 0000318299 SRCO:SeriesCConvertiblePreferredStockMember 2020-05-01 2021-04-30 0000318299 SRCO:SeriesDConvertiblePreferredStockMember SRCO:SettlementOfAccountsPayableMember 2020-05-01 2021-04-30 0000318299 SRCO:SeriesDConvertiblePreferredStockMember 2020-05-01 2021-04-30 0000318299 SRCO:CommonStockOneMember 2020-05-01 2021-04-30 0000318299 SRCO:SeriesDConvertiblePreferredStockMember 2021-05-01 2022-04-30 0000318299 SRCO:SeriesCConvertiblePreferredStockMember 2021-05-01 2022-04-30 0000318299 SRCO:CommonStockTwoMember 2020-05-01 2021-04-30 0000318299 us-gaap:SeriesAPreferredStockMember 2022-04-30 0000318299 us-gaap:SeriesAPreferredStockMember 2021-04-30 0000318299 us-gaap:SeriesBPreferredStockMember 2022-04-30 0000318299 us-gaap:SeriesBPreferredStockMember 2021-04-30 0000318299 us-gaap:SeriesCPreferredStockMember 2021-04-30 0000318299 us-gaap:SeriesDPreferredStockMember 2022-04-30 0000318299 us-gaap:SeriesDPreferredStockMember 2021-04-30 0000318299 us-gaap:FairValueInputsLevel1Member 2022-04-30 0000318299 us-gaap:FairValueInputsLevel2Member 2022-04-30 0000318299 us-gaap:FairValueInputsLevel3Member 2022-04-30 0000318299 us-gaap:FairValueInputsLevel1Member 2021-04-30 0000318299 us-gaap:FairValueInputsLevel2Member 2021-04-30 0000318299 us-gaap:FairValueInputsLevel3Member 2021-04-30 0000318299 us-gaap:ComputerEquipmentMember 2022-04-30 0000318299 us-gaap:ComputerEquipmentMember 2021-04-30 0000318299 us-gaap:WarrantMember 2021-05-01 2022-04-30 0000318299 us-gaap:WarrantMember 2022-04-30 0000318299 SRCO:WarrantOneMember 2022-04-30 0000318299 SRCO:WarrantOneMember 2021-05-01 2022-04-30 0000318299 SRCO:WarrantTwoMember 2022-04-30 0000318299 SRCO:WarrantTwoMember 2021-05-01 2022-04-30 0000318299 SRCO:WarrantThreeMember 2022-04-30 0000318299 SRCO:WarrantThreeMember 2021-05-01 2022-04-30 0000318299 us-gaap:WarrantMember SRCO:NonEmployeesMember 2020-04-30 0000318299 us-gaap:WarrantMember SRCO:NonEmployeesMember 2020-05-01 2021-04-30 0000318299 us-gaap:WarrantMember SRCO:NonEmployeesMember 2021-04-30 0000318299 us-gaap:WarrantMember SRCO:NonEmployeesMember 2021-05-01 2022-04-30 0000318299 us-gaap:WarrantMember SRCO:NonEmployeesMember 2022-04-30 0000318299 SRCO:ExecutiveOfficeSpaceMember 2021-05-01 2022-04-30 0000318299 SRCO:EmploymentAgreementMember SRCO:MrHavensMember 2021-05-01 2022-04-30 0000318299 SRCO:EmploymentAgreementMember SRCO:MrHavensMember 2022-04-30 0000318299 SRCO:EmploymentAgreementMember SRCO:MsAhmanMember 2021-05-01 2022-04-30 0000318299 SRCO:EmploymentAgreementMember SRCO:MsAhmanMember 2022-04-30 0000318299 SRCO:LenderOneMember 2022-04-30 0000318299 SRCO:LenderTwoMember 2022-04-30 0000318299 SRCO:NewYorkCountyKingsMember 2016-09-21 2016-09-22 0000318299 SRCO:PromissoryNoteMember 2015-02-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

(Mark One)

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended April 30, 2022

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________.

 

Commission file number: 0-9483

 

SPARTA COMMERCIAL SERVICES, INC.

(Exact name of registrant as specified in its charter)

 

nevada   30-0298178

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

     
555 Fifth Avenue, 14th Floor, New York, NY   10017
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (212) 239-2666

 

Securities registered pursuant to Section 12(b) of the Exchange Act: 

 

Title of each class   Trading symbol(s)   Name of exchange on which registered
Common Stock, par value $0.001   SRCO   OTC:PINK

 

Securities registered pursuant to Section 12(g) of the Exchange Act:

 

  Common Stock, par value $0.001  
  (Title of class)  

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐ Yes ☒ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceeding12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically and posted every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to file such files). ☒ Yes ☐ No

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company and emerging growth company. See the definitions “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer ☐ (Do not check if a smaller reporting company) Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

 

The aggregate market value of voting and non-voting common equity of the issuer held by non-affiliates, on April 30, 2022 was $978,241

 

As of August 15, 2022, we had 17,501,298 shares of common stock issued and outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE: None.

 

 

 

 

 

 

SPARTA COMMERCIAL SERVICES, INC.

 

TABLE OF CONTENTS

 

    Page
     
PART I  
     
Item 1. Business 3
Item 1A. Risk Factors 11
Item 1B. Unresolved Staff Comments 19
Item 2. Properties 19
Item 3. Legal Proceedings 19
     
PART II  
     
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 20
Item 6. Selected Financial Data 21
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 22
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 27
Item 8. Financial Statements and Supplementary Data 28
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 48
Item 9A. Controls and Procedures 48
Item 9B. Other Information 49
     
PART III  
     
Item 10. Directors, Executive Officers and Corporate Governance 49
Item 11. Executive Compensation 52
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 53
Item 13. Certain Relationships and Related Transactions, and Director Independence 54
Item 14. Principal Accountant Fees and Services 54
Item 15. Exhibits, Financial Statement Schedules 55
     
Signatures 57

 

2

 

 

PART I

 

ITEM 1. BUSINESS

 

General Overview

 

Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation with headquarters in New York City, www.spartacommercial.com. We are a multi-disciplined parent corporation operating across three business sectors – Financial Services, E-Commerce & Mobile Technology, and Health and Wellness, (www.spartacommercial.com).

 

Sparta’s roots are in the Powersports industry. The Company provided retail installment loans and leases through authorized motorcycle dealerships in 33 states, with financing provided by institutional lenders. The Company also maintained a full underwriting and servicing platform for its portfolio. Notwithstanding the discontinuance of our initial focus on consumer loans and leases post Lehman and during the 2008 financial crisis; in 2007, the Company had introduced a new initiative, Municipal Financing, (www.spartamunicipal.com), which has financed over 100 jurisdictions to date. Sparta’s Municipal Finance program is also currently available to all nonprofit organizations, institutions and entities. All nonprofit organizations which adhere to IRS guidelines, including 501 (c) 3 of the Internal Revenue Code, are eligible. Both public nonprofits, also known as public charities supported with publicly collected funds, and private nonprofits, also known as private foundations supported by an individual or business entity, qualify for the program.

 

Vehicle History Reports are a staple of Sparta’s E-Commerce Technology subsidiary iMobile Solutions, Inc. Whether a vehicle is intended for business or recreational use, Sparta’s Vehicle History Reports are highly regarded for accuracy and completeness and have been sold across all 50 states and in 62 countries worldwide. They provide a trusted layer of assurance to vehicle buyers and are available on Kelley Blue Book, AllState Insurance and a range of various dealership websites. They include Cyclechex (Motorcycle History Reports at www.cyclechex.com), RVchex (Recreational Vehicle History Reports at www.rvchex.com), and Truckchex (Heavy Duty Truck History Reports at www.truckchex.com). Consumers, retailers, municipals, nonprofits, auction houses, banks and insurance companies alike scrutinize title history reports for the vital information needed and factored into crucial business decisions that affect the bottom line.

 

The Company’s E-Commerce and Mobile Technology subsidiary name change to iMobile Solutions, Inc., from Specialty Reports, Inc., in 2016, signifies its ever-broadening service offerings in the evolving technology landscape. With iMobile App (www.imobileapp.com), the Company provides mobile technology services, including web and mobile application creation, development and management for a wide range of businesses to increase revenue, build brand recognition, and improve customer engagement. Our ever-broadening business base of mobile application includes vehicle dealerships and racetracks, private clubs and country clubs, schools and entertainment venues, restaurants and grocery stores, as well as various other merchant types. (www.imobileapp.com/app-gallery). The Company also designs, launches, maintains and hosts websites for businesses incorporating SEO (search engine optimization), social media marketing, and online reviews to improve their presence online. We provide specific, tailored action plans for our clients’ websites that include services such as eCommerce, CRM (Customer Relationship Management) development and integration. This custom software not only helps businesses communicate with customers but can also be used for employees to communicate internally. The CRM software can be web based, integrated with a mobile app, or both. We work with clients to understand their unique needs and incorporate the features and requirements that are most important to them and will facilitate their business growth and success. Correspondingly, the Company designs and builds custom kitchen ordering software for independent grocery stores, delicatessens, and other food service businesses. The software can be designed for use in a combination of ways including mobile devices and in-store ordering. The kitchen ordering software is enabled with payment integration, text messaging notification, wireless printing, and other features. iMobile Solutions, Inc. provides a turn-key solution for any business looking to simplify or streamline their kitchen ordering process. Additionally, we offer text messaging services, which supplement business marketing strategies both to gain and retain brand loyalty among its clients, customers and investors. Our text messaging platform allows our clients to easily manage, schedule and analyze text message performance.

 

Sparta created its subsidiary, New World Health Brands, Inc., in April 2019, on the heels of the Agriculture Improvement Act (also known as the Farm Bill), which was signed into law the previous December 20, 2018. Consequently, hemp (CBD) was removed from Schedule 1 of the Controlled Substances Act. Company management recognized the substantial business opportunity that lay ahead in the rapidly expanding hemp-CBD (cannabidiol) market in the United States. During 2019-2020, we sourced, developed and tested 5 CBD product categories totalling 31 products. We procured premium, domestic-grade, full-spectrum, broad-spectrum, and THC free hemp, created product packaging and labelling, and implemented fulfilment to launch an online B to C website: www.newworldhealthcbd.com on December 21, 2019. The Company has since curated its products and currently offers 15 products with plans to add complementary products to our product line. Our CBD products are available in full spectrum, broad spectrum and non-detectable below the legal limit of .3 THC (ND-THC) and come in capsules, oils, tablets, gel caps, tinctures, salves, creams, lotions, as well as pet chews and tinctures. We remain watchful of consumer needs, adjusting our product line offerings either by adding new products, adjusting the potency levels of existing products or discontinuing still others, as warranted. To ensure the safety and quality of our products, all CBD product offerings are exclusively sourced, manufactured and tested at highly accredited testing facilities in the United States and adhere to strict U.S standards and guidelines. Because of our high standards, in-depth quality testing and label transparency, consumers know they can trust us.

 

Sparta’s response to the onset of the COVID 19 pandemic in early 2020 quickly took shape with thorough investigations into evolving customer trends in health and wellness. As a result, we expanded New World Health Brands and developed a new product line of natural dietary supplements. In August 2020, we launched an online B to C website: www.newworldhealthbrands.com, featuring high quality dietary supplements, including vitamins and minerals, such as, Zinc, Magnesium, Boron, Iodine, Beetroot Extract, Selenium, Vitamin B Complex, Vitamin C and PQQ. To ensure the safety and quality of our products, all health and wellness offerings are exclusively sourced and manufactured in the United States and adhere to strict U.S standards and guidelines. Sparta’s commitment to high standards and transparency are tantamount to being a trusted brand.

 

Sparta’s newest subsidiary, Sparta Crypto, Inc., www.SpartaCrypto.com, was established September 25, 2020 and is in the process of completing a proprietary state-of-the-art platform designed to connect users of widely adopted digital currencies with sellers of various goods and services. The platform has not launched and the Company can make no assurances that the described plan will reach implementation. In addition, the Company has completed and tested a cryptocurrency payment gateway called SpartaPayIQ, www.SpartaPayIQ.com, which is functional and was formally announced on March 3, 2022.

 

3

 

 

MOBILE APPS

 

Sparta creates mobile applications (mobile apps) for small and medium-size businesses under the tradename iMobileApp. iMobileApp employs a subscription business model and is positioned as a fast and affordable way for businesses to develop and launch a mobile app. The iMobileApp platform allows businesses to have a high-quality, fully functioning custom mobile app often at a lower cost than traditional marketing efforts, and typically at a significantly lower cost than a commercial quality website.

 

The Company has developed and managed mobile apps since 2011, creating hundreds of mobile apps for a wide variety of businesses for customers in 49 states and Canada. Today, iMobileApp is the largest provider of mobile app technology to the Harley-Davidson dealership network in the United States.

 

Mobile apps are one of the most important digital tools that a consumer-facing business can employ. Smartphones and tablets are now the leading devices for accessing the internet, and it is estimated that upwards of 80% of mobile use time is dedicated to utilizing mobile apps. As consumers become more mobile, businesses are increasingly seeing the need to as well. Currently, the mobile app development industry serving small to medium-sized businesses is fragmented, and the Company believes that iMobileApp can become a brand leader in this category.

 

An iMobileApp provides consumers easy access to a business website simply by touching the Company’s application icon. There is no need to search for or type in a web address. iMobileApp has dozens of basic and advanced functions, including providing businesses the ability to send a segmented promotional message that appears on the consumer’s mobile device front page, rather than in an email or text message. “Geo-fencing” is a feature that allows businesses to message customers who are in the vicinity of their store or event, or even when visiting a competitor.

 

The iMobileApp pricing model includes a modest up-front development fee, and an auto-renewing monthly subscription. Once a business launches an iMobileApp, the Company provides them with marketing tools to assist their customers in downloading the mobile app from the Apple and Android app stores. The Company offers two levels of on-going maintenance and support. The basic subscription provides training, technical support and software updates. The premium-priced program adds a fully managed feature, allowing businesses to contact iMobileApp Customer Service who will initiate campaigns, promotional messaging, and other iMobileApp features on behalf of the client.

 

A partial listing of iMobileApp features includes:

 

Mobile Client Framework (“MCF”) - Our mobile framework software allows us to provide customized apps that can be installed on the individual mobile devices and deployed through the Apple and Android app stores.

 

Content Management System (CMS) -iMobileApp customers can use our web-based content management system to upload images to their mobile app, change text content, change colors, organize the order of tabs, and publish updates to the app.

 

Customized Registration System - iMobileApp customers can elect to present their users with a registration screen on startup that collects information such as first name, last name, email address and telephone number in order to track marketing information and push individual notification messages for future functionality.

 

Push Notification System – A direct communication channel between businesses and their mobile app users. Allows brands to socialize directly with their very best customers, anytime, anywhere, to build a relationship at a one-to-one level.

 

Geo-Fencing Feature – Allows businesses to create an invisible “message fence” around a specific geographic area. When their app users are within the fenced area, the user receives a pre-programmed message on their device. This is especially useful when businesses have special promotions or events they would like to advertise to nearby users who are most likely to take advantage of them. Businesses can also “geo-fence” around a competitor, offering their users special promotions before they enter the competitor’s venue.

 

Inventory Display Manager – Business can manage, display and sell from their inventory on their mobile app. Inventory can be integrated through web link, hand-key, or inventory management data feed.

 

4

 

 

Event Manager – Business can manage and display upcoming events on their mobile app. Customers can view the event calendar, RSVP and Inventory can be integrated through web link, hand-key, or inventory management data feed.

 

Quick Dial Feature – Users tap the Quick Dial option to get a list of the business phone numbers on their mobile phones. The user selects the number to dial by putting their finger on the number. The business can add, remove, and edit phone numbers that appear in the Quick Dial screen from their CMS.

 

Multi-Location Management – Business can add and manage multiple locations on their app, each with distinct hours of operations, user database and notification segmentation. Businesses pay subscription fees for each location they wish to include in their app. Customers can use the client customization portal to add locations to their mobile app.

 

Marketing and Branding of iMobileApp

 

Marketing Materials - We provide customized marketing materials that app customers can download and display digitally or physically.

 

Embedded Product Developer and SRI Branding - The “about” screen of the application contains information useful to the support of the product. It also contains a powered-by-the-product-developer logo and text. iMS can choose to use a different logo, but the powered-by-the-product-developer text remains on the “about” screen.

 

App store and Google Android Distribution - All native applications are deployed through the product developer’s App store and Android Market Place online accounts.

 

Marketing information - If an app customer has enabled first-time user data collection then that information will be available to the app customer on their portal.

 

WEBSITES

 

The Company designs, launches, maintains and hosts websites for businesses incorporating SEO (search engine optimization), social media marketing, and online reviews to improve their presence online. We provide specific, tailored action plans for our clients’ websites that include services such as eCommerce, CRM (Customer Relationship Management) development and integration. This custom software not only helps businesses communicate with customers but can also be used for employees to communicate internally. The CRM software can be web based, integrated with a mobile app, or both. We work with clients to understand their unique needs and incorporate the features and requirements that are most important to them and will facilitate their business growth and success. Correspondingly, the Company designs and builds custom kitchen ordering software for independent grocery stores, delicatessens, and other food service businesses. The software can be designed for use in a combination of ways including mobile devices and in-store ordering. The kitchen ordering software is enabled with payment integration, text messaging notification, wireless printing, and other features. iMobile Solutions, Inc. provides a turn-key solution for any business looking to simplify or streamline their kitchen ordering process. Additionally, we offer text messaging services, which supplement business marketing strategies both to gain and retain brand loyalty among its clients, customers and investors. Our text messaging platform allows our clients to easily manage, schedule and analyze text message performance.

 

VEHICLE HISTORY REPORTS

 

The vehicle history report group is currently marketing through its websites: Cyclechex Motorcycle History Reports© (www.cyclechex.com), RVchex™ RV History Reports (www.rvchex.com), and Truckchex Heavy Duty Truck History Reports (www.truckchex.com). These reports contain valuable information for consumers, dealers, insurers, auction houses, and lenders. The information includes a vehicle’s history, such as disclosed damage, salvaged or rebuilt title brands, the number of previous owners, the last recorded odometer reading, the manufacturer’s original equipment, and OEM recall data. We assemble the data for these reports from multiple sources, including, but not limited to, governmental agencies, in order to provide the most current information available for the benefit of all interested parties. We believe our products offer a compelling value because they are priced modestly and we provide a no-hassle, 90-day and 100% money-back guarantee. We are confident that our Specialty Reports provide buyers and sellers the peace of mind that comes from being able to make an informed decision.

 

In June 2010, iMobile Solutions, Inc. entered into an exclusive five-year agreement with a U.S. government authorized third-party distributor of on-line data from National Motor Vehicle Title System (NMVTIS) for NMVTIS data on motorcycles, scooters, ATVs and recreational vehicles. This agreement has been renewed on a year to year basis.

 

5

 

 

NMVTIS is an information system that federal law required the United States Department of Justice to establish and to provide an electronic means to verify vehicle title, brand, and theft data among motor vehicle administrators, law enforcement officials, prospective purchasers and insurance carriers. NMVTIS was initially authorized in the Anti-Car Theft Act of 1992 and reauthorized by the Anti-Car Theft Improvements Act of 1996. After passage of the 1996 reauthorization, responsibility was transferred from the U.S. Department of Transportation to the U.S. Department of Justice. The NMVTIS system is a Department of Justice program currently operated by the American Association of Motor Vehicle Administrators (AAMVA). The system also provides a means for states to share title information in order to prevent fraud and other crime.

 

NMVTIS was created to:

 

Prevent the introduction or reintroduction of stolen motor vehicles into interstate commerce
   
Protect states, consumers (both individual and commercial), and other entities from fraud
   
Reduce the use of stolen vehicles for illicit purposes including funding of criminal enterprises
   
Provide consumer protection from unsafe vehicles

 

NMVTIS information is supplied by state motor vehicle agency records and entire sectors (e.g., insurance, auto recyclers/junk/salvage, etc.) addressed by the Anti-Car Theft Act. As opposed to purchasing information from specific businesses or companies, entities are required to provide specific information to NMVTIS in a specific format. NMVTIS is intended to serve as a reliable source of title and brand history for automobiles, motorcycles and other vehicles. However, there are certain pieces of vehicle history data that NMVTIS’ database does not contain; for example, a vehicle’s repair history. Currently the data provided to NMVTIS by states is provided in a variety of time frames; while some report and update NVMTIS data in real-time (as title transactions occur) others send updates less frequently, such as once every 24 hours or within a period of days.

 

Vehicle History Reports benefit consumers:

 

Consumers can purchase reports directly from the Cyclechex, RVchex, or Truckchex website
   
Consumers can purchase reports via an Affiliate website

 

Vehicle History Reports benefit dealers:

 

Dealers can purchase a block of history reports from Cyclechex, RVchex, or Truckchex (with pricing incentives to purchase a larger quantity of reports)
   
Reports facilitate acceptance of trade-in vehicles and add value to the purchase of any pre-owned motorcycle, RV, automobile, light truck or heavy-duty truck
   
Dealers can provide reports to customers

 

Vehicle History Reports Affiliate Program:

 

Dealers and other industry sources can incorporate the Cyclechex, RVchex, or Truckchex website linking their sales and marketing strategies
   

Affiliates earn commission on Cyclechex, RVchex, or Truckchex history reports generated from their sites

 

Cyclechex Motorcycle History Reports®

 

Cyclechex Motorcycle History Reports (Cyclechex.com) contain valuable information for consumers, motorcycle dealers, insurers, auction houses, and lenders including whether a pre-owned motorcycle is a specific model year, make and model, if it has reported damage, its title history including the last recorded odometer reading, any salvage or damaged titles, the manufacturer’s original equipment, and OEM recall data.

 

6

 

 

For consumers looking to buy a pre-owned motorcycle or a retail motorcycle dealer considering a trade-in or the purchase of other used motorcycles, a Cyclechex Motorcycle History Report can be invaluable. Moreover, for those dealers who want to provide a higher level of confidence to a potential buyer about the true history of the motorcycle being considered for purchase, the Cyclechex Motorcycle History Report is an outstanding sales support tool.

 

Our system extracts information from multiple sources, including, but not limited to, governmental agencies, in order to provide the most current information available for the benefit of all interested parties. With a no-hassle, 90-day, 100% money-back guarantee, and at a modest cost, a Cyclechex Motorcycle History Report provide buyers and sellers peace of mind for decision-making. This critical information is available to any interested party by entering a seventeen digit Vehicle Identification Number (VIN), which covers vehicles dating back to 1981, on our website.

 

In February 2014, we announced a reciprocal marketing agreement with Allstate insurance company that makes Cyclechex Motorcycle History Reports a recommended tool for Allstate customers. The Company also enjoys reciprocal a marketing agreement with Kelley Blue Book.

 

RVchex™ Recreational Vehicle History Reports

 

RV History Reports (RVchex.com) contains important and valuable information about any reported damage, salvage, and other relevant data concerning a particular pre-owned RV. Our system extracts information from multiple data sources, including, but not limited to, government agencies throughout the United States. RVchex.com delivers up-to-date, accurate information to consumers, RV dealers, lenders, insurers, and other interested parties, and we offer a no-hassle, 100% money-back guarantee. This critical information is available to any interested party by entering a seventeen digit Vehicle Identification Number (VIN) on our website.

 

Truckchex Heavy Duty Truck History Reports

 

The Truckchex Heavy Duty Truck History Report (Truckchex.com) contains valuable information for truck drivers, trucking companies, dealers, insurers, auction houses, and lenders, including whether a specific pre-owned commercial truck has reported damage, recorded accidents, post-accident inspections, inspection violations, the last recorded odometer reading, any salvage or damaged titles, the manufacturer’s original equipment, and OEM recall data. Our system extracts information from multiple data sources, including, but not limited to, governmental agencies throughout the United States. Truckchecks.com delivers up-to-date, accurate to consumers, truck dealers, lenders, insurers, and other interested parties, and we offer a no-hassle, 100% money-back guarantee. This critical information is available to any interested party by entering a seventeen digit Vehicle Identification Number (VIN) on our website.

 

The following websites are among those affiliated with iMobile Solutions, Inc. used to appropriately direct customer inquiries to our history report products:

 

www.kbb.com

https://www.nationalpowersports.net/

www.motorcycle-histories.com

www.motorcycleshippers.jcmotors.com

www.cyclepedia.com

http://www.allstateridernews.com/offers

 

Each of our four-vehicle history reports search government databases for over 90 types of vehicle title problems and over 28 million Salvage or Loss title records. Our reports provide some, if not all, of the following information:

 

Crushed Vehicles

Disclosed Damage

Last Recorded Odometer Reading

Manufacturers’ Recall History

Manufacturers’ Specifications

Multi-State Searches

Rebuilt Titles

Salvage-Stolen Titles

Salvaged or Damaged Titles

VIN Decoding

Crash Data

Inspection Data

 

7

 

 

MUNICIPAL AND NON-PROFIT LEASING OF ESSENTIAL EQUIPMENT

 

Notwithstanding our discontinuance of consumer financing, we continue to offer, on a pass through basis, an equipment-leasing product for local and state agencies as well as non-profit organizations throughout the country seeking a better and more economical way to finance their essential equipment needs, including, but not limited to, police motorcycles, cruisers, buses, fire trucks, and EMS equipment. We are continuing to expand our roster of equipment manufacturers and the types of equipment we lease to agencies.

 

NEW WORLD HEALTH BRANDS CBD

 

During 2019-2020, management sourced, developed and tested 5 CBD product categories totaling 31 products, procured product packaging, created clear-transparency labeling, implemented fulfillment and launched an on-line B2C website, www.newworldhealthcbd.com. The Company has since curated its products and currently offers 15 products with plans to add complementary products to our product line.

 

Sourcing CBD Products

 

All of our CBD products are sourced through third party suppliers in Arizona, Colorado, and Wyoming. NWHB carries single compound isolates, as well as products made from high quality, whole-plant, industrial hemp extracts, containing a full-spectrum of phytocannabinoids, including CBD, terpenes, flavonoids, and other minor, but valuable hemp compounds. Hemp extracts from Industrial Hemp are generally cannabis with less than 0.3% tetrahydrocannabinol (“THC”). Cannabis, which contains THC, causes psychoactive effects when consumed. NWHB does not produce or sell any products derived from high-THC cannabis/marijuana plants. Our products come from domestic seed, have clean label transparency and are third party tested for CBD potency, heavy metals, pesticides, microbials, and more, by ISO/IEC 17025 accredited labs.

 

NWHB manages risks that are associated with third-party suppliers and manufacturers by identifying and qualifying alternative providers. NWHB regularly assess its supply chain for any threats to business continuity. None of the third party suppliers are considered to be material to the business on a standalone basis and as any given supplier is lost in a specific region, NWHB has replaced supplier without material disruption as it can contract with multiple alternative suppliers and manufacturers.

 

CBD Product Categories

 

Our product line consists of only industrial hemp-based CBD containing zero or less than 0.03% THC. We do not manufacture or market edibles. We do not manufacture or market CBD vapes. Our present product base consists of products in 5 categories: tinctures, capsules & tablets, topicals, Zero THC and tinctures and chews for pets. The per serving dosage of CBD products ranges from 3.3mg to 50mg, depending on the dose. Our product line includes: tinctures of various sizes and flavors: capsules of differing potency and quantity; tablets of differing potency and quantity; salve of differing potency and quantity; creams and lotions of differing potency and quantity; and pet chews and tinctures.

 

NEW WORLD HEALTH BRANDS - WELLNESS

 

Our Wellness products feature high quality dietary supplements, including vitamins and minerals, such as, Zinc, Magnesium, Boron, Iodine, Selenium, Vitamin B Complex, Vitamin C and PQQ. In addition to our B to C website: www.newworldhealthbrands.com, our Wellness products are also offered on on-line marketplaces such as Amazon. We continue to study the market as we consider new products to add to our offerings.

 

8

 

 

Strategic Advantage

 

NWHB benefits from the parent Company’s vertical integration of supply and service chains providing support of its on demand web/mobile application development/maintenance, accounting, corporate governance, and real time customer support across the NWHB product line. This relationship results in significant time and cost efficiencies and fosters a mutually beneficial parent/subsidiary relationship.

 

As the NWHB subsidiary grows, the Company will help NWHB develop its own managerial control group at such time as the subsidiary can afford an incremental building of a dedicated management team.

 

MARKETING AND SALES

 

Our marketing starts with product development. We create compelling products that: (i) in the case of iMobile Solutions, Inc. and iMobileApp, provide a variety of small to mid-sized businesses with a state-of-the-art website and mobile application solutions, and (ii) in the case of our four vehicle history report products, provide historical title information that assists consumers in purchase decision-making and dealers, auction houses, or other entities in making a sale or evaluating a vehicle.

 

iMobile Solutions, Inc. (iMS)

 

The primary marketing objective for iMS is to continue penetrating new business verticals and to be the leader is mobile app development for growing businesses. While an iMobileApp can benefit any business, the Company identifies and focuses marketing efforts on specific verticals, currently comprised of vehicle dealers, country clubs, racetracks, restaurants, etc., to build a presence in certain industries and become the “go-to” mobile app developer for those markets. As we continue to target franchised vehicle dealers by type of product and manufacturer by specifically approaching each dealership in their dealer network to promote our iMS mobile application we are gaining market share of the vehicle dealer marketplace. By selling our mobile applications throughout one manufacturer’s dealer network, we benefit from “word of mouth” referrals while building a recognizable presence in that particular market. For example, a leading motorcycle manufacturer has over 1,400 authorized dealers worldwide. By penetrating this market, we significantly improve our credibility with their entire dealer network, resulting in the individual dealers being more receptive to our sales call, and making them more likely to purchase an iMobileApp and refer us to other dealers.

 

Additional marketing has been done through targeted advertising as well as news stories in relevant trade publications.

 

iMobileApp (iMA)

 

There are two primary areas of focus to continue gaining market share for iMA – digital marketing and targeted sales efforts.

 

The digital marketing strategy is predicated on the fact that the business mobile app marketplace is emerging and highly fragmented. In parallel, the web is not yet dominated by any one business mobile app competitor. Our strategy is to build a strong digital web presence that will help grow our business in the short term, and establish iMA as the market leader in web search as the industry consolidates. The cornerstone of our digital strategy is a state-of-the-art web management platform (see www.iMobileApp.com) that is highly search engine optimized (SEO) in structure and content. Page rank and traffic will increase over time as we support the website with traffic building efforts through blogging, social networking, ad-clicks, remarketing, and continual technical and content optimization. The goal is to have a leadership market share in organic and accidental search for businesses seeking mobile application solutions.

 

Traditional sales and marketing efforts will be employed against key categories that have an established high level of acceptance for mobile apps and/or in which iMA has already established market share. Efforts will include inside sales calls, email campaigns, category trade association marketing, and customer referrals.

 

9

 

 

Vehicle History Reports

 

The vehicle categories that we are targeting - motorcycles, recreational vehicles and commercial trucks – are not the focus of our largest competitors (CARFAX®, AutoCheck®). Distribution in the vehicle history reports industry is web-based, and digital competition in our targeted categories is relatively weak and fragmented. Our digital strategy is to become the leading search result for consumers seeking information on used powersports vehicles RV’s, and heavy-duty trucks. We employ an advanced web management platform that is highly search engine optimized (SEO). Page rank and traffic will increase over time as we support the website with traffic building efforts through blogging, social networking, ad-clicks, remarketing, and continual technical and content optimization.

 

An equally important digital strategy is our affiliate and cross-marketing programs. By working with leading companies that serve this category – like AutoTrader®, National Powersports Distributors, Kelley Blue Book®, and AllState® Insurance – we are able to cross-promote our powersports and RV history reporting products on their websites. Consumers who are on affiliate or marketing partner sites can become aware of our reporting services and click through to our websites. If a purchase is completed, the referring affiliate receives a commission on the sale or in some cases may extend a discount to their customers.

 

In December 2010, Powersports Business chose Cyclechex as one of their “Nifty 50” winners, recognizing it as one of the top 50 new powersports products introduced during the year.

 

SRI has considerable opportunity to increase brand awareness and grow traffic through product development, targeted marketing programs and strategic partnerships.

 

Municipal and Non-Profit Leasing

 

In 2011, the Company launched a website (www.spartamunicipal.com) exclusively dedicated to the Company’s municipal business line that began in 2007. With this site, agency heads, police and fire department chiefs, dealerships, and other municipal financing decision makers as well as non-profits have direct online access to information about the Municipal Lease Program, including how it benefits governmental agency economic interests, and specifics about terms and options. Marketing efforts, when budgets allow, include attending tradeshows, advertising in industry publication, direct mail/email campaigns, and indirect marketing such as referrals by prior municipal customers or dealerships. Sparta’s municipal program is also included in the corporate sites of Harley-Davidson© and BMW Motorrad USA Police Motors for government fleet leasing which results in direct inquiries from municipalities.

 

New World Health Brands CBD

 

Our initial marketing strategy has been a direct-to-consumer online sales approach via our website www.newworldhealthcbd.com within the United States, by using e-commerce to reach consumers to introduce and guide them through the CBD buying process. Starting with a solid foundation of content and robust product offerings, our marketing strategy will continue to be supplemented with social media exposure, (Facebook and Instagram) and ultimately retail distribution as the strategy evolves. At present, NWHB has developed preliminary distribution within the New York City metro area within independent pharmacies, medical supply stores, smoke shops, spas, and independent retail food stores. Using data collection and customer analysis from e-commerce sales will continue to be a significant component of NWHB’s marketing strategy. Direct-to-consumer e-commerce sales give an unprecedented opportunity to gain significant insight into how to better support the customer based on data, including buying habits, purchase frequency, and in many cases, how the product is being used, whether it be general wellness, health conditions, etc. By building customer trust with a focus on premium, quality products and live customer service, we expect to build a well-recognized brand. Through our own social media and blogging platforms, management expects New World Health Brands will continue to grow CBD organic sales and revenue by promoting our products as trusted brands for consumers who desire premium CBD products.

 

Sales and Customer Support

 

An internal team is responsible for closing sales on leads generated from web inquires, email responses, inside sales calls and customer referrals. A future sales team will target businesses, trade associations, national chains, manufacturers, vehicle dealers and vehicle auction houses.

 

Customer service is based in our New York City office.

 

10

 

 

Competition

 

While there are numerous entities offering customized mobile apps, we believe that iMobileApp is a leading pre-packaged customizable mobile app for small to medium sized business, such as restaurants, country clubs, social clubs, racetracks, grocery stores, agriculture dealers, vehicle dealers, and more, at a price point significantly below other vendors of customized apps for the vehicle dealer industry.

 

Because of our strong commitment to customer service and our compelling product, we believe that our iMobileApp product can be effectively and competitively marketed.

 

The two major providers of used automobile history reports, CARFAX® and AutoCheck® do not provide motorcycle, recreational vehicle or heavy duty truck history reports. In fact, CARFAX® states on their website FAQ’s that their database contains records primarily of cars and light trucks and “for heavy trucks, RVs, or motorcycles, CARFAX® recommends checking with your DMV, enthusiast forums, and of course a pre-purchase vehicle inspection.” AutoCheck® states on its web site “AutoCheck® only reports on information for cars and light trucks.” We have not identified direct competition of the RV space and do not intend to compete directly with either CarFax® or AutoCheck®.

 

Competition within the CBD-based hemp products industry is very fragmented and highly competitive. The competition is comprised of publically and privately-owned companies and tend to be diverse in terms of geographic market coverage and variety of product mix offered. The “CBD industry” includes tinctures, capsules and tablets, topicals, patches, edibles, vapes, smokables and drinkables all based on pure CBD, defined as containing less than 0.3% THC; blended CBD and THC. NWHB is focused on marketing only hemp-based CBD products. To our knowledge there are only four public companies selling only CBD products. Because of this fragmented market where there is not one sole widely recognized brand, we believe that by focusing on high quality, gluten free, non-GMO, pure CBD products using targeted brand marketing programs we can make New World Health Brands initially a regionally recognized brand and then, potentially, a nationally recognized brand.

 

Employees

 

As of April 30, 2022, we had 6 full-time employees, 1 part-time employee, and 5 interns.

 

ITEM 1A. RISK FACTORS

 

The Company’s forward-looking statements are subject to uncertainties and risks, among them the adverse effects of the COVID-19 pandemic. The Company’s operations — from supply chain and distribution – are impacted by government regulations and legislation, the economic landscape, revenue fluctuations, diminished customer base, competing products, regulatory changes, common share price volatility, availability of capital, successful integration of new businesses, and including but not limited to risks and uncertainties discussed under the heading “Risk Factors” in this MD&A and the Company’s other filings with the SEC. The impact of any risk, uncertainty or factor on a particular forward-looking statement is not determinable with certainty as these are interdependent, and the Company’s future course of action depends on Management’s assessment of all relevant information available at the time. Except to the extent required by law, the Company assumes no obligation to publicly update or revise any forward-looking statements made in this MD&A, whether as a result of new information, future events or otherwise. All subsequent forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company’s behalf, are expressly qualified in their entirety by these cautionary statements.

 

We are subject to certain risks and uncertainties in our business operations that are described below. The risks and uncertainties described below are not the only risks we face. Additional risks and uncertainties not presently known or that are currently deemed immaterial may also impair our business operations.

 

Risks Related To Our Financial Condition

 

We have a history of operating losses.

 

Through our fiscal year ended April 30, 2022, we have incurred significant expenses and have sustained significant losses. We have an accumulated deficit of $71,661,656 at April 30, 2022 and a negative working capital of $17,024,467.

 

11

 

 

Our business requires additional amounts of capital, and we will need to obtain additional financing in the near future.

 

To expand our business, we need raise additional capital to support our operations until we become cash flow positive. We will have to raise approximately $1 million over the next twelve months to support our business. As our business grows, we will need to seek additional financing to fund growth. There can be no assurance that we will have sufficient capital or be able to secure credit facilities when needed. The failure to obtain additional funds, when required, on satisfactory terms and conditions, would have a material and adverse effect on our business, operating results, and financial condition, and ultimately could result in the cessation of our business.

 

To the extent that we raise additional capital by issuing equity securities, our stockholders may experience substantial dilution. In addition, any new equity securities may have greater rights, preferences or privileges than our existing common stock. A material shortage of capital will require us to take drastic steps such as reducing our level of operations, disposing of selected assets or seeking an acquisition partner. If cash is insufficient, we will not be able to continue operations.

 

We have a significant amount of debt which could impact our ability to continue to implement our business plan.

 

We have incurred total liabilities of $17,287,217 as of April 30, 2022. Unless we can restructure some or all this outstanding debt, and raise sufficient capital to fund our continued development, we will be unable to pay these obligations as our current operations do not generate significant revenue.

 

Our auditor’s opinion expresses doubt about our ability to continue as a “going concern”.

 

The independent auditor’s report on our April 30, 2022, and April 30, 2021 consolidated financial statements state that our historical losses raise substantial doubts about our ability to continue as a going concern. We cannot assure you that we will be able to generate revenues or maintain any line of business that might prove to be profitable. Our ability to continue as a going concern is subject to our ability to generate a profit or obtain necessary funding from outside sources, including obtaining additional funding from the sale of our securities, increasing sales, or obtaining credit lines or loans from various financial institutions where possible. If we are unable to develop our business, we may have to discontinue operations or cease to exist, which would be detrimental to the value of our common stock. We can make no assurances that our business operations will develop and provide us with significant cash to continue operations.

 

Risks Related to the Company

 

We are a small company in the information technology business.

 

We are a relatively new entrant into the businesses of providing vehicle history reports and building mobile apps. We indirectly compete with major, well capitalized, suppliers of automobile history reports. While these companies do not presently offer motorcycle or RV history reports, there is no guaranty they will not do so in the future. Many small “players” characterize the mobile app development business. While we believe we are better suited to build, service, and market mobile apps than our competitors, there is no assurance that we can continue to do so.

 

We will require additional capital to implement our business plan and marketing strategies which we may be unable to secure.

 

Under our business plan, we intend to build and expand our operations substantially over the next several years. Our cash on hand is insufficient for our operational needs. We therefore need additional financing for working capital purposes and to grow our business. There is no assurance that additional financing will be available on acceptable terms, or at all. If we fail to obtain additional financing as needed, we may be required to reduce or halt our anticipated expansion plans and our business and results of operations could be materially, adversely affected. There can be no assurance that additional financing will be available on terms deemed to be acceptable by us, and in our stockholders’ interests.

 

12

 

 

We face security risks related to our electronic processing of sensitive and confidential customer and associate data.

 

Given the nature of our business, we and/or our service providers collect process and retain sensitive and confidential customer data, including credit card information. Despite our current security measures, our facilities and systems, and those of our third-party service providers, may be vulnerable to information security breaches, acts of vandalism, computer viruses or other similar attacks. An information security breach involving the disclosure of confidential data could damage our reputation and our customers’ willingness to shop on our websites, and subject us to possible legal liability. In addition, we may incur material remediation costs as a result of an information security breach, including liability for stolen customer or associate data, repairing system damage or providing credit monitoring or other benefits to customers or associates affected by the breach.

 

We could be harmed by data loss or other security breaches

 

As a result of our services being web-based and the fact that we process and/or our service providers, store and transmit large amounts of data, including personal information, for our customers, failure to prevent or mitigate data loss or other security breaches, including breaches of our vendors’ technology and systems, could expose us or our customers to a risk of loss or misuse of such information, adversely affect our operating results, result in litigation or potential liability for us and otherwise harm our business. We use third party technology and systems for a variety of reasons, including, without limitation, encryption and authentication technology, employee email, content delivery to customers, back-office support and other functions. Although we and our service providers have developed systems and processes that are designed to protect customer information and prevent data loss and other security breaches, such measures cannot provide absolute security.

 

A variety of factors and economic forces may affect our operating results.

 

Our operating results may differ from current forecasts and projections significantly in the future because of a variety of factors, many of which are outside our control. These factors include, without limitation, the receipt of revenues, which is difficult to forecast accurately, the amount and timing of capital expenditures and other costs relating to the expansion of our operations, the introduction of new products or services by us or our competitors, borrowing costs, pricing changes in the industry, technical difficulties, general economic conditions, and economic conditions specific to our marketplace. The success of an investment in a vehicle history report and mobile app-based venture is dependent, at least, in part, on extrinsic economic forces, including the supply of and demand for such services. No assurance can be given that we will be able to generate sufficient revenue to cover our cost of doing business. Furthermore, our revenues and results of operations will be subject to fluctuations based upon general economic conditions. Economic factors like unemployment, interest rates, and the availability of credit generally, municipal government and corporate budget constraints affecting equipment and technology purchases, the rate of inflation, and consumer perceptions of the economy may affect the volume of history report purchases.

 

We are dependent on our management and the loss of any officer could hinder our implementation of our business plan.

 

We are heavily dependent upon management, the loss of any one of whom could have a material adverse effect on our ability to implement our business plan. While we have entered into an employment agreement with our Chief Executive Officer, this employment agreement could be terminated for a variety of reasons. We do not presently carry key man insurance on the life of any employee. If, for some reason, the services of management, or of any member of management, were no longer available to us, our operations and proposed businesses and endeavors may be materially adversely affected. Any failure of management to implement and manage our business strategy may have a material adverse effect on us. There can be no assurance that our operating and financial control systems will be adequate to support our future operations. Furthermore, the inability to continue to upgrade the operating and financial control systems, the inability to recruit and hire necessary personnel or the emergence of unexpected expansion difficulties could have a material adverse effect on our business, financial condition or results of operations.

 

13

 

 

Our business is dependent on intellectual property rights and we may not be able to protect such rights successfully.

 

Our intellectual property, including our license agreements and other agreements, which establish our rights to proprietary intellectual property, our Cyclechex, RVchex, and Truckchex vehicle history reports and our SMA and iMA mobile apps are of great value to our business operations. Infringement or misappropriation of our intellectual property could materially harm our business. We rely on a combination of trade secret, copyright, trademark, and other proprietary rights laws to protect our rights to this valuable intellectual property. Third parties may try to challenge our intellectual property rights. In addition, our business is subject to the risk of third parties infringing or circumventing our intellectual property rights. We may need to resort to litigation in the future to protect our intellectual property rights, which could result in substantial costs and diversion of resources. Our failure to protect our intellectual property rights could have a material adverse effect on our business and competitive position.

 

COVID-19.

 

In December 2019, a novel coronavirus disease (“COVID-19”) was reported and in January 2020, the World Health Organization (“WHO”) declared it a Public Health Emergency of International Concern. On February 28, 2020, the WHO raised its assessment of the COVID-19 threat from high to very high at a global level due to the continued increase in the number of cases and affected countries, and on March 11, 2020, the WHO characterized COVID-19 as a pandemic.

 

COVID-19 has impacted some of our customers. Our business, results and financial condition will depend on current and future developments, which are highly uncertain and cannot be predicted at this time. While the Company’s day-to-day operations beginning March 2020 have been impacted, we have suffered less immediate impact as most staff can work remotely and can work remotely and can continue to develop our product offerings. Notwithstanding, revenues relating to mobile applications in certain verticals such as dealerships and racetracks fell and resulted in forebearance or cancellations during the pandemic.

 

Risks Related to our Subsidiary, New World Health Brands, Inc. (NWHB)

 

NWHB has limited operating history.

 

NWHB is still in an early phase and is just beginning to implement its business plan. There can be no assurance that it will ever operate profitably. The likelihood of its success should be considered in light of the problems, expenses, difficulties, complications and delays usually encountered by companies in their early stages of development, with low barriers to entry. NWHB may not be successful in attaining the objectives necessary for it to overcome these risks and uncertainties.

 

We need to raise additional capital to meet our future business requirements and such capital raising may be costly or difficult to obtain and could dilute current stockholders’ ownership interests.

 

At this time, we have not secured or identified any additional financing to support NWHB. We do not have any firm commitments or other identified sources of additional capital from third parties or from our officers and directors or from other shareholders. There can be no assurance that additional capital will be available to us, or that, if available, it will be on terms satisfactory to us. Any additional financing will involve dilution to our existing shareholders. If we do not obtain additional capital on terms satisfactory to us, or at all, it may cause us to delay, curtail, scale back or forgo some or all of our business operations, which could have a material adverse effect on our business and financial results and investors would be at risk to lose all or a part of any investment in our Company.

 

Our future success will depend on our ability to increase revenues.

 

NWHB is in a highly fragmented market for the delivery CBD based products and faces numerous risks and uncertainties in achieving sustainable revenues and positive cash flow. We launched our website, located at www.newworldhealthcbd.com, in November 2018. We have engaged in identifying reliable sources of quality inventory, package design, launched a business to consumer website, implemented affiliate software, and designed brochures and other such marketing materials to enable us to carry out our business plan. These expenditures have resulted in operating losses. In order to be successful, we must increase our revenues from the sale of our products to individuals and marketing affiliates. In order to increase our revenues, we must successfully:

 

14

 

 

  create and implement a marketing plan to attract individuals and retailers to our CBD products;
  increase traffic to our website by developing relationships with popular websites;
  convert online visitors to clients;
  attract, retain, and motivate qualified personnel with marketing and product development experience to serve in various capacities, including sales and marketing positions;
  respond effectively to competitive pressures from other providers of CBD products;

 

If we are not successful in the execution of these strategies, our business, results of operations and financial condition will be materially adversely affected.

 

NWHB has losses which we expect to continue and there is no assurance our future operations will result in profitable revenues. If we cannot generate sufficient revenues to operate profitably or are unable to raise additional funds, we may consider a merger, acquisition, joint venture, strategic alliance, a roll-up, or other business combination to increase business.

 

We face intense competition from within the hemp-based CBD industry.

 

NWHB competes with many providers of hemp-based CBD products because our market poses no substantial barriers to entry. We expect this competition to continue to intensify. The types of companies with which we compete include:

 

  fully integrated companies such as Aphria Inc., Charlotte’s Web™ and Curaleaf Holdings Inc.; and
  start-up companies entering the market

 

Our future success will depend on our ability to increase and enhance our market position by: (1) maintaining the quality of our product offerings, (2) developing new products, (3) keeping our pricing models on par with those of our competitors, (4) increasing our online visibility, and (5) developing a nationally recognized and respected brand.

 

Many of our existing competitors, as well as several potential competitors, may have longer operating histories, greater name recognition, larger customer bases and significantly greater financial, technical, and marketing resources than we do. This may enable them to respond more quickly to new or emerging consumer demands, or to devote greater resources to the development, promotion, and sale of their products than we can. These competitors and potential competitors may be able to undertake more extensive marketing campaigns, adopt more aggressive pricing policies and make more attractive offers to potential employees. In addition, current and prospective competitors may establish cooperative relationships among themselves or with third parties to improve their ability to address the needs of our existing and prospective customers. If these events occur, they could have a materially adverse effect on our revenue. Increased competition could also result in price reductions, reduced margins or loss of market share, any of which would adversely affect our business, results of operations and financial condition. See “Description of Business” and “Competition.”

 

We also believe our ability to compete depends on several factors outside of our control, including:

 

  the prices at which others offer competitive products, including aggressive price competition and discounting;
  the ability of our competitors to undertake more extensive marketing campaigns than we can; and
  the extent of our competitors’ responsiveness to customer needs.

 

In order to be competitive, we must have the ability to respond promptly and efficiently to the ever-changing marketplace. We must establish our name as a reliable and constant source of the highest quality products.

 

15

 

 

We may not be successful in increasing our brand awareness which would adversely affect our business, result of operations, and financial condition.

 

Our future success will depend, in part, on our ability to increase the brand awareness of our website and the products we offer. If our marketing efforts are unsuccessful or if we cannot increase our brand awareness, our business, financial condition, and results of operations would be materially adversely affected. In order to build our brand awareness, we must succeed in our marketing efforts, provide high quality products and increase traffic to our website.

 

We may not be able to successfully manage our growth.

 

For NWHB to succeed, it needs to experience significant expansion. There can be no assurance that it will achieve this expansion. This expansion, if accomplished, may place a significant strain on the Company’s management, operational and financial resources. To manage any material growth, the Company will be required to implement operational and financial systems, procedures and controls. It also will be required to expand its finance, administrative and operations staff. There can be no assurance that the Company’s current and planned personnel, systems, procedures and controls will be adequate to support its future operations at any increased level. The Company’s failure to manage growth effectively could have a material adverse effect on its business, results of operations and financial condition.

 

If we do not successfully establish and maintain our brand as highly trusted and respected or are unable to attract and retain clients, we could sustain loss of revenues, which could significantly affect our business, financial condition, and results of operations.

 

In order to attract and retain a client base and increase business, we must establish, maintain and strengthen our name and the products we provide. In order to be successful in establishing our reputation, clients must perceive us as a trusted source for quality products and customer service. If we are unable to attract and retain clients with our current marketing plans, we may not be able to successfully establish our name and reputation, which could significantly affect our business, financial condition and results of operations.

 

Uninsured Losses

 

NWHB may obtain comprehensive insurance, including liability, fire and extended coverage, as is customarily obtained by business entities. Certain types of losses of a catastrophic nature, however, such as losses from floods, tornados, thunderstorms, hurricanes and earthquakes, are uninsurable or not economically insurable to the full extent of potential loss. Other uninsurable events such as “Acts of God”, work stoppages, pandemics, regulatory actions, or other causes, could interrupt operations and adversely affect NWHB’s results of operations.

 

RISKS RELATED TO OUR INDUSTRY

 

We are dependent on third party merchant credit card processors.

 

Our future success will depend, in significant part, upon third party credit card processing firms. Loss of our merchant services credit card processing firm and the inability to rapidly replace that firm could have a substantial negative effect on our business.

 

We are dependent on the Internet infrastructure.

 

Our future success will depend, in significant part, upon the maintenance of the various components of the Internet infrastructure, such as a reliable backbone network with the necessary speed, data capacity and security, and the timely development of enabling products, such as high-speed modems, which provide reliable and timely Internet access and services. To the extent that the Internet continues to experience increased numbers of users, frequency of use or increased user bandwidth requirements, we cannot be sure that the Internet infrastructure will continue to be able to support the demands placed on it or that the performance or reliability of the Internet will not be adversely affected. Furthermore, the Internet has experienced a variety of outages and other delays as a result of damage to portions of its infrastructure or otherwise, and such outages or delays could adversely affect our website and the websites of our co-branded partners, as well as the Internet service providers and online service providers our customers use to access our services. In addition, the Internet could lose its viability as a commercial medium due to delays in the development or adoption of new standards and protocols that can handle increased levels of activity. We cannot predict whether the infrastructure and complementary products and services necessary to maintain the Internet as a viable commercial medium will be developed or maintained. The threat of hacking is an ongoing one and to the best of our ability we will monitor our servers, maintain up-to-date anti-virus and anti-malware programs and keep our employees advised as to proper computer security.

 

16

 

 

Cannabis and hemp are subject to government regulation at the federal, state, and local level.

 

The passage of the 2018 farm bill or Agricultural Improvement Act of 2018 resulted in the removal of hemp (CBD) from Schedule 1 of the Controlled Substances Act, the most tightly restricted category reserved for drugs that have “no currently accepted medical use”. Marijuana (cannabis) remains a federally controlled substance. The farming of hemp is now legal, and CBD is readily obtainable in most parts of the United States. As of February 3, 2022, 37 states, three territories, and Washington, DC have passed Legal Medical Marijuana Laws and as of May 27, 2022, 19 states, two territories, and Washington DC have passed Legal Recreational Marijuana Laws. In December 2015, the FDA eased the regulatory requirements to allow researchers to conduct CBD trials. While the trend toward continued legalization of industrial hemp-based CBD products is favorable, there is no guarantee that this trend will continue.

 

Risks Related to Investment in our Company

 

The market for our common stock could be volatile and could decline when you want to sell your holdings.

 

Our common stock trades on the OTC Pink under the symbol SRCO. Numerous factors, many of which are beyond our control, may cause the market price of our common stock to fluctuate significantly. These factors include but are not limited to: (i) actual or anticipated changes in our earnings, fluctuations in our operating results or our failure to meet the expectations of financial market analysts and investor; (ii) changes in financial estimates by us or by any securities analysts who might cover our stock; (iii) speculation about our business in the press or the investment community; (iv) stock market price and volume fluctuations of other publicly traded companies and, in particular, those that are in our industry; (v) our potential inability to pay back outstanding notes or debentures, or contractual obligations related to the cancellation thereof; (vi) investor perceptions of our respective industries in general and our Company in particular; (vii) the operating and stock performance of comparable companies; (viii) general economic conditions and trends; (ix) major catastrophic events; (x) announcements by us or our competitors of new products, significant acquisitions, strategic partnerships or divestitures; (xi) changes in accounting standards, policies, guidance, interpretation or principles; (xii) sales of our common stock, including sales by our directors, officers or significant stockholders; and (xiii) additions or departures of key personnel.

 

Moreover, securities markets may from time-to-time experience significant price and volume fluctuations for reasons unrelated to operating performance of particular companies. These market fluctuations may adversely affect the price of our common stock and other interests in our Company at a time when you want to sell your interest in us.

 

Our common stock will be subject to the “penny stock” rules of the SEC, which may make it more difficult for stockholders to sell our common stock.

 

The Securities and Exchange Commission has adopted Rule 15g-9 which establishes the definition of a “penny stock,” for the purposes relevant to us, as any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain exceptions. For any transaction involving a penny stock, unless exempt, the rules require (i) that a broker or dealer approve a person’s account for transactions in penny stocks; and (ii) the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.

 

In order to approve a person’s account for transactions in penny stocks, the broker or dealer must (i) obtain financial information and investment experience objectives of the person; and (ii) make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.

 

17

 

 

The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the Commission relating to the penny stock market, which, in highlight form (i) sets forth the basis on which the broker or dealer made the suitability determination; and (ii) that the broker or dealer received a signed, written agreement from the investor prior to the transaction.

 

Disclosure also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.

 

The regulations applicable to penny stocks may severely affect the market liquidity for our common stock and could limit an investor’s ability to sell our common stock in the secondary market.

 

We are subject to variable conversion prices and adjustments related to certain of our convertible notes and our common stock purchase warrants which could cause significant dilution to stockholders and adversely impact the price of our common stock.

 

Certain of our securities are subject to variable conversion prices and adjustments. As a result, future conversion of debt into shares of common stock or issuance of new convertible debt may result in significant dilution to our shareholders. There were approximately 42 million potential shares at April 30, 2022. The number of potential shares will likely vary based on fluctuations in the trading price of our stock. We are negotiating potential settlements of debt to reduce the number of potential shares. (SEE ITEM # 3 LEGAL PROCEEDINGS).

 

Failure to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business and operating results and stockholders could lose confidence in our financial reporting.

 

Effective internal controls are necessary for us to provide reliable financial reports and effectively prevent fraud. If we cannot provide reliable financial reports or prevent fraud, our operating results could be harmed. Failure to achieve and maintain an effective internal control environment, regardless of whether we are required to maintain such controls, could also cause investors to lose confidence in our reported financial information, which could have a material adverse effect on our stock price. Because of our limited resources, management has concluded that our internal control over financial reporting may not be effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Furthermore, we have not obtained an independent audit of our internal controls and, as a result, we are not aware of any deficiencies which would result from such an audit. Further, at such time as we are required to comply with the internal controls’ requirements of the Sarbanes-Oxley Act, we may incur significant expenses in having our internal controls audited and in implementing any changes which are required.

 

We have not paid dividends on our common stock in the past and do not expect to pay dividends on our common stock for the foreseeable future. Any return on investment may be limited to the value of our common stock.

 

No cash dividends have been paid on our common stock. We expect that any income received from operations will be devoted to our future operations and growth. We do not expect to pay cash dividends on our common stock in the near future. Payment of dividends would depend upon our profitability at the time, cash available for those dividends, and other factors as our board of directors may consider relevant. If we do not pay dividends, our common stock may be less valuable because a return on an investor’s investment will only occur if our stock price appreciates.

 

18

 

 

The requirements of being a public company may strain our resources, divert management’s attention and affect our ability to attract and retain qualified board members.

 

We are a public company and are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, and the Sarbanes-Oxley Act. The Exchange Act requires, among other things, that we file annual, quarterly and current reports with respect to our business and financial condition. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal controls for financial reporting. For example, Section 404 of the Sarbanes-Oxley Act of 2002 requires that our management report on, and our independent auditors attest to, the effectiveness of our internal controls structure and procedures for financial reporting. Section 404 compliance may divert internal resources and will take a significant amount of time and effort to complete. We may not be able to successfully complete the procedures and certification and attestation requirements of Section 404 by the time we will be required to do so. If we fail to do so, or if in the future our Chief Executive Officer, Chief Financial Officer or independent registered public accounting firm determines that our internal controls over financial reporting are not effective as defined under Section 404, we could be subject to sanctions or investigations by the SEC or other regulatory authorities. Furthermore, investor perceptions of our Company may suffer, and this could cause a decline in the market price of our common stock. Irrespective of compliance with Section 404, any failure of our internal controls could have a material adverse effect on our stated results of operations and harm our reputation. If we are unable to implement these changes effectively or efficiently, it could harm our operations, financial reporting or financial results and could result in an adverse opinion on internal controls from our independent auditors. We may need to hire a number of additional employees with public accounting and disclosure experience in order to meet our ongoing obligations as a public company, which will increase costs. Our management team and other personnel will need to devote a substantial amount of time to new compliance initiatives and to meeting the obligations that are associated with being a public company, which may divert attention from other business concerns, which could have a material adverse effect on our business, financial condition and results of operations.

 

Future sales of our equity securities could result in downward selling pressure on our securities, and may adversely affect the stock price.

 

In the event that our equity securities are sold or convertible debt is converted into equity securities, there is a risk of downward pressure may result, making it difficult for an investor to sell his or her securities at any reasonable price, if at all. Future sales of substantial amounts of our equity securities in the public market, or the perception that such sales could occur, could put downward selling pressure on our securities, and adversely affect the market price of our common stock.

 

We have authorized a class of preferred stock that may alter the rights of common stockholders by giving preferred stockholders greater dividend rights, liquidation rights and voting rights than our common stockholders have.

 

Our board is empowered to issue, without stockholder approval, preferred stock, on one or more series, with dividend, liquidation, conversion, voting or other rights that could adversely affect the voting power or other rights of the holders of common stock. From time to time, we have designated, and may in the future designate, series of preferred stock carrying various preferences and rights different from, and greater than, our common stock. As of April 30, 2022, we have three series of preferred stock outstanding. Preferred stock could be utilized, under certain circumstances, as a method of discouraging, delaying or preventing a change in control of the Company.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

Not applicable.

 

ITEM 2. PROPERTIES

 

Our executive offices are located at 555 Fifth Avenue, 14th Floor, New York, NY 10017. We had an agreement for use of office space at this location under a sub-lease which expired July 31, 2018 and continues on a month-to-month basis thereafter. For the year ending April 30, 2022 and 2021, the rent was $59,400 and $70,200 respectively.

 

ITEM 3. LEGAL PROCEEDINGS

 

As of April 30, 2022, we have not been named as parties to any further legal proceedings except as those disclosed prior and as updated below. From time to time, of course, we may become involved in further legal proceedings, which sometimes arise due to the very nature of and in the ordinary course of this business.

 

By way of background, the Company had received notices dated April 1, 2016, May 13, 2016 and July 22, 2016 from two lenders claiming defaults relating to conversion requests of $8,365.00 in principal plus interest, attorney fees and $5,000.00 in principal plus interest also seeking stock conversions aside from the stated principal and interest with regard to notes in the total amounts of $55,125.00 and $27,500.00, respectively, which the Company has declined to process and believes it has valid, meritorious defenses in that regard. The Company believes these claims are contingent, unliquidated and disputes same. While there can be no assurances that the Company would prevail in any potential litigation with regard to claims brought against the Company, these potential liabilities have been recorded in the unaudited condensed consolidated financial statements.

 

19

 

 

With respect to the above claims, on September 22, 2016, a motion for summary judgment in lieu of complaint was filed in the Supreme Court in the State of New York: County of Kings, against the Company by a lender for the amount of $102,170.82 in principal and stock conversion interest, plus fees and costs. The Plaintiff’s motion for summary judgment in lieu of complaint was denied on May 5, 2017. On August 22, 2018, Plaintiff thereafter brought a second motion seeking summary judgment on the issue of liability which was, again, denied by the Court on March 14, 2019. The most recent appearance in this matter had been scheduled for March 13, 2020, at which time, the Court marked the case “adjourned without a date”, due to the restrictions imposed on the Courts arising from the COVID-19 pandemic. No further Court appearances have been scheduled, to date, in this matter. However, most notably, a favorable decision from the New York State Court of Appeals regarding the very same types of transactions have since been determined to be criminally usurious and, therefore, unenforceable. These were the very same defenses raised on behalf of the Company.

 

On October 26, 2018, a second lender commenced an action in the Supreme Court of the State of New York: New York County alleging damages from unpaid principal arising from a promissory note dated February 26, 2015 in the amount of $50,000.00 plus damages including interest and stock conversions, costs and fees. There are cross dispositive motions pending which are scheduled to be heard in September, 2022. The Company disputes the enforceability of such claims for the similar reasons, as stated above, based on the Court of Appeals ruling as to the unenforceable nature of such claims demanding usurious interest rates.

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Market Information (Check dates and numbers in table below)

 

Our common stock is currently quoted on the OTC Bulletin Board under the symbol “SRCO”. The following table sets forth, for the calendar periods indicated, the range of the high and low closing prices of our common stock, as reported by the OTCBB. The quotations represent inter-dealer prices without retail mark-ups, mark-downs or commissions, and may not necessarily represent actual transactions.

 

   High   Low 
Fiscal Year 2022          
First quarter (May 1, 2021 – July 31, 2021)  $0.2   $0.07 
Second quarter (August 1, 2021 – October 31, 2021)  $0.11   $0.0548 
Third quarter (November 1, 2021 – January 31, 2022)  $0.28   $0.0418 
Fourth quarter (February 1, 2022 – April 30, 2022)  $0.28   $0.0811 
Fiscal Year 2021          
First quarter (May 1, 2020 – July 31, 2020)  $0.6   $0.11 
Second quarter (August 1, 2020 – October 31, 2020)  $0.43   $0.23 
Third quarter (November 1, 2020 – January 31, 2021)  $0.42   $0.0966 
Fourth quarter (February 1, 2021 – April 30, 2021)  $0.1   $0.049 

 

Holders

 

The approximate number of holders of record of our common stock as of April 30, 2022 was 3,082 excluding stockholders holding common stock under nominee security position listings.

 

20

 

 

Dividends

 

We have never declared any cash dividends on our common stock. Future cash dividends on the common stock, if any, will be at the discretion of our Board of Directors and will depend on our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions, including any restrictions pursuant to the terms of senior securities outstanding, and other factors that the Board of Directors may consider important. The Board of Directors does not intend to declare or pay cash dividends in the foreseeable future. It is the current policy to retain all earnings, if any, to support future growth and expansion.

 

As of April 30, 2022, we had outstanding 125 shares of Series A Convertible Preferred Stock, $.001 par value. The Series A shares pay a 6% annual dividend that may be paid in cash or shares of common stock at our option. As of April 30, 2022, we have not distributed any dividends on the Series A shares, in cash or in shares of common stock. Upon conversion of the Series A shares, all accrued and unpaid dividends are extinguished. As of April 30, 2022, there was $11,574 of accrued Series A dividends payable.

 

As of April 30, 2022, and April 30, 2021, we had no shares of Series B preferred stock outstanding or dividends payable.

 

As of April 30, 2022, and April 30, 2021, we had 2,163,000, and 4,132,269 shares of Series C convertible preferred stock outstanding, respectively. The Series C convertible preferred stock is non dividend paying.

 

As of April 30, 2022, and April 30, 2021, we had 618,411 and 1,493,962 shares of Series D convertible preferred stock outstanding, respectively. The Series D convertible preferred stock is non dividend paying.

 

Recent Sales of Unregistered Securities

 

Each of the issuance and sale of securities described below was deemed to be exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended, as transactions by an issuer not involving a public offering. No advertising or general solicitation was employed in offering the securities. Each purchaser is a sophisticated investor (as described in Rule 506(b) (2) (ii) of Regulation D) or an accredited investor (as defined in Rule 501 of Regulation D), and each received adequate information about the Company or had access to such information, through employment or other relationships, to such information.

 

Issuance of common stock and restricted preferred units:

 

During year ended April 30, 2022, the Company:

 

Converted 1,010,703 shares of series C preferred stocks issued an aggregate of 3,305,860 shares of common stock valued at $506,078.The Company also converted 162,519 series D convertible preferred stock and issued an aggregate of 650,076 shares of common valued at $162,519.

 

Issued 355,000 common shares for commitment and default shares relating to promissory notes.

 

Sold to fourteen accredited investors 8,563,531 shares of common stock for cash or conversions of $644,968 and; actual shares were not issued yet and recorded as commons stocks to be issued.

 

Sold to three accredited investors 520,000 shares of Sparta Crypto, Inc,’s common stock for cash of $130,000; actual shares were not issued yet and recorded as common stocks to be issued.

 

ITEM 6. SELECTED FINANCIAL DATA

 

Not applicable.

 

21

 

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

“FORWARD-LOOKING” INFORMATION

 

This report on Form 10-K contains various statements that may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Rule 175 promulgated thereunder, Section 21E of the Securities Exchange Act of 1934, as amended, and Rule 3b-6 promulgated thereunder which represent our expectations and beliefs, including, but not limited to, statements concerning the Company’s business and financial plans and prospects and are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” and other similar expressions can, but not always, identify forward-looking statements, which speak only as of the date such statement was made. We base these forward-looking statements on our current expectations and projections about future events, our assumptions regarding these events and our knowledge of facts at the time the statements are made. These statements by their nature involve substantial risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors. Risks and uncertainties that could cause our financial performance to differ materially from our goals, plans, expectations and projections expressed in forward-looking statements include those set forth in our filings with the Securities and Exchange Commission (“SEC”), including Item 1A of the Company’s Annual Report of Form 10-K for the year ended April 30, 2022. Forward-looking statements speak only as of the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made or to reflect the occurrence of unanticipated events. You should consider any forward-looking statements in light of this explanation, and we caution you about relying on forward-looking statements.

 

The following discussion and analysis should be read in conjunction with the information set forth in the audited financial statements for the years ended April 30, 2022 and April 30, 2021 and footnotes found in the Company’s Annual Report on Form 10-K.

 

RESULTS OF OPERATIONS

 

For the year ended April 30, 2022, our revenues from continuing operations decreased approximately 5% as compared to the year ended April 30, 2021. We have continued to incur significant expenses and have sustained significant losses.

 

Revenues-Continuing Operations

 

Revenues totaled $245,469 in fiscal 2022 compared to revenues of $259,731 in fiscal 2021, primarily due to the COVID-19 pandemic and a simultaneous downturn in the nationwide economy, which affected the utilization and purchases of our mobile apps, history reports and CBD/Wellness products, as well as insufficient funds to support an adequate level of sales, marketing, and advertising. Our Information Technology revenues declined $26,271 or 11% from $245,675 in fiscal 2021 to $219,404 in the current fiscal year. NWHB revenues in the current fiscal year were $26,065 compared to $14,056 in the previous fiscal year. NWHB products revenues increase by 85%. This is primarily due to the COVID 19 impact in previous fiscal year which brought the revenue significantly less.

 

Net other expenses in fiscal 2022 was $7,721,368 compared with net other expenses of $1,094,584 in fiscal 2021. Net other expenses for the current fiscal year was primarily due to loss in changes in fair value of derivative liabilities.

 

Cost of Revenue

 

Cost of revenue consists of costs and fees paid to third parties to construct and maintain mobile apps, as well as fees for subscription services related to vehicle history reports.

 

22

 

 

Costs and Expenses-Continuing Operations

 

General and administrative expenses were $1,199,416 during the year ended April 30, 2022, compared to $1,394,881 during the year ended April 30, 2021, a decrease of $195,465, or 14% primarily due to overall decrease in expense due to non-cash expenses to management and consulting fees paid in year of $464,718 this was offset by the increase in Professional fees of $202,675, these are fees paid to consultants for strategic management and business developments. The Company also incurred $271,138 in research and development costs related to the development of SpartaPayIQ. The following are the major expense categories:

 

   2022   2021  

Increase

(Decrease)

   % 
Salaries and related Expenses   577,290    554,780    22,510    4.06%
Advertising and Marketing   27,888    14,266    13,622    95.49%
General office Expenses   147,462    140,251    7,211    5.14%
Legal and Professional Fees   330,265    127,590    202,675    158.85%
Taxes and Licenses   17,837    6,023    11,814    196.15%
SEC related Expenses   18,316    12,153    6,163    50.71%
Office Rent   59,400    70,200    (10,800)   -15.38%
Software Development Cost   20,958    -    20,958    -100.00%
Bad Debts   -    4,900    (4,900)   -100.00%
Non cash expenses        464,718    (464,718)   -100.00%
    1,199,416    1,394,881           

 

Other (income) expense

 

Other (income) expense in April 30,2022 is comprised primarily of finance cost $601,279 and loss on value of derivative liabilities $7,132,045 while in fiscal year 2021 comprises of finance cost of $723,003 and loss on value of derivative liabilities $504,599.

 

Net Loss

 

Our net loss attributable to common stockholders for the year ended April 30, 2022, increased by $6,687,778 to $8,991,437 from a loss of $2,303,659 for the year ended April 30, 2021. This increase in net loss for the year was primarily due to the increase other expenses as discussed above.

 

LIQUIDITY AND CAPITAL RESOURCES

 

As of April 30, 2022, we had an accumulated deficit of $73,984,687 and a total stockholders’ deficit of $20,734,865. We generated a deficit in cash flow from operations of $1,170,621 for the year ended April 30, 2022. This deficit results primarily from our net loss of $8,988,614, partially decreased by noncash loss from change in fair value of derivative liabilities of $7,132,042.

 

We met our cash requirements during the period through revenue of $245,469 and proceeds from the issuances of convertible and other notes of $302,381, and we sold common stock for proceeds of $890,000.

 

We do not anticipate incurring significant research and development expenditures, and we do not anticipate the sale or acquisition of any significant property, plant or equipment, during the next twelve months. At April 30, 2022, we had 6 full time employees, one part time employee, and 5 interns. If we fully implement our business plan, we anticipate our employment base may increase during the next twelve months. As we continue to expand, we will incur additional cost for personnel. This potential increase in personnel is dependent upon our generating increased revenues and obtaining sources of financing. There is no guarantee that we will be successful in raising the funds required or generating revenues sufficient to fund the potential increase in the number of employees. Our employees are not represented by a union.

 

While we have raised capital to meet our working capital and financing needs in the past, additional financing is required in order to meet our current and potential future cash flow deficits from operations.

 

We continue to seek additional financing, which may be in the form of senior debt, subordinated debt or equity. We currently have no commitments for financing that are not at the investor’s election. There is no guarantee that we will be successful in raising the funds required to support our operations.

 

We estimate that we will need approximately $1,000,000 in addition to our normal operating cash flow to conduct operations during the next twelve months. However, there can be no assurance that additional private or public financing, including debt or equity financing, will be available as needed, or, if available, on terms favorable to us. Any additional equity financing may be dilutive to stockholders and such additional equity securities may have rights, preferences or privileges that are senior to those of our existing common or preferred stock. Furthermore, debt financing, if available, will require payment of interest and may involve restrictive covenants that could impose limitations on our operating flexibility. However, if we are not successful in generating sufficient liquidity from operations or in raising sufficient capital resources, on terms acceptable to us, this could have a material adverse effect on our business, results of operations, liquidity and financial condition, and we will have to adjust our planned operations and development on a more limited scale.

 

23

 

 

The effect of inflation on our revenue and operating results was not significant. Our operations are located in North America and there are no seasonal aspects that would have a material effect on our financial condition or results of operations.

 

AUDITOR’S OPINION EXPRESSES DOUBT ABOUT THE COMPANY’S ABILITY TO CONTINUE AS A “GOING CONCERN”

 

The independent auditors report on our April 30, 2022 and 2021 financial statements included in the Company’s Annual Report states that the Company’s historical losses and the lack of revenues raise substantial doubts about the Company’s ability to continue as a going concern, due to the losses incurred and its lack of significant operations. If we are unable to develop our business, we have to discontinue operations or cease to exist, which would be detrimental to the value of the Company’s common stock. We can make no assurances that our business operations will develop and provide us with significant cash to continue operations.

 

In order to improve the Company’s liquidity, the Company’s management is actively pursuing additional financing through discussions with investment bankers, financial institutions and private investors. There can be no assurance the Company will be successful in its effort to secure additional financing.

 

We continue to experience net operating losses. Our ability to continue as a going concern is subject to our ability to develop profitable operations. We are devoting substantially all of our efforts to developing our business and raising capital. Our net operating losses increase the difficulty in meeting such goals and there can be no assurances that such methods will prove successful.

 

Product Research and Development

 

We do not anticipate incurring significant research and development expenditures during the next twelve months.

 

Acquisition or Disposition of Plant and Equipment

 

We do not anticipate the acquisition or sale of any significant property, plant or equipment during the next twelve months.

 

Number of Employees

 

From our inception through the period ended April 30, 2022, we have relied on the services of outside consultants for services and currently have six full-time employees, one part-time employee and five interns. In order for us to attract and retain quality personnel, we anticipate we will have to offer competitive salaries to future employees. If we fully implement our business plan, we anticipate our employment base may increase during the next twelve months. As we continue to expand, we will incur additional cost for personnel. This projected increase in personnel is dependent upon our generating revenues and obtaining sources of financing. There is no guarantee that we will be successful in raising the funds required or generating revenues sufficient to fund the projected increase in the number of employees.

 

Inflation

 

The impact of inflation on our costs and the ability to pass on cost increases to our customers over time is dependent upon market conditions. We are not aware of any inflationary pressures that have had any significant impact on our operations over the past year, and we do not anticipate that inflationary factors will have a significant impact on future operations.

 

24

 

 

CRITICAL ACCOUNTING POLICIES

 

The preparation of our financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and judgments that affect our reported assets, liabilities, revenues, and expenses, and the disclosure of contingent assets and liabilities. We base our estimates and judgments on historical experience and on various other assumptions, we believe to be reasonable under the circumstances. Future events, however, may differ markedly from our current expectations and assumptions. While there are a number of significant accounting policies affecting our financial statements, we believe the following critical accounting policy involves the most complex, difficult and subjective estimates and judgments.

 

Revenue Recognition

 

During the first quarter of 2018, the Company adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606), using the cumulative-effect method. The new standard requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The adoption did not have an impact in our consolidated financial statements, other than the enhancement of our disclosures related to our revenue-generating activities.

 

The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions.

 

Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable.

 

Information Technology:

 

The Company recognizes revenue when the following criteria have been met: persuasive evidence of an arrangement exists, no significant Company obligations remain, collection of the related receivable is reasonably assured, and the fees are fixed or determinable. The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions.

 

Revenues from mobile app products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery.

 

New World Health Brands:

 

Revenues from New World Health Brands products are generally recognized upon delivery.

 

Stock-Based Compensation

 

The Company adopted Financial Accounting Standards Board Accounting Standard Codification Topic 718 (“ASC 718-10”), which records compensation expense on a straight-line basis, generally over the explicit service period of three to five years.

 

ASC 718-10 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company’s Consolidated Statement of Operations. The Company is using the Black-Scholes option-pricing model as its method of valuation for share-based awards. The Company’s determination of fair value of share-based payment awards on the date of grant using an option-pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to the Company’s expected stock price volatility over the term of the awards, and certain other market variables such as the risk free interest rate.

 

25

 

 

Inventories

 

The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health Brands business.

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “Accounting for Derivative Instruments and Hedging Activities” (“ASC 815-40”).

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

 

Derivative Liabilities

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

For information regarding recent accounting pronouncements and their effect on the Company, see “Recent Accounting Pronouncements” in Note A of the Notes to Consolidated Financial Statements contained herein.

 

In March 2018, the FASB issued ASU 2018-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting” (“ASU 2018-09”). This ASU makes several modifications to Topic 718 related to the accounting for forfeitures, employer tax withholding on share-based compensation, and the financial statement presentation of excess tax benefits or deficiencies. ASU 2018-09 also clarifies the statement of cash flows presentation for certain components of share-based awards. The standard is effective for interim and annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company adopted this guidance on May 1, 2019 and it did not have an impact on the Company’s consolidated financial statements and related disclosures.

 

In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements - Going Concern (Topic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). This amendment prescribes that an entity should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. The amendments became effective for the Company’s annual and interim reporting periods beginning May 1, 2019. The Company will begin evaluating going concern disclosures based on this guidance upon adoption.

 

26

 

 

The FASB issued the following accounting standard updates related to Topic 606, Revenue Contracts with Customers:

 

ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”) in May 2014. ASU 2014-09 requires entities to recognize revenue through the application of a five-step model, which includes identification of the contract, identification of the performance obligations, determination of the transaction price, allocation of the transaction price to the performance obligations and recognition of revenue as the entity satisfies the performance obligations.
ASU No. 2018-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2018-08”) in March 2018. ASU 2018-08 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on principal versus agent considerations.
ASU No. 2018-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing (“ASU 2018-10”) in April 2018. ASU 2018-10 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas.
ASU No. 2018-11, Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2018 EITF Meeting (SEC Update) (“ASU 2018-11”) in May 2018. ASU 2018-11 rescinds SEC paragraphs pursuant to two SEC Staff Announcements at the March 3, 2018 EITF meeting. The SEC Staff is rescinding SEC Staff Observer comments that are codified in Topic 605 and Topic 932, effective upon adoption of Topic 606.
ASU No. 2018-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients in May 2018. ASU 2018-12 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on a few narrow areas and adds some practical expedients to the guidance.

 

These ASUs became effective for the Company beginning interim period beginning May 1, 2018. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (Topic 842) “Leases.” Topic 842 supersedes the lease requirements in Accounting Standards Codification (ASC) Topic 840, “Leases.” Under Topic 842, lessees are required to recognize assets and liabilities on the balance sheet for most leases and provide enhanced disclosures. Leases will continue to be classified as either finance or operating. The Company adopted Topic 842 effective May 1, 2019 using a modified retrospective method and elected not to recognize leases with terms of 12 months or less. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

Off-Balance Sheet Arrangements

 

We do not maintain off-balance sheet arrangements, nor do we participate in non-exchange traded contracts requiring fair value accounting treatment.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

27

 

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

    Page
     
Report of Independent Registered Public Accounting Firm (PCAOB 6285)   29
Consolidated Balance Sheets as of April 30, 2022 and 2021   31
Consolidated Statements of Operations for the years ended April 30, 2022 and 2021   32
Consolidated Statements of Deficit for the years ended April 30, 2022 and 2021   33
Consolidated Statements of Cash Flows for the years ended April 30, 2022 and 2021   34
Notes to Consolidated Financial Statements   35

 

28

 

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and

Board of Directors of Sparta Commercial Services, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Sparta Commercial Services, Inc. (the “Company”) as of April 30, 2022 and 2021, the related consolidated statements of operations, deficit, and cash flows for each of the two years in the period ended April 30, 2022, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of April 30, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended April 30, 2022, in conformity with accounting principles generally accepted in the United States of America.

 

Substantial Doubt About the Company’s Ability to Continue as a Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As discussed in Note B to the accompanying financial statements, the Company has incurred recurring losses and generated negative cash flows from operating activities since inception. As of April 30, 2022, the Company had an accumulated deficit and a working capital deficit. The Company’s cash balance and revenues generated are not currently sufficient and cannot be projected to cover its operating expenses for the next twelve months from the filing date of this report. These factors among others raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements. Management’s plans are also described in Note 3. The consolidated financial statements do not include adjustments that might result from the outcome of this uncertainty.

 

Basis of Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to fraud or error. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

331 Newman Springs Road P (732) 822-4427
Building 1, 4th Floor, Suite 143 F (732) 510-0665
Red Bank, NJ 07701  

 

29
 

 

Critical Audit Matters

 

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

Accounting for Embedded Derivative Liabilities Related to Convertible Debentures

 

As described in Notes A and C to the financial statements, the Company had convertible debentures that required accounting considerations and significant estimates.

 

The Company determined that variable conversion features issued in connection with certain convertible debentures required derivative liability classification. These variable conversion features were initially measured at fair value and subsequently have been remeasured to fair value at each reporting period. The Company determined the fair value of the embedded derivatives using the Black-Scholes-Merton option pricing model.

 

We identified the accounting considerations and related valuations, including the related fair value determinations of the embedded derivative liabilities of such as a critical audit matter. The principal considerations for our determination were: (1) the accounting consideration in determining the nature of the various features (2) the evaluation of the potential derivatives and potential bifurcation in the instruments, and (3) considerations related to the determination of the fair value of the various debt and equity instruments and the conversion features that include valuation models and assumptions utilized by management. Auditing these elements is especially challenging and requires auditor judgement due to the nature and extent of audit effort required to address these matters, including the extent of specialized skill or knowledge needed.

 

Our audit procedures related to management’s conclusion on the evaluation and related valuation of embedded derivatives, included the following, among others: (1) evaluating the relevant terms and conditions of the various financings, (2) assessing the appropriateness of conclusions reached by the Company with respect to the accounting for the convertible debt, and the assessment and accounting for potential derivatives and (3) independently recomputing the valuations determined by Management.

 

/s/ Boyle CPA, LLC

 

We have served as the Company’s auditor since 2018

Red Bank, NJ

August 15, 2022

 

331 Newman Springs Road P (732) 822-4427
Building 1, 4th Floor, Suite 143 F (732) 510-0665
Red Bank, NJ 07701  

 

30
 

 

SPARTA COMMERCIAL SERVICES, INC.

CONSOLIDATED BALANCE SHEETS

FOR THE YEARS ENDED APRIL 30, 2022 AND 2021

 

   April 30, 2022   April 30, 2021 
         
ASSETS          
Current Assets          
Cash and cash equivalents  $317   $396 
Accounts receivable   -    469 
Inventory   8,422    13,823 
Other current assets   -    - 
Total Current Assets   8,739    14,688 
Property and equipment, net of accumulated depreciation and amortization of $213,262 and $213,262, respectively   -    - 
Other assets   -    9,628 
Deposits   9,000    9,000 
Total assets  $17,739   $33,316 
           
LIABILITIES AND DEFICIT          
Liabilities:          
Current Liabilities          
Bank overdraft  $27,202   $49,041 
Accounts payable and accrued expenses   4,354,129    3,627,831 
Short Term Loan   141,585    409,013 
Current portion notes payable   5,250,084    4,680,275 
Deferred revenue   13,385    13,946 
Derivative liabilities   9,549,640    3,446,738 
Total Current Liabilities   19,336,025    12,226,844 
           
Loans payable-related parties   432,403    432,403 
Total Long Term Liabilities   432,403    432,403 
           
Total liabilities  $19,768,428   $12,659,247 
           
Stockholders’ Deficit:          
Preferred stock, $0.001 par value; 10,000,000 shares authorized of which 35,850 shares have been designated as Series A convertible preferred stock, with a stated value of $100 per share, 125 and 125 shares issued and outstanding, respectively   12,500    12,500 
Preferred stock B, 1,000 shares have been designated as Series B redeemable preferred stock, $0.001 par value, with a liquidation and redemption value of $10,000 per share, 0 and 0 shares issued and outstanding, respectively        - 
Preferred stock C, 200,000 shares have been designated as Series C redeemable, convertible preferred, $0.001 par value, with a liquidation and redemption value of $10 per share, 4,145 and 4,145 shares issued and outstanding, respectively   2,363    4,145 
Preferred stock D, 2,000,000 shares have been designated as Series D redeemable, convertible preferred, $0.001 par value, with a liquidation and redemption value of $1.00 per share, 1,494 and 4,494 shares issued and outstanding as of April 30, 2022 and 2021, respectively   618    1,494 
Common stock, $0.001 par value; 750,000,000 shares authorized, and 15,128,005 and 9,809,877 shares issued and outstanding, respectively   15,128    9,810 
Common stock to be issued 8,916,805 and 1,214,528 respectively   8,292    1,215 
Additional paid-in-capital   53,210,921    51,351,156 
Accumulated deficit   (73,984,686)   (64,993,250)
Total deficiency in stockholders’ equity   (20,734,864)   (13,612,930)
           
Non-controlling interest   984,175    986,999 
           
Total Deficit   (19,750,689)   (12,625,931)
Total Liabilities and Deficit  $17,739   $33,316 

 

See accompanying notes to consolidated financial statements.

 

31
 

 

SPARTA COMMERCIAL SERVICES, INC.

CONSOLIDATED STATEMENT OF OPERATIONS

FOR THE YEARS ENDED APRIL 30, 2022 AND 2021

 

   2022   2021 
Revenue          
Information technology  $219,404   $245,675 
New World Health Brands   26,065    14,056 
Total Revenue   245,469    259,731 
Less Cost of goods sold   42,161    60,986 
Gross profit   203,308   198,745 
Operating expenses:          
General and administrative   1,199,416    1,394,881 
Research and development   217,138    - 
Total operating expenses  1,470,554   1,394,881 
Loss from operations   (1,267,246)  (1,196,136)
Other (income) expense:          
Other income   (11,956)  (7,690)
Forgiveness of debt        (125,328)
Financing cost   601,279    723,003 
Amortization of debt discount        - 
Loss (gain) in changes in fair value of derivative liability   7,132,043    504,599 
Total other (income) expense  $7,721,366   $1,094,584 
Net income (loss)   (8,988,614)   (2,290,720)
Net loss (income) attributed to non-controlling interest   2,823   (12,748)
Preferred dividend        (191)
Net income (loss) attributed to common stockholders  $(8,991,437)  $(2,303,659)
Basic and diluted loss per share:          
Loss from continuing operations attributable to Sparta Commercial Services, Inc. common stockholders   (0.66)   (0.37)
Loss from discontinued operations attributable to Sparta Commercial Services, Inc. common stockholders   -    0.0000 
Net loss attributable to Sparta Commercial Services, Inc. common stockholders  $(0.66)  $(0.37)
Weighted average shares outstanding   13,686,995    6,270,929 

 

See accompanying notes to consolidated financial statements.

 

32
 

 

SPARTA COMMERCIAL SERVICES, INC.

CONSOLIDATED STATEMENTS OF DEFICIT

FOR THE YEARS ENDED APRIL 30, 2022 AND 2021

 

   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Interest   Total 
   Series A   Series C   Series D           Common Stock   Additional       Non     
   Preferred Stock   Preferred Stock   Preferred Stock   Common Stock   to be issued   Paid in   Accumulated   controlling     
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Interest   Total 
Balance April 30, 2021   125   $12,500    4,132,269   $4,145    1,494,962   $1,494    9,809,877   $9,810    1,214,528   $1,215   $51,351,156   $(64,993,250)  $986,999   $(12,625,931)
Conversion of Preferred to common shares             (1,688,269)   (1,501)   (467,551)   (467)   3,194,418    3,194    995,500    995    1,656,493              1,658,714 
Conversion of notes to common shares             -    -    -    -    125,000    125    -    -    24,875         -    25,000 
Issuance of preferred shares             (281,000)   (281)   (409,000)   (409)             (1,725,176)  $(2,350)   (317,979)             (321,019)
Issuance of common shares for cash                                           8,916,805    8,917    501,083              510,000 
Issuance of shares for services                                 731,623    732              158,279              159,011 
Stocks issued for settlement of payables                                 427,235    427              24,636              25,063 
Stocks issued for equity                                 355,000    355              59,356              59,711 
Stocks issued from to be issued                                 484,852    485    (484,852)   (485)   (246,978)             (246,978)
Preferred dividends                                                                    - 
Net loss for the year   -    -    -    -    -    -    -    -    -    -    -    (8,991,437)   (2,823)   (8,994,260)
Balance April 30, 2022   125   $12,500    2,163,000   $2,363    618,411   $618    15,128,005   $15,128    8,916,805   $8,292   $53,210,921   $(73,894,687)  $984,176   $(19,750,689)
                                                                       
Balance April 30, 2020   125   $12,500    4,132,129   $4,005    1,132,962   $1,132    9,433,282   $9,433    847,865   $848   $50,120,928   $(62,702,339)  $974,251    11,591,617
Issuance of Preferred and Common Stock for Cash             140    140                        366,663    367    234,995              235,502 
Conversion of Accrued Compensation to Series D Preferred Stock                       362,000    362                        311,001              311,363 
Options issued for compensation and accrued compensation                                                     621,665              621,665 
Shares issued for services                                 126,595    127              25,192              25,319 
Conversion of convertible notes                                 250,000    250              49,750              50,000 
Preferred dividend                                                          (191)        (191)
Net loss       -         -         -         -         -     -     (2,290,720)   12,748    (2,277,972)
Balance April 30, 2021   125   $  12,500      4,132,269   $4,145    1,494,962   $1,494      9,809,877   $9,810      1,214,528   $1,215   $51,351,156   $  (64,993,250)  $  986,999   $(12,625,931)

 

See accompanying notes to consolidated financial statements.

 

33
 

 

SPARTA COMMERCIAL SERVICES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   2022   2021 
         
CASH FLOWS FROM OPERATING ACTIVITIES          
Net loss  $(8,988,614)  $(2,290,720)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   -    - 
Loss (Gain) from change in fair value of derivative liabilities   6,102,902    644,613 
Amortization of debt discount   -    (312,049)
Non-cash financing cost   59,465    723,003 
Forgiveness of debt   786,091    382,931 
Stock based compensation   159,009    464,718 
Changes in operating assets and liabilities          
Accounts receivable   469    951 
Inventory   5,401    9,508 
Other assets   9,628   470 
Accounts payable and accrued expenses   695,589    (299,504)
Deferred revenue   (561)   (2,308)
Net cash used in operating activities   (1,170,621)   (678,387)
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of equipment   -    - 
Net cash (used in) investing activities   -    - 
CASH FLOWS FROM FINANCING ACTIVITIES          
Bank overdraft   (21,839)   34,268 
Proceeds from sale of stock   890,000    235,502 
Net Proceeds from notes payable   302,381    409,013 
Payments on notes payable          
Proceeds from related party notes   -      
Payments on related party notes   -      
Net cash provided by financing activities   1,170,542    678,783 
           
Net (decrease) increase in cash  $(79)  $396 
           
Cash and cash equivalents, beginning of period   396    - 
Cash and cash equivalents , end of period  $317   $396 
           
Cash paid for:          
Interest          
Income taxes  $-   $- 

 

See accompanying notes to consolidated financial statements.

 

34
 

 

SPARTA COMMERCIAL SERVICES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

APRIL 30, 2022 AND 2021

 

NOTE A – SUMMARY OF ACCOUNTING POLICIES

 

A summary of the significant accounting policies applied in the preparation of the accompanying financial statements follows.

 

Business

 

Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation serving four markets. Sparta is a technology company that develops, markets and manages business websites and mobile applications (mobile apps) for smartphones and tablets. The Company also owns and manages websites which sell on-demand motorcycle, recreational vehicle, power-sport vehicle and truck title history reports for consumers, retail dealers, auction houses, insurance companies and banks/finance companies. Lastly, since 2007, Sparta has administered leasing programs nationwide for local and/or state agencies seeking to finance municipal vehicles and equipment. The Company also introduced a new business line in the rapidly expanding Hemp-CBD (cannabidiol) market.

 

In 2016, the Company changed the name of its majority-owned subsidiary Specialty Reports, Inc., to iMobile Solutions, Inc. The new name reflects the Company’s strategic evolution and focus on the growing mobile application market domestically.

 

Sparta’s mobile application (mobile app) offerings have broadened our base beyond our original base of vehicle dealers to include a wide range of businesses including, but not limited to, agriculture dealerships, racetracks, private clubs, country clubs, restaurants and grocery stores. We also offer a private label version of our mobile app framework to enable other businesses to offer custom apps to their customers.

 

The Company also designs, launches, maintains, and hosts websites for businesses. We provide specific, tailored action plans for our clients’ websites that include services such as eCommerce, CRM (Customer Relationship Management) development and integration, ordering system creation and integration, SEO (search engine optimization), social media marketing, and online reviews to improve their presence online. In addition, we offer text messaging services which are vital for businesses’ marketing, retention and loyalty strategies. Our text messaging platform allows our clients to easily manage, schedule, and analyze text message performance.

 

The Company’s vehicle history reports include Cyclechex (Motorcycle History Reports at www.cyclechex.com); RVchecks (Recreational Vehicle History Reports at www.rvchecks.com); and Truckchex (Heavy Duty Truck History Reports at www.truckchex.com). Our Vehicle History Reports are designed for consumers, retail dealers, auction houses, insurance companies and banks/finance companies.

 

Sparta also administers a Municipal Leasing Program for local and/or state agencies throughout the country who are seeking a better and more economical way to finance their essential equipment needs, including police motorcycles, cruisers, buses, fire trucks, and EMS equipment. We are continuing to expand our roster of equipment manufacturers and the types of equipment we lease.

 

New World Health Brands, Inc. (NWHB) was formed in April 2019 as a subsidiary and new business line of Sparta Commercial Services, Inc. While anticipating, and with the passing of the 2018 Farm Bill, which resulted in the removal of hemp (CBD) from Schedule 1 of the Controlled Substances Act. Sparta’s management recognized a substantial potential business opportunity in the rapidly expanding Industrial Hemp-CBD (Cannabinol) market in the United States. During 2019-2020, management sourced, developed and lab tested 5 CBD product categories totaling 31 products, procured product packaging, labeling, implemented fulfillment and launched an on-line B2C website, www.newworldhealthcbd.com. The Company has since curated its products and currently offers 15 products with plans to add complementary products to our product line.

 

35
 

 

Sparta’s newest subsidiary, Sparta Crypto, Inc., www.SpartaCrypto.com, was established September 25, 2020 and is in the process of completing a proprietary state-of-the-art platform designed to connect users of widely adopted digital currencies with sellers of various goods and services. The platform has not launched and the Company can make no assurances that the described plan will reach implementation. In addition, the Company has completed and tested a cryptocurrency payment gateway called SpartaPayIQ, www.SpartaPayIQ.com, which is functional and was formally announced on March 3, 2022.

 

Sparta’s offices are located at 555 Fifth Avenue, 14th Floor, New York, NY 10017, (212) 239-2666. The Company maintains a corporate website at www.spartacommercial.com.

 

We identify our ongoing information technology business in two reporting groups: mobile apps/websites and vehicle history reports, both of which operate under our wholly owned subsidiary, iMobile Solutions, Inc. The latest product offering, via www.newworldhealthcbd.com, offering a full array of hemp-derived CBD products, is contained in our subsidiary, New World Health Brands, Inc.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its majority owned subsidiary. All material intercompany transactions and balances have been eliminated in consolidation. The third party ownership of the Company’s subsidiary is accounted for as noncontrolling interest in the consolidated financial statements. Changes in the noncontrolling interest are reported in the statement of stockholders’ deficit.

 

Estimates

 

The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.

 

Revenue Recognition

 

During the first quarter of 2018, the Company adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606), using the cumulative-effect method. The new standard requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The adoption did not have an impact in our consolidated financial statements, other than the enhancement of our disclosures related to our revenue-generating activities.

 

The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions.

 

Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable.

 

The following table presents our revenues disaggregated by revenue source:

 

   2022   2021 
   Year Ended April 30, 
   2022   2021 
Information Technology  $219,404   $245,675 
New World Health Brands   26,065    14,056 
 Revenues  $245,469   $259,731 

 

36
 

 

Cash Equivalents

 

For the purpose of the accompanying financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents.

 

Website Development Costs

 

The Company recognizes website development costs in accordance with ASC 350-50, “Accounting for Website Development Costs.” As such, the Company expenses all costs incurred that relate to the planning and post implementation phases of development of its website. Direct costs incurred in the development phase are capitalized and recognized over the estimated useful life. Costs associated with repair or maintenance for the website are included in cost of net revenues in the current period expenses.

 

Fair Value Measurements

 

The Company adopted ASC 820, “Fair Value Measurements (“ASC 820”).” ASC 820 establishes a three-level fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets the lowest priority to unobservable inputs to fair value measurements of certain assets and Liabilities. The three levels of the fair value hierarchy under ASC 820 are described below:

 

Level 1 — Quoted prices for identical instruments in active markets. Level 1 assets and liabilities include debt and equity securities and derivative contracts that are traded in an active exchange market, as well as certain securities that are highly liquid and are actively traded in over-the-counter markets.
   
Level 2 — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which all significant inputs and significant value drivers are observable in active markets.
   
Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value measurements. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques based on significant unobservable inputs, as well as management judgments or estimates that are significant to valuation.

 

This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not always be available.

 

Income Taxes

 

We utilize ASC 740 “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at year-end based on enacted laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.

 

The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.

 

Stock Based Compensation

 

We account for our stock based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

 

37
 

 

We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.

 

Inventories

 

The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health Brands business.

 

Property and Equipment

 

Property and equipment are recorded at cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is calculated using the straight-line method over the estimated useful lives. Estimated useful lives of major depreciable assets are as follows:

 

   
Leasehold improvements 3 years
Furniture and fixtures 7 years
Website costs 3 years
Computer Equipment 5 years

 

Concentrations of Credit Risk

 

Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.

 

Net Loss Per Share

 

The Company uses ASC 260-10, “Earnings Per Share,” for calculating the basic and diluted loss per share. The Company computes basic loss per share by dividing net loss and net loss attributable to common shareholders by the weighted average number of common shares outstanding. Common equivalent shares are excluded from the computation of net loss per share if their effect is anti-dilutive.

 

At April 30, 2022 and 2021 42 million potential shares (including 847,866 shares to be issued included on the balance sheet) and 10,397,258 potential shares (including 807,866 shares to be issued included on the balance sheet), respectively, were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share.

 

Derivative Liabilities

 

The Company assessed the classification of its derivative financial instruments as of April 30, 2022 and 2021 which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

38
 

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “Accounting for Derivative Instruments and Hedging Activities”.

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

 

Reclassifications

 

Certain reclassifications have been made to conform to prior periods’ data to the current presentation. These reclassifications had no effect on reported losses.

 

Recent Accounting Pronouncements

 

In March 2019, the FASB issued ASU 2019-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting” (ASU 2018-09). This ASU makes several modifications to Topic 718 related to the accounting for forfeitures, employer tax withholding on share-based compensation, and the financial statement presentation of excess tax benefits or deficiencies. ASU 2018-09 also clarifies the statement of cash flows presentation for certain components of share-based awards. The standard is effective for interim and annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company adopted this guidance on May 1, 2019 and it did not have an impact on the Company’s consolidated financial statements and related disclosures.

 

In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements - Going Concern (Topic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”). This amendment prescribes that an entity should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. The amendments became effective for the Company’s annual and interim reporting periods beginning May 1, 2019. The Company will begin evaluating going concern disclosures based on this guidance upon adoption.

 

The FASB issued the following accounting standard updates related to Topic 606, Revenue Contracts with Customers:

 

●  ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”) in May 2014. ASU 2014-09 requires entities to recognize revenue through the application of a five-step model, which includes identification of the contract, identification of the performance obligations, determination of the transaction price, allocation of the transaction price to the performance obligations and recognition of revenue as the entity satisfies the performance obligations.
ASU No. 2018-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2018-08”) in March 2018. ASU 2019-08 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on principal versus agent considerations.

 

39
 

 

ASU No. 2018-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing (“ASU 2018-10”) in April 2018. ASU 2018-10 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas.
ASU No. 2018-11, Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2018 EITF Meeting (SEC Update) (“ASU 2018-11”) in May 2018. ASU 2018-11 rescinds SEC paragraphs pursuant to two SEC Staff Announcements at the March 3, 2018 EITF meeting. The SEC Staff is rescinding SEC Staff Observer comments that are codified in Topic 605 and Topic 932, effective upon adoption of Topic 606.
ASU No. 2018-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients in May 2018. ASU 2018-12 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on a few narrow areas and adds some practical expedients to the guidance.

 

These ASUs became effective for the Company beginning interim period beginning May 1, 2018. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (Topic 842) “Leases.” Topic 842 supersedes the lease requirements in Accounting Standards Codification (ASC) Topic 840, “Leases.” Under Topic 842, lessees are required to recognize assets and liabilities on the balance sheet for most leases and provide enhanced disclosures. Leases will continue to be classified as either finance or operating. The Company adopted Topic 842 effective May 1, 2019 using a modified retrospective method and elected not to recognize leases with terms of 12 months or less. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, we have not determined whether implementation of such proposed standards would be material to our consolidated financial statements.

 

NOTE B – GOING CONCERN MATTERS

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, the Company has incurred recurring losses and generated negative cash flows from operating activities since inception. As of April 30, 2022, the Company had an accumulated deficit of $73,984,686 and a working capital deficit (total current liabilities exceeded total current assets) of $19,327,286. The Company’s cash balance and revenues generated are not currently sufficient and cannot be projected to cover its operating expenses for the next twelve months from the filing date of this report. These factors among others raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements.

 

The Company’s existence is dependent upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that the Company’s efforts will be successful. No assurance can be given that management’s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

 

In order to improve the Company’s liquidity, the Company’s management is actively pursuing additional equity financing through discussions with investment bankers, private equity groups, and private investors. There can be no assurance that the Company will be successful in its effort to secure additional equity financing.

 

40
 

 

NOTE C – NOTES PAYABLE AND DERIVATIVES

 

The Company has outstanding numerous notes payable to various parties. The notes bear interest at rates of 5% - 20% per year and are summarized as follows:

 

Notes Payable  April 30, 2022   April 30, 2021 
Notes convertible at holder’s option  $2,980,848   $2,522,925 
Notes convertible at Company’s option   335,700    335,700 
Non-convertible notes payable   1,933,536    1,821,650 
Subtotal   5,250,084    4,680,275 
Less debt discount   -    - 
Total  $5,250,084   $4,680,275 

 

Certain of the notes payable contain variable conversion rates and the conversion features are classified as derivative liabilities. The conversion prices are based on the market price of the Company’s common stock, at discounts of 30% to 48% to market value.

 

Amortization of debt discount for the years ended April 30, 2022 and 2021 was $0 and $0, respectively.

 

The Company’s derivative financial instruments consist of embedded derivatives related to the outstanding short term Convertible Notes Payable. These embedded derivatives include certain conversion features indexed to the Company’s common stock. The accounting treatment of derivative financial instruments requires that the Company record the derivatives and related items at their fair values as of the inception date of the Convertible Notes Payable and at fair value as of each subsequent balance sheet date. In addition, under the provisions of Accounting Standards Codification subtopic 815-40, Derivatives and Hedging; Contracts in Entity’s Own Equity (“ASC 815-40”), as a result of entering into the Convertible Notes Payable, the Company is required to classify all other non-employee stock options and warrants as derivative liabilities and mark them to market at each reporting date. Any change in fair value inclusive of modifications of terms will be recorded as non-operating, non-cash income or expense at each reporting date. If the fair value of the derivatives is higher at the subsequent balance sheet date, the Company will record a non-operating, non-cash charge. If the fair value of the derivatives is lower at the subsequent balance sheet date, the Company will record non-operating, non-cash income.

 

The change in fair value of the derivative liabilities of convertible notes outstanding at April 30, 2022 and 2021 was calculated with the following average assumptions, using a Black-Scholes option-pricing model are as follows:

 

Significant Assumptions:       
Risk free interest rate  Ranging from  0.16% to 0.20 
Expected stock price volatility      369%
Expected dividend payout      0 
Expected options life in years  Ranging from   1 year to 2 years 

 

Changes in derivative liability during the years ended April 30, 2022 and 2021 were:

 

   April 30, 
   2022   2021 
Balance, beginning of year  $4,252,446   $2,802,125 
Derivative liability reclassified to additional paid in capital   (474,420)   (573,397)
Derivative financial liability arising on the issue of convertible notes and warrants        715,411 
Fair value adjustments   3,728,206    1,310,307 
Balance, end of year  $7,506,232   $4,252,446 

 

41
 

 

NOTE D – LOANS PAYABLE TO RELATED PARTIES

 

As of April 30, 2022, and 2021, aggregated loans payable, without demand and with no interest, to officers and directors were $432,403 and $432,403, respectively.

 

NOTE EEQUITY TRANSACTIONS

 

Common Stock

 

The Company is authorized to issue 750,000,000 shares of common stock, $0.001 par value.

 

On December 30, 2020, Sparta Commercial Services, Inc. (the “Company”) filed with the Secretary of State of the state of Nevada, a Certificate of Amendment to its Articles of Incorporation (the “Amendment”), attached herewith as Exhibit 3.1, and incorporated by reference. The Amendment will be effective as of December 30, 2020. On July 9, 2020, the Board of Directors of the Company declared July 30, 2020 as the effective date for the 1 for 100 reverse stock split (the “Reverse Stock Split”), previously approved by the stockholders of the Company by written consent in accordance with the information contained in the Schedule 14C Information Statement filed with the Securities and Exchange Commission on July 9, 2020. FINRA reviewed and authorized the corporate action changing the effective date to December 30, 2020 (the “Effective Date”).

 

As a result of the Reverse Stock Split, every one hundred shares of outstanding common stock will automatically be converted into one shares of the Company’s common stock immediately prior to the opening of trading on the next business day after the Effective Date. If, as a result of the reverse split, a stockholder is left with a fractional share, that stockholder shall receive one full share in lieu of such fractional share. Immediately after the effectiveness of the reverse split, there will be 7,027,930 shares of the Company’s common stock issued and outstanding. The aggregate number of shares of common stock that the Company is authorized to issue remains the same and was unaffected by the Reverse Stock Split. All outstanding stock options and other contractual rights including the preferred stock entitling the holders of such rights to acquire shares of common stock outstanding at the Effective Date will be appropriately adjusted to give effect to the Reverse Stock Split.

 

The Company had 15,125,005 and 9,809,877 shares (post-split) of common stock issued and outstanding as of April 30, 2022 and 2021, respectively. The Company had 8,916,805 and 1,214,528 shares of common classified as to be issued at April 30, 2022 and April 30, 2021, respectively.

 

Preferred Stock

 

The Company is authorized to issue 10,000,000 shares of preferred stock with $0.001 par value per share, of which 35,850 shares have been designated as Series A convertible preferred stock with a $100 stated value per share; 1,000 shares have been designated as Series B Preferred Stock with a $10,000 per share liquidation value; 4,200,000 shares have been designated as Series C Preferred Stock with a $10 per share liquidation value, and 2,000,000 shares have been designated as Series D Preferred Stock with a $1 per share liquidation value.

 

As of April 30, 2022, and 2021 the Company had:

  

Preferred stock outstanding shares  2022   2021 
Series A   125    125 
Series B   -    - 
Series C   2,163,000    4,132,269 
Series D   618,411    1,493,962 

 

42
 

 

Equity Transactions

 

During the year ended April 30, 2022 the Company:

 

  ●  Issued 731,623 common shares for consulting services valued at $159,010.
  Issued 3,305,860 common shares upon the conversion of 1,010,703 shares of Series C Convertible Preferred stock.
  Issued 650,076 common shares upon the conversion of 162,519 shares of Series D Convertible Preferred stock.
  Sold to fourteen accredited investors 8,563,531 shares of common stock for cash or conversions of $644,968; actual shares were not issued yet and recorded as commons stocks to be issued.
  Sold to three accredited investors 520,000 shares of Sparta Crypto, Inc,’s common stock for cash of $130,000; actual shares were not issued yet and recorded as commons stocks to be issued.
  On January 3, 2022, entered into agreements with Anthony L. Havens, the Company’s Chief Executive Officer (“Havens”) and Sandra L. Ahman, the Company’s Vice-President of Operations (“Ahman”) whereby Havens and Ahman agreed to convert debt owed to them in exchange for non-qualified stock options.
  Havens agreed to convert $137,465.76 of deferred salary in exchange for a stock option agreement (the “Havens Stock Option Agreement”) to purchase 1,718,322 shares of the Company’s common stock.
  Ahman agreed to convert $125,000 of deferred salary in exchange for a stock option agreement (the “Ahman Stock Option Agreement” and with the Havens Stock Option Agreement, the “Stock Option Agreements”) to purchase 1,562,500 shares of the Company’s common stock.
  On January 3, 2022, the Company granted to each of its two independent Directors five year options to purchase 187,500 shares of the Company’s common stock at $0.08 per share. The options vest in three equal tranches over three years. These options represent compensation for past service on the board.
  On January 3, 2022, the Company granted its CEO, Anthony L Havens and Vice President of Operations, Sandra L Ahman, five year options to purchase an aggregate of 750,000 shares of the Company’s common stock at $0.08 per share. The options vest in three equal tranches over three years.
  On January 3, 2022, the Company granted to four employees, five year options to purchase an aggregate of 437,500 shares of the Company’s common stock at $0.08 per share. The options vest in three equal tranches over three years.

 

During the year ended April 30, 2021, the Company:

 

  Sold 140,000 Units of Series C convertible preferred stock for $70,000
  Issued 311,378 Units of Series D convertible preferred stock upon the conversion of accounts payable aggregating $311,378
  Issued 50,455 Units of Series D convertible preferred stock upon the conversion of $50,455 of the Company’s subsidiary preferred stock
  Pursuant to agreement, issued 250,000 shares of the Company’s Common Stock, valued at $50,000
  Pursuant to Conversions of Preferred Series D convertible preferred stock, issued 890,540 shares of the Company’s Common Stock, valued at $222,635
  Pursuant to Conversions of Preferred Series C convertible preferred stock, issued 2,086,848 shares of the Company’s Common Stock, valued at $231,872
  Pursuant to agreement, issued 3,000,000 shares of common stock valued at $6,000

 

43
 

 

NOTE F – FAIR VALUE MEASUREMENTS

 

The Company follows the guidance established pursuant to ASC 820 which established a framework for measuring fair value and expands disclosure about fair value measurements. ASC 820 defines fair value as the amount that would be received for an asset or paid to transfer a liability (i.e., an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes the following three levels of inputs that may be used:

 

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets and liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

 

Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data.

 

Level 3: Unobservable inputs when there is little or no market data available, thereby requiring an entity to develop its own assumptions. The fair value hierarchy gives the lowest priority to Level 3 inputs.

 

The table below summarizes the fair values of financial liabilities as of April 30, 2022:

 

   Fair Value at   Fair Value Measurement Using 
   April 30, 2022   Level 1   Level 2   Level 3 
Derivative liabilities  $9,549,640    -    -   $9,549,640 

 

Fair values of financial liabilities as of April 30, 2021 are as follows:

 

   Fair Value at   Fair Value Measurement Using 
   April 30, 2021   Level 1   Level 2   Level 3 
Derivative liabilities   $4,252,466    -    -   $4,252,466 

 

The following is a description of the valuation methodologies used for these items:

 

Derivative liabilities — these instruments consist of certain variable conversion features related to notes payable obligations and certain outstanding warrants. These instruments were valued using pricing models which incorporate the Company’s stock price, volatility, U.S. risk free rate, dividend rate and estimated life.

 

The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value in accordance with ASC Topic 825 “The Fair Value Option for Financial Issuances”.

 

NOTE G - PROPERTY AND EQUIPMENT

 

Major classes of property and equipment at April 30, 2022 and 2021 consist of the followings:

 

           
   2022   2021 
Computer equipment, software and furniture  $213,262   $213,262 
Less: accumulated depreciation   (213,262)   (213,262)
Net property and equipment  $-   $- 

 

All equipment are fully depreciated as of the fiscal year end April 30, 2022 and 2021. No additional investment in equipment for both fiscal year.

 

NOTE H – WARRANTS:

 

During the year ended April 30, 2022, the company issued a total of 4,843,322 warrants to employees and service provider at an average option strike price of $0.17 per share. As of April 30, 2022, 3,801,657 of these warrants were vested. Computed fair value was $228,099.

 

44
 

 

The following table summarizes the changes in warrants:

 

    Warrants Outstanding       Warrants Exercisable 
Exercise Prices   Number Outstanding   Weighted
Average
Remaining
Contractual
Life (Years)
   Weighted
Average
Exercise Price
   Number Exercisable   Weighted
Average
Exercise Price
 
$0.3080    1,465,960    3   $0.3080    1,298,738   $0.3080 
$0.2750    1,613,426    3   $0.2750    1,613,426   $0.2750 
$0.0800    4,843,322    3   $0.0800    3,801,657    0.0800 

 

Transactions involving stock warrants issued to non-employees are summarized as follows:

 

   Number
of Shares
   Weighted
Average
Exercise
Price Per Share
 
Outstanding at April 30, 2020   5,310,745   $0.16190 
Granted   2,395,380    0.17097 
Canceled or expired   (400)   0.17000 
           
Outstanding at April 30, 2021   7,705,725    .016190 
Granted   -    - 
Exercised   -    - 
Canceled or expired   (216,983)   0.16010 
Outstanding at April 30, 2022   7,922,708   $0.16190 

 

45
 

 

NOTE I - INCOME TAXES

 

At April 30, 2022, the Company has available for federal income tax purposes a net operating loss carry forward of approximately $65,338,601 that may be used to offset future taxable income and expiring through the tax year 2036, subject to certain limitation pursuant to Internal Revenue Code Section 382. The Company has provided a valuation reserve against the full amount of the net operating loss benefit, since in the opinion of management based upon the earnings history of the Company; it is more likely than not that, the benefits will not be realized.

 

A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

           
   Years Ended April 30, 
   2022   2021 
Federal statutory income tax rate   (21.0)%   (21.0)%
State income taxes, net of federal benefit   (7.1)   (7.1)
Permanent differences   6.7    6.7 
Change in valuation allowance   21.4    21.4 
           
Provision for income taxes   0.0%   0.0%

 

Components of deferred tax assets as of April 30, 2022 and estimated 2021 are as follows:

 

           
   April 30, 
   2022   2021 
Noncurrent:          
Net operating loss carry forward  $14,753,877   $13,167,491 
Valuation allowance   (14,753,877)   (13,167,491)
Net deferred tax asset  $-   $- 

 

NOTE J - COMMITMENTS AND CONTINGENCIES

 

Operating Lease Commitments

 

Our executive offices are located in New York, NY. We have an agreement for use of office space at this location under a sub-lease which expired on July 31, 2018, and continues a month-to-month basis thereafter. The monthly base rent is $5,100.

 

Rent expense was $64,800 and $70,200 for the years ended April 30, 2022, and 2021, respectively.

 

Employment and Consulting Agreements

 

The Company does not have employment agreements with any of its non-executive employees.

 

The Company has consulting agreements with outside contractors to provide marketing and financial advisory services. The agreements are generally for a term of 12 months from inception and renewable automatically from year to year unless either the Company or consultant terminates such engagement by written notice.

 

The Company entered into five year employment agreements with its CEO, Anthony L Havens and Vice President of Operations, Sandra L Ahman. As part of their employment agreements, Mr. Havens received five year options to purchase 37,625,574 shares of the Company’s common stock at $0.00308 per share. The options vest in three equal tranches over three years. Ms. Ahman received five year options to purchase 12,541,858 shares of the Company’s common stock at $0.00308 per share. The options vest in three equal tranches over three years.

 

46
 

 

Litigation

 

The Company is subject to legal proceedings and claims which arise in the ordinary course of its business. Sparta can make no representations about the potential outcome of such proceedings.

 

As of April 30, 2022, we have not been named as parties to any further legal proceedings except as those disclosed prior and as updated below. From time to time, of course, we may become involved in further legal proceedings, which sometimes arise due to the very nature of and in the ordinary course of this business.

 

By way of background, the Company had received notices dated April 1, 2016, May 13, 2016 and July 22, 2016 from two lenders claiming defaults relating to conversion requests of $8,365.00 in principal plus interest, attorney fees and $5,000.00 in principal plus interest also seeking stock conversions aside from the stated principal and interest with regard to notes in the total amounts of $55,125.00 and $27,500.00, respectively, which the Company has declined to process and believes it has valid, meritorious defenses in that regard. The Company believes these claims are contingent, unliquidated and disputes same. While there can be no assurances that the Company would prevail in any potential litigation with regard to claims brought against the Company, these potential liabilities have been recorded in the unaudited condensed consolidated financial statements.

 

With respect to the above claims, on September 22, 2016, a motion for summary judgment in lieu of complaint was filed in the Supreme Court in the State of New York: County of Kings, against the Company by a lender for the amount of $102,170.82 in principal and stock conversion interest, plus fees and costs. The Plaintiff’s motion for summary judgment in lieu of complaint was denied on May 5, 2017. On August 22, 2018, Plaintiff thereafter brought a second motion seeking summary judgment on the issue of liability which was, again, denied by the Court on March 14, 2019. The most recent appearance in this matter had been scheduled for March 13, 2020, at which time, the Court marked the case “adjourned without a date”, due to the restrictions imposed on the Courts arising from the COVID-19 pandemic. No further Court appearances have been scheduled, to date, in this matter. However, most notably, a favorable decision from the New York State Court of Appeals regarding the very same types of transactions have since been determined to be criminally usurious and, therefore, unenforceable. These were the very same defenses raised on behalf of the Company.

 

On October 26, 2018, a second lender commenced an action in the Supreme Court of the State of New York: New York County alleging damages from unpaid principal arising from a promissory note dated February 26, 2015 in the amount of $50,000.00 plus damages including interest and stock conversions, costs and fees. There are cross dispositive motions pending which are scheduled to be heard in September, 2022. The Company disputes the enforceability of such claims for the similar reasons, as stated above, based on the Court of Appeals ruling as to the unenforceable nature of such claims demanding usurious interest rates.

 

NOTE K – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events for recognition and disclosure as of August 15, 2022 which is the date the financial statements were available to be issued. No other matters were identified affecting the accompanying financial statements and related disclosures.

 

47
 

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None

 

ITEM 9.01 - FINANCIAL STATEMENTS AND EXHIBITS

 

(a) Financial Statements of Business Acquired. N/A

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Exchange Act that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure. We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Principal Financial Officer, of the effectiveness of our disclosure controls and procedures as of April 30, 2022. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls, the Chief Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were not effective.

 

Management Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) of the Exchange Act. Under the supervision and with the participation of our Chief Executive Officer and Principal Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of April 30, 2022 using the criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

 

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of the Company’s financial reporting. In our assessment of the effectiveness of internal control over financial reporting as of April 30, 2022, we determined that control deficiencies existed that constituted material weaknesses, as described below:

 

lack of documented policies and procedures;
●  we have no audit committee;
there is a risk of management override given that our officers have a high degree of involvement in our day-to-day operations;
there is no effective separation of duties, which includes monitoring controls, between the members of management.

 

48
 

 

Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. As a result, we have not been able to take steps to improve our internal controls over financial reporting during the year ended April 30, 2022. However, to the extent possible, we will implement procedures to assure that the initiation of transactions, the custody of assets and the recording of transactions will be performed by separate individuals. Management is currently evaluating what steps can be taken in order to address these material weaknesses.

 

Accordingly, we concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by our internal controls.

 

As a result of the material weaknesses described above, management has concluded that we did not maintain effective internal control over financial reporting as of April 30, 2022 based on criteria established in Internal Control—Integrated Framework issued by COSO.

 

In light of these significant deficiencies, we performed additional analyses and procedures in order to conclude that our consolidated financial statements for the year ended April 30, 2022 included in this Annual Report on Form 10-K were fairly stated in accordance with U.S. GAAP. Accordingly, management believes that despite our significant deficiency, our consolidated financial statements for the year ended April 30, 2022 are fairly stated, in all material respects, in accordance with U.S. GAAP.

 

This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit a smaller reporting company to provide only management’s report in its annual report.

 

Changes in Internal Controls

 

During the fiscal year ended April 30, 2022, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

Not applicable.

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATION GOVERNANCE

 

Our Management

 

The following table sets forth our executive officers and directors and their respective ages and positions as of April 30, 2022.

 

Name   Age   Position
Anthony L. Havens   68   Chief Executive Officer, President, Principal Financial Officer and Chairman
Kristian Srb   67   Director
Jeffrey Bean   69   Director
Sandra L. Ahman   58   Vice President, Secretary and Director

 

49
 

 

Management Profiles

 

Anthony L. Havens, Founder, Chief Executive Officer, President, and Chairman. On February 27, 2004, Mr. Havens became our Chief Executive Officer, President and Chairman of the Board. Mr. Havens served as acting Chief Financial Officer from July 2005 to September 2006. Mr. Havens resumed serving as acting Chief Financial Officer on January 31, 2016, upon the retirement of the Chief Financial Officer. He is involved in all aspects of Sparta’s operations, including providing strategic direction, and developing sales and marketing strategies. From 1994 to 2004, Mr. Havens was Chief Executive Officer and a director of American Motorcycle Leasing Corp. He co-founded American Motorcycle Leasing Corp. in 1994, and developed its operating platform and leasing program to include a portfolio, which includes both prime and sub-prime customers. Mr. Havens has over 20 years of experience in finance and investment banking.

 

Kristian Srb, Director. Mr. Srb joined our Board of Directors in December 2004. Mr. Srb has been a director of American Motorcycle Leasing Corp. from 1994 to the present. Mr. Srb was President of American Motorcycle Leasing Corp. from 1994 to 1999. Since 1999, Mr. Srb has engaged in private investment activities. He has over 16 years’ experience in international brand development and management, including for 13 years with Escada A.G.

 

Jeffrey Bean, Director. Mr. Bean joined our Board of Directors in December 2004. Mr. Bean is the founder and President of Bean Foods, LLC. Formed in July 2006 the company develops, owns and operates quick serve restaurants in Georgia. Prior to founding Bean Foods, Mr. Bean was the founding partner for GoMotorcycle.com, a business that engaged in the sale of motorcycle parts and accessories over the Internet. Mr. Bean was an institutional broker and trader at a major commodities trading firm from 1985 to 1997. From 1977 to 1985, Mr. Bean was President of Thomaston Press, Ltd., a printing concern. He received a B.A. degree from the University of Virginia.

 

Sandra L. Ahman, Vice President, Secretary and Director. On March 1, 2004, Sandra Ahman became Vice President of Operations and Secretary of Sparta, and a Director on June 1, 2004. She served as a Vice President of our predecessor entity, Sparta Commercial Services, LLC since its inception in 2001 until its dissolution in February 2006. From 1994 to 2004, she was Vice President of Operations of American Motorcycle Leasing Corp. Prior to joining American Motorcycle Leasing Corp., Ms. Ahman was with Chatham Capital Partners, Ltd. Before joining Chatham in 1993, she was Manager, Human Resources for Comart and Aniforms, a sales promotion and marketing agency in New York, where she worked from 1986 to 1993. For the past 15 years, Ms. Ahman has been a volunteer with The Children’s Aid Society in New York City, a membership of 500 committed volunteers, serving from 2000 to 2002 as President of its Associates Council, from 2002 to 2005 as Chairman of the Associates Council, and from 2002 to 2012 as a member of the Advisory Council of their Board of Trustees.

 

Board of Directors Information and Corporate Governance

 

There are no family relationships among our executive officers or directors. None of our directors or officers serves or has served during the past five years as a director of another reporting company or a registered investment company. Based solely in reliance on representations made by our officers and directors, during the past ten years, none of the following occurred with respect to such persons: no petition under the Federal bankruptcy laws or any state insolvency law was filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court for the business or property of such persons, or any partnership in which he or she was a general partner or any corporation or business association of which he or she was an executive officer at or within two years before the time of such filing; no such persons were convicted in a criminal proceeding or are a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); no such persons were the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of any competent jurisdiction, permanently or temporarily enjoining, or of any federal or state authority barring, suspending or otherwise limiting, their involvement in any type of business practice, or in securities or banking or other financial institution activities; and no such persons were found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or by the Commodity Futures Trading Commission to have violated any federal or state securities or commodities law, and the judgment has not been reversed, suspended or vacated.

 

50
 

 

The number of directors shall be between two (2) and ten (10). The number of directors shall be set by the then current members of the Board of Directors. The size of the Board of Directors is four (4). A director need not be a stockholder. In the case of a vacancy as a result in an increase in the number of directors, the Board of Directors shall fill such vacancy at a special meeting thereof. In seeking candidates for directors, our Board may use their business, professional and personal contacts; accept the recommendations from other Board members, stockholders or management. Current members of the Board are considered for re-election. The process for evaluating candidates and the manner of evaluation is the same regardless of the category of person recommending the proposed candidate. The Board considers business experience, mix of skills and other criteria and qualities appropriate for Board membership, including: intelligence, high personal and professional ethics, values, integrity and sound judgment; education; business and professional skills and experience; familiarity with our business and the industry in general; independence from management; ability to devote sufficient time to Board business; commitment to regularly attend and participate in meetings of our Board and its committees; and concern for the long-term interests of the stockholders. While such factors important in evaluating candidates, we do not impose any specific, minimum qualifications for director nominees.

 

Our Board of Directors does not currently maintain a separately designated standing audit, nominating, or compensation committee, or other similar committee, of the Board of Directors, and we do not have audit, nominating, or compensation committee, or other similar charter. Functions customarily performed by such committees are performed by our Board as a whole as our operations have been limited and we have had a small number of officers and a small number of directors since inception. We are not required to maintain such committees under the applicable rules of the OTC Bulletin Board. None of our directors qualifies as an “audit committee financial expert.” As all of our Board members are officers or nominees of a substantial stockholder who may not be deemed independent, we have not established separate Board committees.

 

The Board of Directors has not adopted a specific process with respect to security holder communications, but security holders wishing to communicate with the Board of Directors may do so by mailing such communications to the Board of Directors at our offices.

 

Code of Ethics

 

We have adopted a “code of ethics”, as defined by the SEC, which applies to all our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, and persons performing similar functions.

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Securities Exchange Act of 1934, as amended, requires Sparta’s executive officers, directors, and persons who beneficially own more than ten percent of Sparta’s common stock to file with the Securities and Exchange Commission initial reports of beneficial ownership and reports of changes in beneficial ownership of Sparta’s common stock. Such persons are also required by Securities and Exchange Commission regulations to furnish Sparta with copies of all such Section 16(a) forms filed by such person. Based solely on a review of the copies of such reports furnished to Sparta in connection with the fiscal year ended April 30, 2022, Sparta is not aware of any material delinquencies in the filing of such reports.

 

51
 

 

ITEM 11. EXECUTIVE COMPENSATION

 

Summary Compensation Numbers below are not updated

 

The table below sets forth information concerning the compensation we paid to our Chief Executive Officer and our next two most highly compensated executive officers who served during our fiscal year ended April 30, 2022 (“Named Executive Officers”).

 

                    Stock     Option     All Other        
        Salary     Bonus     Awards     Awards     Compensation     Total  
Name and Principal Position   Year   ($)(a)     ($)     ($)     ($)     ($)(b)     ($)  
                                         
Anthony L. Havens   2022     280,000                 -       28,494               308,494  
Chief Executive Officer   2021     280,000               -       -               280,000  
                                                     
Sandra L. Ahman   2022     140,000       -       -      

14,247

      -       154,247  
Vice President, Operations   2021     140,000       -       -          -            -       140,000  

 

(a) For Mr. Havens includes accrued, unpaid net salary of $30,851 and $112,408 at year end 2022 and 2021, respectively. For Ms. Ahman, includes accrued, unpaid net salary of $91,029 and $63,526 at year end 2022 and 2021 respectively.
(b) This column reports the total amount of perquisites and other benefits provided, if such total amount exceed $10,000.

 

In general, compensation payable to a Named Executive Officer consists of a base salary, a stock or stock option award, and may include a cash bonus. During our 2021 fiscal year, we had in effect a written employment agreement with the Mr. Havens and Ms. Ahman. Our compensation system has generally not been tied to performance-based conditions other than the passage of time.

 

Employment Agreements with CEO and Vice President Operations

 

We entered into an employment agreement, dated as of July 9, 2020, with Anthony L. Havens who serves as our Chief Executive Officer. The agreement was for an initial term of five years, and provided for automatic extensions for one five-year period and for additional one-year periods, unless written notice is given three months prior to the expiration of any such term that the term will not be extended. His base salary is at an annual rate of $280,000. He is entitled to defer a portion of his base salary each year. He is entitled to annual increases in his base salary and other compensation as may be determined by the Board of Directors. He is entitled to six weeks of paid vacation per year, health insurance, short term and long-term disability insurance, retirement benefits, fringe benefits, and other employee benefits on the same basis as is generally made available to other senior executives. He is entitled to reimbursement of reasonable business expenses incurred by him in accordance with Company policies. If terminated, he is entitled to three months of severance for up to six months of service for each year of employment, plus full participation in all standard employee benefits during the period of severance payments. The employment agreement provides for termination for cause. If he resigns for good reason or is terminated without cause within twelve months after a change in control, he is entitled to receive an additional lump sum payment equal to the greater of the severance payment or the balance of his base salary for the remaining employment term, continued coverage under any welfare benefits plans for two years, and full vesting of any account balance under a 401(k) plan. For purposes of the employment agreement, a change in control refers to:

 

  a change in voting power, due to a person becoming the beneficial owner of 50% or more of the voting power of our securities and our largest stockholder;
  during any period of two consecutive years, individuals who at the beginning of such period constitute the Board of Directors, including later approved directors, ceasing to constitute a majority of the board;
  a merger or consolidation of our Company with a third party, after which our stockholders do not own more than 50% of the voting power; or
  a sale of all or substantially all of our assets to a third party.

 

If we elect not to renew the employment agreement, he shall be entitled to receive severance equal to thirty months of his base salary plus standard employment benefits. If we fail to fully perform all or any portion of our post-termination obligations, we are be obligated to pay to him an amount equal to five times the value of the unperformed obligation.

 

We entered into an employment agreement, dated as of July 9, 2020, with Sandra L. Ahman who serves as our Vice President of Operations. The agreement was for an initial term of five years, and provided for automatic extensions for one five-year period and for additional one-year periods, unless written notice is given three months prior to the expiration of any such term that the term will not be extended. Her base salary is at an annual rate of $140,000. She is entitled to defer a portion of her base salary each year. She is entitled to annual increases in her base salary and other compensation as may be determined by the Board of Directors. She is entitled to six weeks of paid vacation per year, health insurance, short term and long-term disability insurance, retirement benefits, fringe benefits, and other employee benefits on the same basis as is generally made available to other senior executives. She is entitled to reimbursement of reasonable business expenses incurred by her in accordance with Company policies. If terminated, she is entitled to three months of severance for up to six months of service for each year of employment, plus full participation in all standard employee benefits during the period of severance payments. The employment agreement provides for termination for cause. If she resigns for good reason or is terminated without cause within twelve months after a change in control, she is entitled to receive an additional lump sum payment equal to the greater of the severance payment or the balance of her base salary for the remaining employment term, continued coverage under any welfare benefits plans for two years, and full vesting of any account balance under a 401(k) plan. For purposes of the employment agreement, a change in control refers to:

 

  a change in voting power, due to a person becoming the beneficial owner of 50% or more of the voting power of our securities and our largest stockholder;
  during any period of two consecutive years, individuals who at the beginning of such period constitute the Board of Directors, including later approved directors, ceasing to constitute a majority of the board;
  a merger or consolidation of our Company with a third party, after which our stockholders do not own more than 50% of the voting power; or
  a sale of all or substantially all of our assets to a third party.

 

If we elect not to renew the employment agreement, she shall be entitled to receive severance equal to thirty months of her base salary plus standard employment benefits. If we fail to fully perform all or any portion of our post-termination obligations, we are be obligated to pay to her an amount equal to five times the value of the unperformed obligation.

 

52
 

 

Outstanding Equity Awards at Fiscal Year End

 

The following table sets forth information concerning outstanding equity awards held by the Name Executive Officers as of April 30, 2022.

 

    Option Awards     Stock Awards  
Name  

Number of securities underlying unexercised options (#)

Exercisable

   

Number of securities underlying unexercised options (#)

Unexercisable

   

Option

exercise price ($)

   

Option

expiration date

    Number of shares or units of stock that have not vested (#)     Market value of shares or units of stock that have not vested ($)  
Anthony L. Havens     3,480,731               0.1530       4/31/2024       458,750       110,100  
Sandra L. Ahman     2,824,072               0.1530       4/31/2024       367,352       88,164  

 

Compensation of Directors

 

In fiscal 2022, non-employee directors were compensated for their services in the amounts set forth below.

 

Name 

Fees earned

or paid in
cash

($)

  

Stock

awards

($)(a)

  

Option

awards

($)(b)

  

All other

compensation

($)

 

 

Total

($)

 
Jeffrey Bean   0    0    3,188      3,188 
Kristian Srb   0    0    3,188      3,188 

 

(a) Represents the stock-based compensation recognized in accordance with ASC 718. Stock-based awards are valued at the fair value on the grant date using a Black-Scholes model. Assumptions made in the valuation of stock-based awards are discussed in Note M to the consolidated financial statements.
(b) On January 3, 2022, the Company issued 187,500 options to Mr. Bean and 187,500 options to Mr. Srb, exercisable at $0.08 per share until January 3, 2027; options for both Mr. Bean and Mr. Srb are subject to vesting at the rate of 62,500 options on the grant date, 62,500 options on January 3, 2023, and 62,500 options on January 23, 2024.

 

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

In May 2009, the Company’s Board of Directors authorized a 2009 Consultant Stock Plan covering 133,334 shares of the Company’s common stock for purposes of compensation of certain consultants. Effective June 12, 2013, the Plan was amended to increase the authorized number of shares by 500,000 bringing the total number of authorized shares to 633,333. During the fiscal year ended April 30, 2022, no shares were issued under the plan.

 

In October 2014, the Company’s Board of Directors approved the “2014 Equity Incentive Plan” authorizing the issuance of up to 3,000,000 shares of the Company’s common stock or common stock purchase options. The purpose of the 2014 Equity Incentive Plan (the “2014 Plan”) is to advance the interests of Sparta Commercial Services, Inc. (the “Company”) and its shareholders by enabling the Company and its Subsidiaries to attract and retain persons of ability to perform services for the Company and its Subsidiaries by providing an incentive to such individuals through equity participation in the Company and by rewarding such individuals who contribute to the achievement by the Company of its economic objectives. The shares underlying the 2014 Plan were registered on Form S-8 with the Securities and Exchange Commission on November 3, 2014. During the fiscal year ended April 30, 2022, no shares of common stock were issued under the 2014 Plan.

 

Common Stock

 

The table below sets forth information regarding the beneficial ownership of our common stock as of August 10, 2022 by: each of our directors; each of our executive officers; all of our executive officers and directors as a group; and each person known by us to be the beneficial owner of more than 5% of our common stock.

 

Beneficial ownership is determined in accordance with the rules of the SEC and includes voting and investment power. Under SEC rules, a person is deemed to be the beneficial owner of securities, which may be acquired by such person upon the exercise of options and warrants or the conversion of convertible securities within 60 days from the date on which beneficial ownership is to be determined. Each beneficial owner’s percentage ownership is determined by dividing the number of shares beneficially owned by that person by the 17,501,298 outstanding shares as of August 10, 2022, increased to reflect the beneficially owned shares underlying options, warrants or other convertible securities included in that person’s holdings, but not those underlying shares held by any other person.

 

 

Name (a) 

Number of Shares

Beneficially Owned

  

Percentage of Class

Beneficially Owned

 
Anthony L. Havens (1)   3,004,579    14.654%
Kristian Srb (2)   548,642    3.040%
Jeffrey Bean (3)   545,680    3.024%
Sandra L. Ahman (4)   2,456,799    12.310%
All current directors and named officers as a group (4 in all)   6,555,700    27.260%

 

(a) Unless indicated otherwise, the address for each person named in the table is c/o Sparta Commercial Services, Inc., 555 Fifth Avenue, 14th Floor. New York, NY 10017.
   
(1)

Excludes approximately 500 shares of common stock owned by Mr. Havens’ son held in an irrevocable trust account. Mr. Havens is not the trustee for his son’s trust account, and does not have the sole or shared power to vote or direct the vote of such shares. Mr. Havens disclaims beneficial ownership of such shares held in his son’s trust account.

   
 

Includes (i) 250,838 vested stock options, all exercisable at $0.308 per share until July 9, 2025, (ii) 886,154 vested stock options, all exercisable at $0.275 per share until July 22, 2025, (iii) 166,667 vested stock options all exercisable at $0.08 per share until January 3, 2027 and (iv) 1,718,322 vested stock options all exercisable at $0.08 per share until January 3, 2027.

 

53
 

 

(2) Includes 482,143 vested stock options, all exercisable at $0.308 per share until July 9, 2025 and 62,500 vested stock options, all exercisable at $0.08 per share until January 3, 2027.
   
(3) Includes 482,143 vested stock options, all exercisable at $0.308 per share until July 9, 2025 and 62,500 vested stock options, all exercisable at $0.08 per share until January 3, 2027.
   
(4) Includes (i) 83,613 vested stock options, all exercisable at $0.308 per share until July 9, 2025, (ii) 727,273 vested stock options, all exercisable at $0.275 per share until July 22, 2025, (iii) 83,333 vested stock options, all exercisable at $0.08 per share until January 3, 2027 and (iv) 1,562,500 vested stock options, all exercisable at $0.08 per share until January 3, 2027.

 

Changes in Control

 

Other than outstanding convertible securities, we do not have any arrangements that may result in a change in control.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

There were no transactions with our Directors during the fiscal years ended April 30, 2022 and 2021. As of April 30, 2022, we owed Mr. Srb $395,643 and Ms. Ahman $36,760.

 

Director Independence

 

None of our directors, other than Kristian Srb and Jeffrey Bean, is deemed an independent director. For purposes of determining independence, we are applying the independence standards of the NASDAQ Stock Market LLC.

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

Audit Fees

 

Fees for audit services provided by Boyle CPA, LLC, our principal independent registered public accounting firm, during the fiscal years ended April 30, 2022 and 2021 were $14,000 and $14,000, respectively. Audit fees consist of the aggregate fees billed for the audits of our annual financial statements, the reviews of our quarterly financial statements, and services that are normally provided in connection with statutory and regulatory filings or engagements for those fiscal years.

 

Audit-Related Fees

 

Fees for audit-related services provided by our principal independent registered public accounting firm during the fiscal years ended April 30, 2022 and 2021 were $0. Audit-related fees consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements outside of those fees disclosed above under the caption Audit Fees.

 

Tax Fees

 

Fees for tax services provided by our principal independent registered public accounting firm during the fiscal years ended April 30, 2022 and 2021 were $0 and $0, respectively. Tax fees consist of fees billed for tax compliance, tax advice, and tax planning.

 

54
 

 

All Other Fees

 

There were no other fees billed for services our principal independent registered public accounting firm for the fiscal years ended April 30, 2022 and 2021.

 

Pre-Approval Policies and Procedures

 

Our Board of Directors has a policy that requires pre-approval of all audit, audit-related, tax services, and other services, including non-audit services, performed by our independent registered public accounting firm. All services performed by our principal independent registered public accounting firm, and all fees paid, in our fiscal years ended April 30, 2022 and 2021 were pre-approved. The Board of Directors is responsible for matters typically performed by an audit committee. We do not presently have a separate audit committee of the Board of Directors. The Board of Directors considered whether, and determined that, the auditor’s provision of audit and non-audit services was compatible with maintaining the auditor’s independence.

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

(a) List of documents filed as a part of this report:

 

  (1) Index to Condensed Consolidated Financial Statements
   
  Report of Registered Independent Certified Public Accounting Firm
  Consolidated Balance Sheets as of April 30, 2022 and 2021
  Consolidated Statements of Losses for the years ended April 30, 2022 and 2021
  Consolidated Statement of Deficit for the two years ended April 30, 2022
  Consolidated Statements of Cash Flows for the years ended April 30, 2022 and 2021
  Notes to Consolidated Financial Statements
   
  (2) Index to Financial Statement Schedules

 

Not required.

 

55
 

 

(3) Index to Exhibits

 

Exhibit Number   Description of Exhibit
3(i)(1)   Articles of Incorporation of Tomahawk Oil and Minerals, Inc. (Incorporated by reference to Exhibit 3(i) (1) of Form 10-KSB filed on August 13, 2004)
3(i)(2)   Certificate of Amendment of Articles of Incorporation, November 1983 (Incorporated by reference to Exhibit 3(i) (2) of Form 10-KSB filed on August 13, 2004)
3(i)(3)   Certificate of Amendment of Articles of Incorporation for name change, August 2004 (Incorporated by reference to Exhibit 3(i) of Form 8-K filed on August 27, 2004)
3(i)(4)   Certificate of Amendment of Articles of Incorporation for increase in authorized capital, September 2004 (Incorporated by reference to Exhibit 3(i) of Form 8-K filed on September 17, 2004)
3(i)(5)   Certificate of Amendment of Articles of Incorporation for decrease in authorized capital, December 2004 (Incorporated by reference to Exhibit 3(i) of Form 8-K filed on December 23, 2004)
3(i)(6)   Certificate of Designation for Series A Redeemable Preferred Stock, December 2004 (Incorporated by reference to Exhibit 3(i) of Form 8-K filed on January 4, 2005)
3(i)(7)   Certificate of Designation for Series B Preferred Stock (Incorporated by reference to Exhibit B to Preferred Stock Purchase Agreement, dated as of July 29, 2009
3(i)(8)   Certificate of Amendment of Articles of Incorporation for increase in authorized capital, September 21, 2009 (Incorporated by reference to Exhibit 3(i)(8) of Form S-1 filed on October 2, 2009)
3(i)(9)   Certificate of Designations of Series C Convertible Preferred Stock (Incorporated by reference to Exhibit 5.03(i) of Form 8-K filed on November 19, 2009)
3(i)(10)   Certificate of Designation of Series D Convertible Preferred Stock (Incorporated by reference to Exhibit 3.1 of Form 8-K filed on August 14, 2018)
3(ii)(1)   By-laws (Incorporated by reference to Exhibit 3(ii) (1) of Form 10-KSB filed on August 13, 2004)
3(ii)(2)   By-laws Resolution (Incorporated by reference to Exhibit 3(ii) (2) of Form 10-KSB filed on August 13, 2004)
3(ii)(3)   Board of Directors Resolutions amending By-laws (Incorporated by reference to Exhibit 3(ii) of Form 10-QSB filed on December 15, 2004)
4.1   Form of Stock Option Agreement with Jeffrey Bean (Incorporated by reference to Exhibit 4.1 of Form 10-Q filed on July 9, 2020)
4.2   Form of Stock Option Agreement with Kristian Srb (Incorporated by reference to Exhibit 4.2 of Form 10-Q filed on July 9, 2020)
4.3   Form of Stock Option Agreement with Anthony L. Havens (Incorporated by reference to Exhibit 4.3 of Form 10-Q filed on July 9, 2020)
4.4   Form of Stock Option Agreement with Sandra L. Ahman (Incorporated by reference to Exhibit 4.4 of Form 10-Q filed on July 9, 2020)
4.5   Form of Stock Option Agreement with Anthony L. Havens (Incorporated by reference to Exhibit 4.2 of Form 8-K filed on July 27, 2020)
4.6   Form of Stock Option Agreement with Sandra L. Havens (Incorporated by reference to Exhibit 4.1 of Form 8-K filed on July 27, 2020)
10.1+   Form of Employment Agreement with Anthony L. Havens (Incorporated by reference to Exhibit 10.14 of Form 10-Q filed on July 9, 2020)
10.2+   2005 Stock Incentive Compensation Plan (Incorporated by reference to Exhibit 4 of Form 10-KSB filed on August 13, 2004)
10.3   2010 Consultant Stock Plan (Incorporated by reference to Exhibit 99.1 of Form S-8 filed on May 12, 2009)
10.4+   Form of Employment Agreement with Sandra L Ahman (Incorporated by reference to Exhibit 10.2 of the Form 10-Q filed on July, 9, 2020)
12**   2014 Equity Incentive Plan
14.1   Code of Ethics (Incorporated by reference to Exhibit 14.1 of Form 10-K filed on August 15, 2011)
21.1*   List of Subsidiaries
23.1*   Consent of Boyle CPA, LLC
31.1*   Certification of Chief Executive Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a)
31.2*   Certification of Principal Financial Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a)
32.1*   Certification of Chief Executive Officer and principal financial and accounting officer pursuant to 18 U.S.C. Section 1350
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.

** Incorporated by reference to the registration statement on Form S-8 filed by the registrant with the Commission on November 3, 2014

+ Represents executive compensation plan or agreement

 

56
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SPARTA COMMERCIAL SERVICES, INC.
 
  By:  /s/ Anthony L. Havens
    Anthony L. Havens
    Chief Executive Officer
     
    Date: August 15, 2022

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

 

  By:  /s/ Anthony L. Havens
    Anthony L. Havens
    Chief Executive Officer, President, Interim Principal Financial Officer
    and Chairman of the Board
     
    Date: August 15, 2022
     
  By: /s/ Sandra L. Ahman
    Sandra L. Ahman
    Vice President and Director
     
    Date: August 15, 2022
     
  By: /s/ Kristian Srb
    Kristian Srb
    Director
     
    Date: August 15, 2022
     
  By: /s/ Jeffrey Bean
    Jeffrey Bean
    Director
     
    Date: August 15, 2022

 

57

 

EX-21.1 2 ex21-1.htm

 

EXHIBIT 21.1

 

SUBSIDIARIES OF REGISTRANT

 

The following is a list of subsidiaries of the Company as of April 30, 2022

 

Name   Where Incorporated
     
iMobile Solutions, Inc.   Nevada
New World Health Brands, Inc.   Nevada
Sparta Crypto, Inc.   Nevada

 

 

 

EX-23.1 3 ex23-1.htm

 

EXHIBIT 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-189264) and (File No. 333-199822) of our report, which includes an explanatory paragraph regarding the substantial doubt about the Company’s ability to continue as a going concern, dated August 15, 2022 included in Sparta Commercial Services, Inc.’s Annual Report on Form 10-K for the year ended April 30, 2022.

 

/s/ Boyle CPA, LLC  
Boyle CPA, LLC  
Bayville, NJ  
August 15, 2022  

 

361 Hopedale Drive SE P (732) 822-4427
Bayville, NJ 08721 F (732) 510-0665

 

 

 

EX-31.1 4 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATIONS

 

I, Anthony L. Havens, certify that:

 

1. I have reviewed this Annual Report on Form 10-K for the fiscal year ended April 30, 2022 of Sparta Commercial Services, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. As the registrant’s sole certifying officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. As the registrant’s sole certifying officer, I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 15, 2022  
   
/s/ Anthony L. Havens  
Anthony L. Havens  
Chief Executive Officer, principal executive officer  

 

 

 

 

EX-31.2 5 ex31-2.htm

 

EXHIBIT 31.2

 

CERTIFICATIONS

 

I, Anthony L. Havens, certify that:

 

1. I have reviewed this Annual Report on Form 10-K for the fiscal year ended April 30, 2022 of Sparta Commercial Services, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. As the registrant’s sole certifying officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. As the registrant’s sole certifying officer, I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 15, 2022  
   
/s/ Anthony L. Havens  
Anthony L. Havens  
Principal financial and accounting officer  

 

 

 

EX-32.1 6 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350

 

In connection with the Annual Report of Sparta Commercial Services, Inc. (the “Company”) on Form 10-K for the fiscal year ended April 30, 2022, as filed with the Securities and Exchange Commission on the date therein specified (the “Report”), I, Anthony L. Havens, Chief Executive Officer and principal financial and accounting officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and
   
(2) The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.

 

Date: August 15, 2022

 

  /s/ Anthony L. Havens
 

Anthony L. Havens, Chief Executive Officer,

principal executive officer, principal financial and accounting officer

 

 

 

 

GRAPHIC 7 image_001.jpg begin 644 image_001.jpg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end GRAPHIC 8 form10-k_002.jpg begin 644 form10-k_002.jpg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end EX-101.SCH 9 srco-20220430.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Deficit link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - SUMMARY OF ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - GOING CONCERN MATTERS link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - NOTES PAYABLE AND DERIVATIVES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - LOANS PAYABLE TO RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - EQUITY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - NOTE H – WARRANTS: link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - NOTES PAYABLE AND DERIVATIVES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - EQUITY TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - NOTE H – WARRANTS: (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SCHEDULE OF DISAGGREGATION REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - GOING CONCERN MATTERS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - NOTES PAYABLE AND DERIVATIVES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - LOANS PAYABLE TO RELATED PARTIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - EQUITY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - NOTE H – WARRANTS: (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SCHEDULE OF RECONCILIATION OF INCOME TAX RATE (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 srco-20220430_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 srco-20220430_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 srco-20220430_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Axis] Series A convertible preferred stock [Member] Series B convertible preferred stock [Member] Series C redeemable convertible preferred stock [Member] Series D redeemable convertible preferred stock [Member] Product and Service [Axis] Information Technology [Member] New World Health Brands [Member] Series A Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Series C Preferred Stock [Member] Series D Preferred Stock [Member] Common Stock [Member] Common Stock to be Issued [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Noncontrolling Interest [Member] Long-Lived Tangible Asset [Axis] Leasehold Improvements [Member] Furniture and Fixtures [Member] Website Costs [Member] Computer Equipment [Member] Antidilutive Securities [Axis] Shares to be Issued [Member] Debt Instrument [Axis] Notes Convertible At Holders Option [Member] Notes Convertible At Companys Option [Member] Non Convertible Notes Payable [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Measurement Input Type [Axis] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Price Volatility [Member] Measurement Input Dividend Payout [Member] Measurement Input, Expected Term [Member] Award Type [Axis] Post Split [Member] Common Stock One [Member] Title of Individual [Axis] Fourteen Accredited Investors [Member] Three Accredited Investors [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Havens Stock Option Agreement [Member] Ahman Stock Option Agreement [Member] Two Independent Director [Member] Chief Executive Officer And Vice President [Member] Four Employees [Member] Series C Convertible Preferred Stock [Member] Series D Convertible Preferred Stock [Member] Scenario [Axis] Settlement of Accounts Payable [Member] Common Stock Two [Member] Series B Preferred Stock [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Warrant [Member] Warrant One [Member] Warrant Two [Member] Warrant Three [Member] Non-Employees [Member] Executive Office Space [Member] Employment Agreement [Member] Mr. Havens [Member] Ms. Ahman [Member] Lender One [Member] Lender Two [Member] Legal Entity [Axis] New York County Kings [Member] Promissory Note [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference Auditor Firm ID Auditor Name Auditor Location Statement [Table] Statement [Line Items] ASSETS Current Assets Cash and cash equivalents Accounts receivable Inventory Other current assets Total Current Assets Property and equipment, net of accumulated depreciation and amortization of $213,262 and $213,262, respectively Other assets Deposits Total assets LIABILITIES AND DEFICIT Liabilities: Current Liabilities Bank overdraft Accounts payable and accrued expenses Short Term Loan Current portion notes payable Deferred revenue Derivative liabilities Total Current Liabilities Loans payable-related parties Total Long Term Liabilities Total liabilities Stockholders’ Deficit: Preferred stock value Common stock, $0.001 par value; 750,000,000 shares authorized, and 15,128,005 and 9,809,877 shares issued and outstanding, respectively Common stock to be issued 8,916,805 and 1,214,528 respectively Additional paid-in-capital Accumulated deficit Total deficiency in stockholders’ equity Non-controlling interest Total Deficit Total Liabilities and Deficit Accumulated depreciation and amortization Preferred stock, par value Preferred stock, shares designated Preferred stock, shares issued Preferred stock, shares outstanding Preferred stock, liquidation and redemption value per share Common stock, par value Common stock, shares authorized Common stock shares issued Common stock shares outstanding Common stock to be issued Revenue Total Revenue Less Cost of goods sold Gross profit Operating expenses: General and administrative Research and development Total operating expenses Loss from operations Other (income) expense: Other income Forgiveness of debt Financing cost Amortization of debt discount Loss (gain) in changes in fair value of derivative liability Total other (income) expense Net income (loss) Net loss (income) attributed to non-controlling interest Preferred dividend Net income (loss) attributed to common stockholders Basic and diluted loss per share: Loss from continuing operations attributable to Sparta Commercial Services, Inc. common stockholders Loss from discontinued operations attributable to Sparta Commercial Services, Inc. common stockholders Net loss attributable to Sparta Commercial Services, Inc. common stockholders Weighted average shares outstanding Balance value Beginning balance, shares Issuance of Preferred and Common Stock for Cash Issuance of Preferred and Common Stock for Cash, shares Conversion of Accrued Compensation to Series D Preferred Stock Conversion of Accrued Compensation to Series D Preferred Stock, shares Options issued for compensation and accrued compensation Conversion of Preferred to common shares Conversion of Preferred to common, shares Conversion of convertible notes Conversion of convertible notes, shares Issuance of preferred shares Issuance of preferred, shares Issuance of common shares for cash Issuance of common shares for cash, shares Shares issued for services Shares issued for services, shares Stocks issued for settlement of payables Stocks issued for settlement of payables, shares Stocks issued for equity Stocks issued for equity, shares Stocks issued from to be issued Stocks issued from tobe issued, shares Preferred dividend Net income (loss) alance value Ending balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Loss (Gain) from change in fair value of derivative liabilities Amortization of debt discount Non-cash financing cost Forgiveness of debt Stock based compensation Changes in operating assets and liabilities Accounts receivable Inventory Other assets Accounts payable and accrued expenses Deferred revenue Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of equipment Net cash (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITIES Bank overdraft Proceeds from sale of stock Net Proceeds from notes payable Payments on notes payable Proceeds from related party notes Payments on related party notes Net cash provided by financing activities Net (decrease) increase in cash Cash and cash equivalents, beginning of period Cash and cash equivalents , end of period Cash paid for: Interest Income taxes Accounting Policies [Abstract] SUMMARY OF ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements [Abstract] GOING CONCERN MATTERS Debt Disclosure [Abstract] NOTES PAYABLE AND DERIVATIVES Related Party Transactions [Abstract] LOANS PAYABLE TO RELATED PARTIES Equity [Abstract] EQUITY TRANSACTIONS Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT Note H Warrants NOTE H – WARRANTS: Income Tax Disclosure [Abstract] INCOME TAXES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Business Principles of Consolidation Estimates Revenue Recognition Cash Equivalents Website Development Costs Fair Value Measurements Income Taxes Stock Based Compensation Inventories Property and Equipment Concentrations of Credit Risk Net Loss Per Share Derivative Liabilities Convertible Instruments Reclassifications Recent Accounting Pronouncements SCHEDULE OF DISAGGREGATION REVENUE SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT SCHEDULE OF NOTES PAYABLE SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE SCHEDULE OF WARRANTS ACTIVITY SCHEDULE OF RECONCILIATION OF INCOME TAX RATE SCHEDULE OF DEFERRED TAX ASSETS Schedule of Product Information [Table] Product Information [Line Items]  Revenues Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Computer Equipment Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of earnings per share, amount Retained earnings (accumulated deficit) Working capital deficit Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Subtotal Less debt discount Total Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Derivative liability, measurement input, percentage Derivative liability, measurement input, expected life Balance, beginning of year Derivative liability reclassified to additional paid in capital Derivative financial liability arising on the issue of convertible notes and warrants Fair value adjustments Balance, end of year Common stock discount rate, percentage Amortization of debt discount Loans payable to officers and directors Schedule of Stock by Class [Table] Class of Stock [Line Items] Preferred Stock Stockholders' equity, reverse stock split Issuance of shares, reverse stock splits Common Stock, Shares, Outstanding Common Stock, Shares Subscribed but Unissued Issuance of stock for service, shares Issuance of stock for service, value Common shares issued upon conversion Converted common shares Number of stocks sold during period Sale of stock Convertion of deferred salary Stock option, grants Contractual term Share Price Share based compensation vesting period Issuance of stock, shares Issuance of stock, values Convertion of convertible securities, shares Convertion of convertible securities, value Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Derivative liabilities Computer equipment, software and furniture Less: accumulated depreciation Net property and equipment Warrants outstanding, exercise price Warrants outstanding, number Warrants outstanding, weighted average remaining contractual life (years) Warrants outstanding, weighted average exercise price Warrants exercisable, number exercisable Warrants exercisable, weighted average exercise price Number of shares, warrants outstanding, beginning balance Weighted average exercise price per share, warrants outstanding, beginning balance Number of shares, warrants grants Weighted average exercise price per share, warrants grants Number of shares, warrants canceled or expired Weighted average exercise price per share, warrants canceled or expired Weighted average exercise price per share, warrants outstanding, beginning balance Number of shares, warrants exercised Weighted average exercise price per share, warrants exercised Number of shares, warrants outstanding, ending balance Weighted average exercise price per share, warrants outstanding, ending balance Stock issued for services Stock option price per share Warrants vested Fair value adjustment of warrants Federal statutory income tax rate State income taxes, net of federal benefit Permanent differences Change in valuation allowance Provision for income taxes Net operating loss carry forward Valuation allowance Net deferred tax asset Operating loss carry forwards, net Operating loss carryforwards, expiration date Lease expiring date Rent expenses Debt instrument, term Number of shares issued during the period Share price Shares vested term Debt principal amount Aggregate note amount Loss on contingent Bank overdraft. Series A convertible preferred stock [Member] Series B convertible preferred stock [Member] Series C redeemable convertible preferred stock [Member] Series D redeemable convertible preferred stock [Member] Debt forgiveness. Financing cost. Common Stock to be Issued [Member] Shares Issued For Conversion Of Preferred Value. Common shares issued for cash Shares issued for settlement of accounts payable. Stocks issued from to be issued. Stock issued during period value issuance of preferred and common stock for cash. Conversion of accrued compensation to series D preferred stock. Stocks issued for equity. Shares issued for conversion of preferred shares. Common shares issued for cash stock issued during period shares new issues. Shares issued during period shares for settlement of accounts payable. Stocks issued for equity shares. Stocks issued from to be issued shares. Stock issued during period shares issuance of preferred and common stock for cash. Conversion of accrued compensation to series d preferred stock shares. Derivative gain loss on derivative. Amortization of debt discount. Schedule Of Estimated Useful Life Of Property And Equipment [Table Text Block] Information Technology [Member] New World Health Brands [Member] Website Costs [Member] Shares to be Issued [Member] Working capital deficit. Common stock discount rate, percentage. Derivative liability, measurement input, expected life. Measurement Input Dividend Payout [Member] Derivative liability extinguished. Series A Redeemable Preferred Stock [Member] Schedule Of Preferred Stock Outstanding Shares [Table Text Block] Series C Convertible Preferred Stock [Member] Series D Convertible Preferred Stock [Member] Settlement of Accounts Payable [Member] Four Accredited Investors [Member] Settlement notes payable and accrued expenses. Stock issued during period value issued for services one. Stock issued during period shares issued for services one. Series D Convertible Preferred Stock One [Member] Share based compensation arrangement by share based payment award options for deferred salary. Havens Stock Option Agreement [Member] Ahman Stock Option Agreement [Member] Two Independent Director [Member] Chief Executive Officer And Vice President [Member] Four Employees [Member] Warrants [Text Block] Schedule Of Warrants Or Rights Shares Authorized By Exercise Price Range [Table Text Block] Number of preferred stock. Fair value of warrants. Warrants and rights outstanding expected life. Weighted average remaining contractual life (years) Warrant One [Member] Warrant Two [Member] Warrant Three [Member] Warrants outstanding, weighted average exercise price of warrants. Number warrants exercisable. Weighted average exercise price of warrants on exercisable. Non-Employees [Member] Weighted average exercise price, warrants grants. Weighted average exercise price, warrants exercised. Weighted average exercise price, warrants canceled or expired. Operating loss carryforwards, expiration date. Executive Office Space [Member] Employment Agreement [Member] Ms. Ahman [Member] Shares vested term. Mr. Havens [Member] Lender One [Member] Restricted Common Stock Four [Member] New York County Kings [Member] Promissory Note [Member] Common Stock One [Member] Common Stock Two [Member] Post Split [Member] Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. Net income loss available to common stock holders. Derivative liability. Assets, Current Assets Liabilities, Current Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Other Nonoperating Income (Expense) AmortizationOfDebtDiscount Derivative, Gain (Loss) on Derivative, Net Nonoperating Income (Expense) Net Income (Loss) Attributable to Noncontrolling Interest Preferred Stock Dividends, Income Statement Impact NetIncomeLossAvailableToCommonStockholders Shares, Outstanding SharesIssuedForConversionOfPreferredValue Dividends, Preferred Stock Debt Instrument, Decrease, Forgiveness Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Other Operating Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Deferred Revenue Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Investing Activities Proceeds from (Repayments of) Bank Overdrafts Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations WorkingCapitalDeficit Long-Term Debt DerivativeLiability Derivative Liability, Subject to Master Netting Arrangement, before Offset Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net EX-101.PRE 13 srco-20220430_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 14 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover - USD ($)
12 Months Ended
Apr. 30, 2022
Aug. 15, 2022
Cover [Abstract]    
Document Type 10-K  
Amendment Flag false  
Document Annual Report true  
Document Transition Report false  
Document Period End Date Apr. 30, 2022  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --04-30  
Entity File Number 0-9483  
Entity Registrant Name SPARTA COMMERCIAL SERVICES, INC.  
Entity Central Index Key 0000318299  
Entity Tax Identification Number 30-0298178  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 555 Fifth Avenue  
Entity Address, Address Line Two 14th Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10017  
City Area Code (212)  
Local Phone Number 239-2666  
Title of 12(b) Security Common Stock, par value $0.001  
Trading Symbol SRCO  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Public Float $ 978,241  
Entity Common Stock, Shares Outstanding   17,501,298
Documents Incorporated by Reference None  
Auditor Firm ID 6285  
Auditor Name Boyle CPA, LLC  
Auditor Location Red Bank, NJ  
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets - USD ($)
Apr. 30, 2022
Apr. 30, 2021
Current Assets    
Cash and cash equivalents $ 317 $ 396
Accounts receivable 469
Inventory 8,422 13,823
Other current assets
Total Current Assets 8,739 14,688
Property and equipment, net of accumulated depreciation and amortization of $213,262 and $213,262, respectively
Other assets 9,628
Deposits 9,000 9,000
Total assets 17,739 33,316
Current Liabilities    
Bank overdraft 27,202 49,041
Accounts payable and accrued expenses 4,354,129 3,627,831
Short Term Loan 141,585 409,013
Current portion notes payable 5,250,084 4,680,275
Deferred revenue 13,385 13,946
Derivative liabilities 9,549,640 3,446,738
Total Current Liabilities 19,336,025 12,226,844
Loans payable-related parties 432,403 432,403
Total Long Term Liabilities 432,403 432,403
Total liabilities 19,768,428 12,659,247
Stockholders’ Deficit:    
Common stock, $0.001 par value; 750,000,000 shares authorized, and 15,128,005 and 9,809,877 shares issued and outstanding, respectively 15,128 9,810
Common stock to be issued 8,916,805 and 1,214,528 respectively 8,292 1,215
Additional paid-in-capital 53,210,921 51,351,156
Accumulated deficit (73,984,686) (64,993,250)
Total deficiency in stockholders’ equity (20,734,864) (13,612,930)
Non-controlling interest 984,175 986,999
Total Deficit (19,750,689) (12,625,931)
Total Liabilities and Deficit 17,739 33,316
Series A convertible preferred stock [Member]    
Stockholders’ Deficit:    
Preferred stock value 12,500 12,500
Series B convertible preferred stock [Member]    
Stockholders’ Deficit:    
Preferred stock value  
Series C redeemable convertible preferred stock [Member]    
Stockholders’ Deficit:    
Preferred stock value 2,363 4,145
Series D redeemable convertible preferred stock [Member]    
Stockholders’ Deficit:    
Preferred stock value $ 618 $ 1,494
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets (Parenthetical) - USD ($)
Apr. 30, 2022
Apr. 30, 2021
Accumulated depreciation and amortization $ 213,262 $ 213,262
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares designated 10,000,000 10,000,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 750,000,000 750,000,000
Common stock shares issued 15,128,005 9,809,877
Common stock shares outstanding 15,128,005 9,809,877
Common stock to be issued 8,916,805 1,214,528
Series A convertible preferred stock [Member]    
Preferred stock, par value $ 100 $ 100
Preferred stock, shares designated 35,850 35,850
Preferred stock, shares issued 125 125
Preferred stock, shares outstanding 125 125
Series B convertible preferred stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares designated 1,000 1,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Preferred stock, liquidation and redemption value per share $ 10,000 $ 10,000
Series C redeemable convertible preferred stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares designated 200,000 200,000
Preferred stock, shares issued 4,145 4,145
Preferred stock, shares outstanding 4,145 4,145
Preferred stock, liquidation and redemption value per share $ 10 $ 10
Series D redeemable convertible preferred stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares designated 2,000,000 2,000,000
Preferred stock, shares issued 1,494 4,494
Preferred stock, shares outstanding 1,494 4,494
Preferred stock, liquidation and redemption value per share $ 1.00 $ 1.00
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Revenue    
Total Revenue $ 245,469 $ 259,731
Less Cost of goods sold 42,161 60,986
Gross profit 203,308 198,745
Operating expenses:    
General and administrative 1,199,416 1,394,881
Research and development 217,138
Total operating expenses 1,470,554 1,394,881
Loss from operations (1,267,246) (1,196,136)
Other (income) expense:    
Other income (11,956) (7,690)
Forgiveness of debt   (125,328)
Financing cost 601,279 723,003
Amortization of debt discount 0
Loss (gain) in changes in fair value of derivative liability 7,132,043 504,599
Total other (income) expense 7,721,366 1,094,584
Net income (loss) (8,988,614) (2,290,720)
Net loss (income) attributed to non-controlling interest 2,823 (12,748)
Preferred dividend   (191)
Net income (loss) attributed to common stockholders $ (8,991,437) $ (2,303,659)
Basic and diluted loss per share:    
Loss from continuing operations attributable to Sparta Commercial Services, Inc. common stockholders $ (0.66) $ (0.37)
Loss from discontinued operations attributable to Sparta Commercial Services, Inc. common stockholders 0.0000
Net loss attributable to Sparta Commercial Services, Inc. common stockholders $ (0.66) $ (0.37)
Weighted average shares outstanding 13,686,995 6,270,929
Information Technology [Member]    
Revenue    
Total Revenue $ 219,404 $ 245,675
New World Health Brands [Member]    
Revenue    
Total Revenue $ 26,065 $ 14,056
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Deficit - USD ($)
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Balance value $ (12,625,931) $ 11,591,617
Issuance of Preferred and Common Stock for Cash   235,502
Conversion of Accrued Compensation to Series D Preferred Stock   311,363
Options issued for compensation and accrued compensation   621,665
Conversion of Preferred to common shares 1,658,714  
Conversion of convertible notes 25,000 50,000
Issuance of preferred shares (321,019)  
Issuance of common shares for cash 510,000  
Shares issued for services 159,011 25,319
Stocks issued for settlement of payables 25,063  
Stocks issued for equity 59,711  
Stocks issued from to be issued (246,978)  
Preferred dividend (191)
Net income (loss) (8,994,260) (2,277,972)
alance value (19,750,689) (12,625,931)
Common Stock [Member]    
Balance value $ 9,810 $ 9,433
Beginning balance, shares 9,809,877 9,433,282
Conversion of Preferred to common shares $ 3,194  
Conversion of Preferred to common, shares 3,194,418  
Conversion of convertible notes $ 125 $ 250
Conversion of convertible notes, shares 125,000 250,000
Shares issued for services $ 732 $ 127
Shares issued for services, shares 731,623 126,595
Stocks issued for settlement of payables $ 427  
Stocks issued for settlement of payables, shares 427,235  
Stocks issued for equity $ 355  
Stocks issued for equity, shares 355,000  
Stocks issued from to be issued $ 485  
Stocks issued from tobe issued, shares 484,852  
Net income (loss)
alance value $ 15,128 $ 9,810
Ending balance, shares 15,128,005 9,809,877
Common Stock to be Issued [Member]    
Balance value $ 1,215 $ 848
Beginning balance, shares 1,214,528 847,865
Issuance of Preferred and Common Stock for Cash   $ 367
Issuance of Preferred and Common Stock for Cash, shares   366,663
Conversion of Preferred to common shares $ 995  
Conversion of Preferred to common, shares 995,500  
Conversion of convertible notes  
Issuance of preferred shares $ (2,350)  
Issuance of preferred, shares (1,725,176)  
Issuance of common shares for cash $ 8,917  
Issuance of common shares for cash, shares 8,916,805  
Stocks issued from to be issued $ (485)  
Stocks issued from tobe issued, shares (484,852)  
Net income (loss)
alance value $ 8,292 $ 1,215
Ending balance, shares 8,916,805 1,214,528
Additional Paid-in Capital [Member]    
Balance value $ 51,351,156 $ 50,120,928
Issuance of Preferred and Common Stock for Cash   234,995
Conversion of Accrued Compensation to Series D Preferred Stock   311,001
Options issued for compensation and accrued compensation   621,665
Conversion of Preferred to common shares 1,656,493  
Conversion of convertible notes 24,875 49,750
Issuance of preferred shares (317,979)  
Issuance of common shares for cash 501,083  
Shares issued for services 158,279 25,192
Stocks issued for settlement of payables 24,636  
Stocks issued for equity 59,356  
Stocks issued from to be issued (246,978)  
Net income (loss)
alance value 53,210,921 51,351,156
Retained Earnings [Member]    
Balance value (64,993,250) (62,702,339)
Preferred dividend   (191)
Net income (loss) (8,991,437) (2,290,720)
alance value (73,894,687) (64,993,250)
Noncontrolling Interest [Member]    
Balance value 986,999 974,251
Conversion of convertible notes  
Net income (loss) (2,823) 12,748
alance value 984,176 986,999
Series A Preferred Stock [Member] | Preferred Stock [Member]    
Balance value $ 12,500 $ 12,500
Beginning balance, shares 125 125
Net income (loss)
alance value $ 12,500 $ 12,500
Ending balance, shares 125 125
Series C Preferred Stock [Member] | Preferred Stock [Member]    
Balance value $ 4,145 $ 4,005
Beginning balance, shares 4,132,269 4,132,129
Issuance of Preferred and Common Stock for Cash   $ 140
Issuance of Preferred and Common Stock for Cash, shares   140
Conversion of Preferred to common shares $ (1,501)  
Conversion of Preferred to common, shares (1,688,269)  
Conversion of convertible notes  
Issuance of preferred shares $ (281)  
Issuance of preferred, shares (281,000)  
Net income (loss)
alance value $ 2,363 $ 4,145
Ending balance, shares 2,163,000 4,132,269
Series D Preferred Stock [Member] | Preferred Stock [Member]    
Balance value $ 1,494 $ 1,132
Beginning balance, shares 1,494,962 1,132,962
Conversion of Accrued Compensation to Series D Preferred Stock   $ 362
Conversion of Accrued Compensation to Series D Preferred Stock, shares   362,000
Conversion of Preferred to common shares $ (467)  
Conversion of Preferred to common, shares (467,551)  
Conversion of convertible notes  
Issuance of preferred shares $ (409)  
Issuance of preferred, shares (409,000)  
Net income (loss)
alance value $ 618 $ 1,494
Ending balance, shares 618,411 1,494,962
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (8,988,614) $ (2,290,720)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization
Loss (Gain) from change in fair value of derivative liabilities 6,102,902 644,613
Amortization of debt discount (312,049)
Non-cash financing cost 59,465 723,003
Forgiveness of debt 786,091 382,931
Stock based compensation 159,009 464,718
Changes in operating assets and liabilities    
Accounts receivable 469 951
Inventory 5,401 9,508
Other assets 9,628 470
Accounts payable and accrued expenses 695,589 (299,504)
Deferred revenue (561) (2,308)
Net cash used in operating activities (1,170,621) (678,387)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of equipment
Net cash (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES    
Bank overdraft (21,839) 34,268
Proceeds from sale of stock 890,000 235,502
Net Proceeds from notes payable 302,381 409,013
Proceeds from related party notes  
Payments on related party notes  
Net cash provided by financing activities 1,170,542 678,783
Net (decrease) increase in cash (79) 396
Cash and cash equivalents, beginning of period 396
Cash and cash equivalents , end of period 317 396
Cash paid for:    
Income taxes
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF ACCOUNTING POLICIES
12 Months Ended
Apr. 30, 2022
Accounting Policies [Abstract]  
SUMMARY OF ACCOUNTING POLICIES

NOTE A – SUMMARY OF ACCOUNTING POLICIES

 

A summary of the significant accounting policies applied in the preparation of the accompanying financial statements follows.

 

Business

 

Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation serving four markets. Sparta is a technology company that develops, markets and manages business websites and mobile applications (mobile apps) for smartphones and tablets. The Company also owns and manages websites which sell on-demand motorcycle, recreational vehicle, power-sport vehicle and truck title history reports for consumers, retail dealers, auction houses, insurance companies and banks/finance companies. Lastly, since 2007, Sparta has administered leasing programs nationwide for local and/or state agencies seeking to finance municipal vehicles and equipment. The Company also introduced a new business line in the rapidly expanding Hemp-CBD (cannabidiol) market.

 

In 2016, the Company changed the name of its majority-owned subsidiary Specialty Reports, Inc., to iMobile Solutions, Inc. The new name reflects the Company’s strategic evolution and focus on the growing mobile application market domestically.

 

Sparta’s mobile application (mobile app) offerings have broadened our base beyond our original base of vehicle dealers to include a wide range of businesses including, but not limited to, agriculture dealerships, racetracks, private clubs, country clubs, restaurants and grocery stores. We also offer a private label version of our mobile app framework to enable other businesses to offer custom apps to their customers.

 

The Company also designs, launches, maintains, and hosts websites for businesses. We provide specific, tailored action plans for our clients’ websites that include services such as eCommerce, CRM (Customer Relationship Management) development and integration, ordering system creation and integration, SEO (search engine optimization), social media marketing, and online reviews to improve their presence online. In addition, we offer text messaging services which are vital for businesses’ marketing, retention and loyalty strategies. Our text messaging platform allows our clients to easily manage, schedule, and analyze text message performance.

 

The Company’s vehicle history reports include Cyclechex (Motorcycle History Reports at www.cyclechex.com); RVchecks (Recreational Vehicle History Reports at www.rvchecks.com); and Truckchex (Heavy Duty Truck History Reports at www.truckchex.com). Our Vehicle History Reports are designed for consumers, retail dealers, auction houses, insurance companies and banks/finance companies.

 

Sparta also administers a Municipal Leasing Program for local and/or state agencies throughout the country who are seeking a better and more economical way to finance their essential equipment needs, including police motorcycles, cruisers, buses, fire trucks, and EMS equipment. We are continuing to expand our roster of equipment manufacturers and the types of equipment we lease.

 

New World Health Brands, Inc. (NWHB) was formed in April 2019 as a subsidiary and new business line of Sparta Commercial Services, Inc. While anticipating, and with the passing of the 2018 Farm Bill, which resulted in the removal of hemp (CBD) from Schedule 1 of the Controlled Substances Act. Sparta’s management recognized a substantial potential business opportunity in the rapidly expanding Industrial Hemp-CBD (Cannabinol) market in the United States. During 2019-2020, management sourced, developed and lab tested 5 CBD product categories totaling 31 products, procured product packaging, labeling, implemented fulfillment and launched an on-line B2C website, www.newworldhealthcbd.com. The Company has since curated its products and currently offers 15 products with plans to add complementary products to our product line.

 

 

Sparta’s newest subsidiary, Sparta Crypto, Inc., www.SpartaCrypto.com, was established September 25, 2020 and is in the process of completing a proprietary state-of-the-art platform designed to connect users of widely adopted digital currencies with sellers of various goods and services. The platform has not launched and the Company can make no assurances that the described plan will reach implementation. In addition, the Company has completed and tested a cryptocurrency payment gateway called SpartaPayIQ, www.SpartaPayIQ.com, which is functional and was formally announced on March 3, 2022.

 

Sparta’s offices are located at 555 Fifth Avenue, 14th Floor, New York, NY 10017, (212) 239-2666. The Company maintains a corporate website at www.spartacommercial.com.

 

We identify our ongoing information technology business in two reporting groups: mobile apps/websites and vehicle history reports, both of which operate under our wholly owned subsidiary, iMobile Solutions, Inc. The latest product offering, via www.newworldhealthcbd.com, offering a full array of hemp-derived CBD products, is contained in our subsidiary, New World Health Brands, Inc.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its majority owned subsidiary. All material intercompany transactions and balances have been eliminated in consolidation. The third party ownership of the Company’s subsidiary is accounted for as noncontrolling interest in the consolidated financial statements. Changes in the noncontrolling interest are reported in the statement of stockholders’ deficit.

 

Estimates

 

The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.

 

Revenue Recognition

 

During the first quarter of 2018, the Company adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606), using the cumulative-effect method. The new standard requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The adoption did not have an impact in our consolidated financial statements, other than the enhancement of our disclosures related to our revenue-generating activities.

 

The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions.

 

Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable.

 

The following table presents our revenues disaggregated by revenue source:

 

   2022   2021 
   Year Ended April 30, 
   2022   2021 
Information Technology  $219,404   $245,675 
New World Health Brands   26,065    14,056 
 Revenues  $245,469   $259,731 

 

 

Cash Equivalents

 

For the purpose of the accompanying financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents.

 

Website Development Costs

 

The Company recognizes website development costs in accordance with ASC 350-50, “Accounting for Website Development Costs.” As such, the Company expenses all costs incurred that relate to the planning and post implementation phases of development of its website. Direct costs incurred in the development phase are capitalized and recognized over the estimated useful life. Costs associated with repair or maintenance for the website are included in cost of net revenues in the current period expenses.

 

Fair Value Measurements

 

The Company adopted ASC 820, “Fair Value Measurements (“ASC 820”).” ASC 820 establishes a three-level fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets the lowest priority to unobservable inputs to fair value measurements of certain assets and Liabilities. The three levels of the fair value hierarchy under ASC 820 are described below:

 

Level 1 — Quoted prices for identical instruments in active markets. Level 1 assets and liabilities include debt and equity securities and derivative contracts that are traded in an active exchange market, as well as certain securities that are highly liquid and are actively traded in over-the-counter markets.
   
Level 2 — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which all significant inputs and significant value drivers are observable in active markets.
   
Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value measurements. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques based on significant unobservable inputs, as well as management judgments or estimates that are significant to valuation.

 

This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not always be available.

 

Income Taxes

 

We utilize ASC 740 “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at year-end based on enacted laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.

 

The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.

 

Stock Based Compensation

 

We account for our stock based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

 

 

We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.

 

Inventories

 

The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health Brands business.

 

Property and Equipment

 

Property and equipment are recorded at cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is calculated using the straight-line method over the estimated useful lives. Estimated useful lives of major depreciable assets are as follows:

 

   
Leasehold improvements 3 years
Furniture and fixtures 7 years
Website costs 3 years
Computer Equipment 5 years

 

Concentrations of Credit Risk

 

Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.

 

Net Loss Per Share

 

The Company uses ASC 260-10, “Earnings Per Share,” for calculating the basic and diluted loss per share. The Company computes basic loss per share by dividing net loss and net loss attributable to common shareholders by the weighted average number of common shares outstanding. Common equivalent shares are excluded from the computation of net loss per share if their effect is anti-dilutive.

 

At April 30, 2022 and 2021 42 million potential shares (including 847,866 shares to be issued included on the balance sheet) and 10,397,258 potential shares (including 807,866 shares to be issued included on the balance sheet), respectively, were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share.

 

Derivative Liabilities

 

The Company assessed the classification of its derivative financial instruments as of April 30, 2022 and 2021 which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “Accounting for Derivative Instruments and Hedging Activities”.

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

 

Reclassifications

 

Certain reclassifications have been made to conform to prior periods’ data to the current presentation. These reclassifications had no effect on reported losses.

 

Recent Accounting Pronouncements

 

In March 2019, the FASB issued ASU 2019-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting” (ASU 2018-09). This ASU makes several modifications to Topic 718 related to the accounting for forfeitures, employer tax withholding on share-based compensation, and the financial statement presentation of excess tax benefits or deficiencies. ASU 2018-09 also clarifies the statement of cash flows presentation for certain components of share-based awards. The standard is effective for interim and annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company adopted this guidance on May 1, 2019 and it did not have an impact on the Company’s consolidated financial statements and related disclosures.

 

In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements - Going Concern (Topic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”). This amendment prescribes that an entity should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. The amendments became effective for the Company’s annual and interim reporting periods beginning May 1, 2019. The Company will begin evaluating going concern disclosures based on this guidance upon adoption.

 

The FASB issued the following accounting standard updates related to Topic 606, Revenue Contracts with Customers:

 

●  ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”) in May 2014. ASU 2014-09 requires entities to recognize revenue through the application of a five-step model, which includes identification of the contract, identification of the performance obligations, determination of the transaction price, allocation of the transaction price to the performance obligations and recognition of revenue as the entity satisfies the performance obligations.
ASU No. 2018-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2018-08”) in March 2018. ASU 2019-08 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on principal versus agent considerations.

 

 

ASU No. 2018-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing (“ASU 2018-10”) in April 2018. ASU 2018-10 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas.
ASU No. 2018-11, Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2018 EITF Meeting (SEC Update) (“ASU 2018-11”) in May 2018. ASU 2018-11 rescinds SEC paragraphs pursuant to two SEC Staff Announcements at the March 3, 2018 EITF meeting. The SEC Staff is rescinding SEC Staff Observer comments that are codified in Topic 605 and Topic 932, effective upon adoption of Topic 606.
ASU No. 2018-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients in May 2018. ASU 2018-12 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on a few narrow areas and adds some practical expedients to the guidance.

 

These ASUs became effective for the Company beginning interim period beginning May 1, 2018. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (Topic 842) “Leases.” Topic 842 supersedes the lease requirements in Accounting Standards Codification (ASC) Topic 840, “Leases.” Under Topic 842, lessees are required to recognize assets and liabilities on the balance sheet for most leases and provide enhanced disclosures. Leases will continue to be classified as either finance or operating. The Company adopted Topic 842 effective May 1, 2019 using a modified retrospective method and elected not to recognize leases with terms of 12 months or less. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, we have not determined whether implementation of such proposed standards would be material to our consolidated financial statements.

 

XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
GOING CONCERN MATTERS
12 Months Ended
Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN MATTERS

NOTE B – GOING CONCERN MATTERS

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, the Company has incurred recurring losses and generated negative cash flows from operating activities since inception. As of April 30, 2022, the Company had an accumulated deficit of $73,984,686 and a working capital deficit (total current liabilities exceeded total current assets) of $19,327,286. The Company’s cash balance and revenues generated are not currently sufficient and cannot be projected to cover its operating expenses for the next twelve months from the filing date of this report. These factors among others raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements.

 

The Company’s existence is dependent upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that the Company’s efforts will be successful. No assurance can be given that management’s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

 

In order to improve the Company’s liquidity, the Company’s management is actively pursuing additional equity financing through discussions with investment bankers, private equity groups, and private investors. There can be no assurance that the Company will be successful in its effort to secure additional equity financing.

 

 

XML 22 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
NOTES PAYABLE AND DERIVATIVES
12 Months Ended
Apr. 30, 2022
Debt Disclosure [Abstract]  
NOTES PAYABLE AND DERIVATIVES

NOTE C – NOTES PAYABLE AND DERIVATIVES

 

The Company has outstanding numerous notes payable to various parties. The notes bear interest at rates of 5% - 20% per year and are summarized as follows:

 

Notes Payable  April 30, 2022   April 30, 2021 
Notes convertible at holder’s option  $2,980,848   $2,522,925 
Notes convertible at Company’s option   335,700    335,700 
Non-convertible notes payable   1,933,536    1,821,650 
Subtotal   5,250,084    4,680,275 
Less debt discount   -    - 
Total  $5,250,084   $4,680,275 

 

Certain of the notes payable contain variable conversion rates and the conversion features are classified as derivative liabilities. The conversion prices are based on the market price of the Company’s common stock, at discounts of 30% to 48% to market value.

 

Amortization of debt discount for the years ended April 30, 2022 and 2021 was $0 and $0, respectively.

 

The Company’s derivative financial instruments consist of embedded derivatives related to the outstanding short term Convertible Notes Payable. These embedded derivatives include certain conversion features indexed to the Company’s common stock. The accounting treatment of derivative financial instruments requires that the Company record the derivatives and related items at their fair values as of the inception date of the Convertible Notes Payable and at fair value as of each subsequent balance sheet date. In addition, under the provisions of Accounting Standards Codification subtopic 815-40, Derivatives and Hedging; Contracts in Entity’s Own Equity (“ASC 815-40”), as a result of entering into the Convertible Notes Payable, the Company is required to classify all other non-employee stock options and warrants as derivative liabilities and mark them to market at each reporting date. Any change in fair value inclusive of modifications of terms will be recorded as non-operating, non-cash income or expense at each reporting date. If the fair value of the derivatives is higher at the subsequent balance sheet date, the Company will record a non-operating, non-cash charge. If the fair value of the derivatives is lower at the subsequent balance sheet date, the Company will record non-operating, non-cash income.

 

The change in fair value of the derivative liabilities of convertible notes outstanding at April 30, 2022 and 2021 was calculated with the following average assumptions, using a Black-Scholes option-pricing model are as follows:

 

Significant Assumptions:       
Risk free interest rate  Ranging from  0.16% to 0.20 
Expected stock price volatility      369%
Expected dividend payout      0 
Expected options life in years  Ranging from   1 year to 2 years 

 

Changes in derivative liability during the years ended April 30, 2022 and 2021 were:

 

   April 30, 
   2022   2021 
Balance, beginning of year  $4,252,446   $2,802,125 
Derivative liability reclassified to additional paid in capital   (474,420)   (573,397)
Derivative financial liability arising on the issue of convertible notes and warrants        715,411 
Fair value adjustments   3,728,206    1,310,307 
Balance, end of year  $7,506,232   $4,252,446 

 

 

XML 23 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
LOANS PAYABLE TO RELATED PARTIES
12 Months Ended
Apr. 30, 2022
Related Party Transactions [Abstract]  
LOANS PAYABLE TO RELATED PARTIES

NOTE D – LOANS PAYABLE TO RELATED PARTIES

 

As of April 30, 2022, and 2021, aggregated loans payable, without demand and with no interest, to officers and directors were $432,403 and $432,403, respectively.

 

XML 24 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
EQUITY TRANSACTIONS
12 Months Ended
Apr. 30, 2022
Equity [Abstract]  
EQUITY TRANSACTIONS

NOTE EEQUITY TRANSACTIONS

 

Common Stock

 

The Company is authorized to issue 750,000,000 shares of common stock, $0.001 par value.

 

On December 30, 2020, Sparta Commercial Services, Inc. (the “Company”) filed with the Secretary of State of the state of Nevada, a Certificate of Amendment to its Articles of Incorporation (the “Amendment”), attached herewith as Exhibit 3.1, and incorporated by reference. The Amendment will be effective as of December 30, 2020. On July 9, 2020, the Board of Directors of the Company declared July 30, 2020 as the effective date for the 1 for 100 reverse stock split (the “Reverse Stock Split”), previously approved by the stockholders of the Company by written consent in accordance with the information contained in the Schedule 14C Information Statement filed with the Securities and Exchange Commission on July 9, 2020. FINRA reviewed and authorized the corporate action changing the effective date to December 30, 2020 (the “Effective Date”).

 

As a result of the Reverse Stock Split, every one hundred shares of outstanding common stock will automatically be converted into one shares of the Company’s common stock immediately prior to the opening of trading on the next business day after the Effective Date. If, as a result of the reverse split, a stockholder is left with a fractional share, that stockholder shall receive one full share in lieu of such fractional share. Immediately after the effectiveness of the reverse split, there will be 7,027,930 shares of the Company’s common stock issued and outstanding. The aggregate number of shares of common stock that the Company is authorized to issue remains the same and was unaffected by the Reverse Stock Split. All outstanding stock options and other contractual rights including the preferred stock entitling the holders of such rights to acquire shares of common stock outstanding at the Effective Date will be appropriately adjusted to give effect to the Reverse Stock Split.

 

The Company had 15,125,005 and 9,809,877 shares (post-split) of common stock issued and outstanding as of April 30, 2022 and 2021, respectively. The Company had 8,916,805 and 1,214,528 shares of common classified as to be issued at April 30, 2022 and April 30, 2021, respectively.

 

Preferred Stock

 

The Company is authorized to issue 10,000,000 shares of preferred stock with $0.001 par value per share, of which 35,850 shares have been designated as Series A convertible preferred stock with a $100 stated value per share; 1,000 shares have been designated as Series B Preferred Stock with a $10,000 per share liquidation value; 4,200,000 shares have been designated as Series C Preferred Stock with a $10 per share liquidation value, and 2,000,000 shares have been designated as Series D Preferred Stock with a $1 per share liquidation value.

 

As of April 30, 2022, and 2021 the Company had:

  

Preferred stock outstanding shares  2022   2021 
Series A   125    125 
Series B   -    - 
Series C   2,163,000    4,132,269 
Series D   618,411    1,493,962 

 

 

Equity Transactions

 

During the year ended April 30, 2022 the Company:

 

  ●  Issued 731,623 common shares for consulting services valued at $159,010.
  Issued 3,305,860 common shares upon the conversion of 1,010,703 shares of Series C Convertible Preferred stock.
  Issued 650,076 common shares upon the conversion of 162,519 shares of Series D Convertible Preferred stock.
  Sold to fourteen accredited investors 8,563,531 shares of common stock for cash or conversions of $644,968; actual shares were not issued yet and recorded as commons stocks to be issued.
  Sold to three accredited investors 520,000 shares of Sparta Crypto, Inc,’s common stock for cash of $130,000; actual shares were not issued yet and recorded as commons stocks to be issued.
  On January 3, 2022, entered into agreements with Anthony L. Havens, the Company’s Chief Executive Officer (“Havens”) and Sandra L. Ahman, the Company’s Vice-President of Operations (“Ahman”) whereby Havens and Ahman agreed to convert debt owed to them in exchange for non-qualified stock options.
  Havens agreed to convert $137,465.76 of deferred salary in exchange for a stock option agreement (the “Havens Stock Option Agreement”) to purchase 1,718,322 shares of the Company’s common stock.
  Ahman agreed to convert $125,000 of deferred salary in exchange for a stock option agreement (the “Ahman Stock Option Agreement” and with the Havens Stock Option Agreement, the “Stock Option Agreements”) to purchase 1,562,500 shares of the Company’s common stock.
  On January 3, 2022, the Company granted to each of its two independent Directors five year options to purchase 187,500 shares of the Company’s common stock at $0.08 per share. The options vest in three equal tranches over three years. These options represent compensation for past service on the board.
  On January 3, 2022, the Company granted its CEO, Anthony L Havens and Vice President of Operations, Sandra L Ahman, five year options to purchase an aggregate of 750,000 shares of the Company’s common stock at $0.08 per share. The options vest in three equal tranches over three years.
  On January 3, 2022, the Company granted to four employees, five year options to purchase an aggregate of 437,500 shares of the Company’s common stock at $0.08 per share. The options vest in three equal tranches over three years.

 

During the year ended April 30, 2021, the Company:

 

  Sold 140,000 Units of Series C convertible preferred stock for $70,000
  Issued 311,378 Units of Series D convertible preferred stock upon the conversion of accounts payable aggregating $311,378
  Issued 50,455 Units of Series D convertible preferred stock upon the conversion of $50,455 of the Company’s subsidiary preferred stock
  Pursuant to agreement, issued 250,000 shares of the Company’s Common Stock, valued at $50,000
  Pursuant to Conversions of Preferred Series D convertible preferred stock, issued 890,540 shares of the Company’s Common Stock, valued at $222,635
  Pursuant to Conversions of Preferred Series C convertible preferred stock, issued 2,086,848 shares of the Company’s Common Stock, valued at $231,872
  Pursuant to agreement, issued 3,000,000 shares of common stock valued at $6,000

 

 

XML 25 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS
12 Months Ended
Apr. 30, 2022
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS

NOTE F – FAIR VALUE MEASUREMENTS

 

The Company follows the guidance established pursuant to ASC 820 which established a framework for measuring fair value and expands disclosure about fair value measurements. ASC 820 defines fair value as the amount that would be received for an asset or paid to transfer a liability (i.e., an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes the following three levels of inputs that may be used:

 

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets and liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

 

Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data.

 

Level 3: Unobservable inputs when there is little or no market data available, thereby requiring an entity to develop its own assumptions. The fair value hierarchy gives the lowest priority to Level 3 inputs.

 

The table below summarizes the fair values of financial liabilities as of April 30, 2022:

 

   Fair Value at   Fair Value Measurement Using 
   April 30, 2022   Level 1   Level 2   Level 3 
Derivative liabilities  $9,549,640    -    -   $9,549,640 

 

Fair values of financial liabilities as of April 30, 2021 are as follows:

 

   Fair Value at   Fair Value Measurement Using 
   April 30, 2021   Level 1   Level 2   Level 3 
Derivative liabilities   $4,252,466    -    -   $4,252,466 

 

The following is a description of the valuation methodologies used for these items:

 

Derivative liabilities — these instruments consist of certain variable conversion features related to notes payable obligations and certain outstanding warrants. These instruments were valued using pricing models which incorporate the Company’s stock price, volatility, U.S. risk free rate, dividend rate and estimated life.

 

The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value in accordance with ASC Topic 825 “The Fair Value Option for Financial Issuances”.

 

XML 26 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
PROPERTY AND EQUIPMENT
12 Months Ended
Apr. 30, 2022
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

NOTE G - PROPERTY AND EQUIPMENT

 

Major classes of property and equipment at April 30, 2022 and 2021 consist of the followings:

 

           
   2022   2021 
Computer equipment, software and furniture  $213,262   $213,262 
Less: accumulated depreciation   (213,262)   (213,262)
Net property and equipment  $-   $- 

 

All equipment are fully depreciated as of the fiscal year end April 30, 2022 and 2021. No additional investment in equipment for both fiscal year.

 

XML 27 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
NOTE H – WARRANTS:
12 Months Ended
Apr. 30, 2022
Note H Warrants  
NOTE H – WARRANTS:

NOTE H – WARRANTS:

 

During the year ended April 30, 2022, the company issued a total of 4,843,322 warrants to employees and service provider at an average option strike price of $0.17 per share. As of April 30, 2022, 3,801,657 of these warrants were vested. Computed fair value was $228,099.

 

 

The following table summarizes the changes in warrants:

 

    Warrants Outstanding       Warrants Exercisable 
Exercise Prices   Number Outstanding   Weighted
Average
Remaining
Contractual
Life (Years)
   Weighted
Average
Exercise Price
   Number Exercisable   Weighted
Average
Exercise Price
 
$0.3080    1,465,960    3   $0.3080    1,298,738   $0.3080 
$0.2750    1,613,426    3   $0.2750    1,613,426   $0.2750 
$0.0800    4,843,322    3   $0.0800    3,801,657    0.0800 

 

Transactions involving stock warrants issued to non-employees are summarized as follows:

 

   Number
of Shares
   Weighted
Average
Exercise
Price Per Share
 
Outstanding at April 30, 2020   5,310,745   $0.16190 
Granted   2,395,380    0.17097 
Canceled or expired   (400)   0.17000 
           
Outstanding at April 30, 2021   7,705,725    .016190 
Granted   -    - 
Exercised   -    - 
Canceled or expired   (216,983)   0.16010 
Outstanding at April 30, 2022   7,922,708   $0.16190 

 

 

XML 28 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
INCOME TAXES
12 Months Ended
Apr. 30, 2022
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE I - INCOME TAXES

 

At April 30, 2022, the Company has available for federal income tax purposes a net operating loss carry forward of approximately $65,338,601 that may be used to offset future taxable income and expiring through the tax year 2036, subject to certain limitation pursuant to Internal Revenue Code Section 382. The Company has provided a valuation reserve against the full amount of the net operating loss benefit, since in the opinion of management based upon the earnings history of the Company; it is more likely than not that, the benefits will not be realized.

 

A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

           
   Years Ended April 30, 
   2022   2021 
Federal statutory income tax rate   (21.0)%   (21.0)%
State income taxes, net of federal benefit   (7.1)   (7.1)
Permanent differences   6.7    6.7 
Change in valuation allowance   21.4    21.4 
           
Provision for income taxes   0.0%   0.0%

 

Components of deferred tax assets as of April 30, 2022 and estimated 2021 are as follows:

 

           
   April 30, 
   2022   2021 
Noncurrent:          
Net operating loss carry forward  $14,753,877   $13,167,491 
Valuation allowance   (14,753,877)   (13,167,491)
Net deferred tax asset  $-   $- 

 

XML 29 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Apr. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE J - COMMITMENTS AND CONTINGENCIES

 

Operating Lease Commitments

 

Our executive offices are located in New York, NY. We have an agreement for use of office space at this location under a sub-lease which expired on July 31, 2018, and continues a month-to-month basis thereafter. The monthly base rent is $5,100.

 

Rent expense was $64,800 and $70,200 for the years ended April 30, 2022, and 2021, respectively.

 

Employment and Consulting Agreements

 

The Company does not have employment agreements with any of its non-executive employees.

 

The Company has consulting agreements with outside contractors to provide marketing and financial advisory services. The agreements are generally for a term of 12 months from inception and renewable automatically from year to year unless either the Company or consultant terminates such engagement by written notice.

 

The Company entered into five year employment agreements with its CEO, Anthony L Havens and Vice President of Operations, Sandra L Ahman. As part of their employment agreements, Mr. Havens received five year options to purchase 37,625,574 shares of the Company’s common stock at $0.00308 per share. The options vest in three equal tranches over three years. Ms. Ahman received five year options to purchase 12,541,858 shares of the Company’s common stock at $0.00308 per share. The options vest in three equal tranches over three years.

 

 

Litigation

 

The Company is subject to legal proceedings and claims which arise in the ordinary course of its business. Sparta can make no representations about the potential outcome of such proceedings.

 

As of April 30, 2022, we have not been named as parties to any further legal proceedings except as those disclosed prior and as updated below. From time to time, of course, we may become involved in further legal proceedings, which sometimes arise due to the very nature of and in the ordinary course of this business.

 

By way of background, the Company had received notices dated April 1, 2016, May 13, 2016 and July 22, 2016 from two lenders claiming defaults relating to conversion requests of $8,365.00 in principal plus interest, attorney fees and $5,000.00 in principal plus interest also seeking stock conversions aside from the stated principal and interest with regard to notes in the total amounts of $55,125.00 and $27,500.00, respectively, which the Company has declined to process and believes it has valid, meritorious defenses in that regard. The Company believes these claims are contingent, unliquidated and disputes same. While there can be no assurances that the Company would prevail in any potential litigation with regard to claims brought against the Company, these potential liabilities have been recorded in the unaudited condensed consolidated financial statements.

 

With respect to the above claims, on September 22, 2016, a motion for summary judgment in lieu of complaint was filed in the Supreme Court in the State of New York: County of Kings, against the Company by a lender for the amount of $102,170.82 in principal and stock conversion interest, plus fees and costs. The Plaintiff’s motion for summary judgment in lieu of complaint was denied on May 5, 2017. On August 22, 2018, Plaintiff thereafter brought a second motion seeking summary judgment on the issue of liability which was, again, denied by the Court on March 14, 2019. The most recent appearance in this matter had been scheduled for March 13, 2020, at which time, the Court marked the case “adjourned without a date”, due to the restrictions imposed on the Courts arising from the COVID-19 pandemic. No further Court appearances have been scheduled, to date, in this matter. However, most notably, a favorable decision from the New York State Court of Appeals regarding the very same types of transactions have since been determined to be criminally usurious and, therefore, unenforceable. These were the very same defenses raised on behalf of the Company.

 

On October 26, 2018, a second lender commenced an action in the Supreme Court of the State of New York: New York County alleging damages from unpaid principal arising from a promissory note dated February 26, 2015 in the amount of $50,000.00 plus damages including interest and stock conversions, costs and fees. There are cross dispositive motions pending which are scheduled to be heard in September, 2022. The Company disputes the enforceability of such claims for the similar reasons, as stated above, based on the Court of Appeals ruling as to the unenforceable nature of such claims demanding usurious interest rates.

 

XML 30 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUBSEQUENT EVENTS
12 Months Ended
Apr. 30, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE K – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events for recognition and disclosure as of August 15, 2022 which is the date the financial statements were available to be issued. No other matters were identified affecting the accompanying financial statements and related disclosures.

XML 31 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF ACCOUNTING POLICIES (Policies)
12 Months Ended
Apr. 30, 2022
Accounting Policies [Abstract]  
Business

Business

 

Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation serving four markets. Sparta is a technology company that develops, markets and manages business websites and mobile applications (mobile apps) for smartphones and tablets. The Company also owns and manages websites which sell on-demand motorcycle, recreational vehicle, power-sport vehicle and truck title history reports for consumers, retail dealers, auction houses, insurance companies and banks/finance companies. Lastly, since 2007, Sparta has administered leasing programs nationwide for local and/or state agencies seeking to finance municipal vehicles and equipment. The Company also introduced a new business line in the rapidly expanding Hemp-CBD (cannabidiol) market.

 

In 2016, the Company changed the name of its majority-owned subsidiary Specialty Reports, Inc., to iMobile Solutions, Inc. The new name reflects the Company’s strategic evolution and focus on the growing mobile application market domestically.

 

Sparta’s mobile application (mobile app) offerings have broadened our base beyond our original base of vehicle dealers to include a wide range of businesses including, but not limited to, agriculture dealerships, racetracks, private clubs, country clubs, restaurants and grocery stores. We also offer a private label version of our mobile app framework to enable other businesses to offer custom apps to their customers.

 

The Company also designs, launches, maintains, and hosts websites for businesses. We provide specific, tailored action plans for our clients’ websites that include services such as eCommerce, CRM (Customer Relationship Management) development and integration, ordering system creation and integration, SEO (search engine optimization), social media marketing, and online reviews to improve their presence online. In addition, we offer text messaging services which are vital for businesses’ marketing, retention and loyalty strategies. Our text messaging platform allows our clients to easily manage, schedule, and analyze text message performance.

 

The Company’s vehicle history reports include Cyclechex (Motorcycle History Reports at www.cyclechex.com); RVchecks (Recreational Vehicle History Reports at www.rvchecks.com); and Truckchex (Heavy Duty Truck History Reports at www.truckchex.com). Our Vehicle History Reports are designed for consumers, retail dealers, auction houses, insurance companies and banks/finance companies.

 

Sparta also administers a Municipal Leasing Program for local and/or state agencies throughout the country who are seeking a better and more economical way to finance their essential equipment needs, including police motorcycles, cruisers, buses, fire trucks, and EMS equipment. We are continuing to expand our roster of equipment manufacturers and the types of equipment we lease.

 

New World Health Brands, Inc. (NWHB) was formed in April 2019 as a subsidiary and new business line of Sparta Commercial Services, Inc. While anticipating, and with the passing of the 2018 Farm Bill, which resulted in the removal of hemp (CBD) from Schedule 1 of the Controlled Substances Act. Sparta’s management recognized a substantial potential business opportunity in the rapidly expanding Industrial Hemp-CBD (Cannabinol) market in the United States. During 2019-2020, management sourced, developed and lab tested 5 CBD product categories totaling 31 products, procured product packaging, labeling, implemented fulfillment and launched an on-line B2C website, www.newworldhealthcbd.com. The Company has since curated its products and currently offers 15 products with plans to add complementary products to our product line.

 

 

Sparta’s newest subsidiary, Sparta Crypto, Inc., www.SpartaCrypto.com, was established September 25, 2020 and is in the process of completing a proprietary state-of-the-art platform designed to connect users of widely adopted digital currencies with sellers of various goods and services. The platform has not launched and the Company can make no assurances that the described plan will reach implementation. In addition, the Company has completed and tested a cryptocurrency payment gateway called SpartaPayIQ, www.SpartaPayIQ.com, which is functional and was formally announced on March 3, 2022.

 

Sparta’s offices are located at 555 Fifth Avenue, 14th Floor, New York, NY 10017, (212) 239-2666. The Company maintains a corporate website at www.spartacommercial.com.

 

We identify our ongoing information technology business in two reporting groups: mobile apps/websites and vehicle history reports, both of which operate under our wholly owned subsidiary, iMobile Solutions, Inc. The latest product offering, via www.newworldhealthcbd.com, offering a full array of hemp-derived CBD products, is contained in our subsidiary, New World Health Brands, Inc.

 

Principles of Consolidation

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its majority owned subsidiary. All material intercompany transactions and balances have been eliminated in consolidation. The third party ownership of the Company’s subsidiary is accounted for as noncontrolling interest in the consolidated financial statements. Changes in the noncontrolling interest are reported in the statement of stockholders’ deficit.

 

Estimates

Estimates

 

The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.

 

Revenue Recognition

Revenue Recognition

 

During the first quarter of 2018, the Company adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606), using the cumulative-effect method. The new standard requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The adoption did not have an impact in our consolidated financial statements, other than the enhancement of our disclosures related to our revenue-generating activities.

 

The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions.

 

Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable.

 

The following table presents our revenues disaggregated by revenue source:

 

   2022   2021 
   Year Ended April 30, 
   2022   2021 
Information Technology  $219,404   $245,675 
New World Health Brands   26,065    14,056 
 Revenues  $245,469   $259,731 

 

 

Cash Equivalents

Cash Equivalents

 

For the purpose of the accompanying financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents.

 

Website Development Costs

Website Development Costs

 

The Company recognizes website development costs in accordance with ASC 350-50, “Accounting for Website Development Costs.” As such, the Company expenses all costs incurred that relate to the planning and post implementation phases of development of its website. Direct costs incurred in the development phase are capitalized and recognized over the estimated useful life. Costs associated with repair or maintenance for the website are included in cost of net revenues in the current period expenses.

 

Fair Value Measurements

Fair Value Measurements

 

The Company adopted ASC 820, “Fair Value Measurements (“ASC 820”).” ASC 820 establishes a three-level fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets the lowest priority to unobservable inputs to fair value measurements of certain assets and Liabilities. The three levels of the fair value hierarchy under ASC 820 are described below:

 

Level 1 — Quoted prices for identical instruments in active markets. Level 1 assets and liabilities include debt and equity securities and derivative contracts that are traded in an active exchange market, as well as certain securities that are highly liquid and are actively traded in over-the-counter markets.
   
Level 2 — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which all significant inputs and significant value drivers are observable in active markets.
   
Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value measurements. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques based on significant unobservable inputs, as well as management judgments or estimates that are significant to valuation.

 

This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not always be available.

 

Income Taxes

Income Taxes

 

We utilize ASC 740 “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at year-end based on enacted laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.

 

The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.

 

Stock Based Compensation

Stock Based Compensation

 

We account for our stock based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

 

 

We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.

 

Inventories

Inventories

 

The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health Brands business.

 

Property and Equipment

Property and Equipment

 

Property and equipment are recorded at cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is calculated using the straight-line method over the estimated useful lives. Estimated useful lives of major depreciable assets are as follows:

 

   
Leasehold improvements 3 years
Furniture and fixtures 7 years
Website costs 3 years
Computer Equipment 5 years

 

Concentrations of Credit Risk

Concentrations of Credit Risk

 

Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.

 

Net Loss Per Share

Net Loss Per Share

 

The Company uses ASC 260-10, “Earnings Per Share,” for calculating the basic and diluted loss per share. The Company computes basic loss per share by dividing net loss and net loss attributable to common shareholders by the weighted average number of common shares outstanding. Common equivalent shares are excluded from the computation of net loss per share if their effect is anti-dilutive.

 

At April 30, 2022 and 2021 42 million potential shares (including 847,866 shares to be issued included on the balance sheet) and 10,397,258 potential shares (including 807,866 shares to be issued included on the balance sheet), respectively, were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share.

 

Derivative Liabilities

Derivative Liabilities

 

The Company assessed the classification of its derivative financial instruments as of April 30, 2022 and 2021 which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

 

Convertible Instruments

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “Accounting for Derivative Instruments and Hedging Activities”.

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

 

Reclassifications

Reclassifications

 

Certain reclassifications have been made to conform to prior periods’ data to the current presentation. These reclassifications had no effect on reported losses.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In March 2019, the FASB issued ASU 2019-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting” (ASU 2018-09). This ASU makes several modifications to Topic 718 related to the accounting for forfeitures, employer tax withholding on share-based compensation, and the financial statement presentation of excess tax benefits or deficiencies. ASU 2018-09 also clarifies the statement of cash flows presentation for certain components of share-based awards. The standard is effective for interim and annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company adopted this guidance on May 1, 2019 and it did not have an impact on the Company’s consolidated financial statements and related disclosures.

 

In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements - Going Concern (Topic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”). This amendment prescribes that an entity should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. The amendments became effective for the Company’s annual and interim reporting periods beginning May 1, 2019. The Company will begin evaluating going concern disclosures based on this guidance upon adoption.

 

The FASB issued the following accounting standard updates related to Topic 606, Revenue Contracts with Customers:

 

●  ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”) in May 2014. ASU 2014-09 requires entities to recognize revenue through the application of a five-step model, which includes identification of the contract, identification of the performance obligations, determination of the transaction price, allocation of the transaction price to the performance obligations and recognition of revenue as the entity satisfies the performance obligations.
ASU No. 2018-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2018-08”) in March 2018. ASU 2019-08 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on principal versus agent considerations.

 

 

ASU No. 2018-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing (“ASU 2018-10”) in April 2018. ASU 2018-10 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas.
ASU No. 2018-11, Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2018 EITF Meeting (SEC Update) (“ASU 2018-11”) in May 2018. ASU 2018-11 rescinds SEC paragraphs pursuant to two SEC Staff Announcements at the March 3, 2018 EITF meeting. The SEC Staff is rescinding SEC Staff Observer comments that are codified in Topic 605 and Topic 932, effective upon adoption of Topic 606.
ASU No. 2018-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients in May 2018. ASU 2018-12 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on a few narrow areas and adds some practical expedients to the guidance.

 

These ASUs became effective for the Company beginning interim period beginning May 1, 2018. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (Topic 842) “Leases.” Topic 842 supersedes the lease requirements in Accounting Standards Codification (ASC) Topic 840, “Leases.” Under Topic 842, lessees are required to recognize assets and liabilities on the balance sheet for most leases and provide enhanced disclosures. Leases will continue to be classified as either finance or operating. The Company adopted Topic 842 effective May 1, 2019 using a modified retrospective method and elected not to recognize leases with terms of 12 months or less. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, we have not determined whether implementation of such proposed standards would be material to our consolidated financial statements.

XML 32 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF ACCOUNTING POLICIES (Tables)
12 Months Ended
Apr. 30, 2022
Accounting Policies [Abstract]  
SCHEDULE OF DISAGGREGATION REVENUE

The following table presents our revenues disaggregated by revenue source:

 

   2022   2021 
   Year Ended April 30, 
   2022   2021 
Information Technology  $219,404   $245,675 
New World Health Brands   26,065    14,056 
 Revenues  $245,469   $259,731 
SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT

 

   
Leasehold improvements 3 years
Furniture and fixtures 7 years
Website costs 3 years
Computer Equipment 5 years
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
NOTES PAYABLE AND DERIVATIVES (Tables)
12 Months Ended
Apr. 30, 2022
Debt Disclosure [Abstract]  
SCHEDULE OF NOTES PAYABLE

The Company has outstanding numerous notes payable to various parties. The notes bear interest at rates of 5% - 20% per year and are summarized as follows:

 

Notes Payable  April 30, 2022   April 30, 2021 
Notes convertible at holder’s option  $2,980,848   $2,522,925 
Notes convertible at Company’s option   335,700    335,700 
Non-convertible notes payable   1,933,536    1,821,650 
Subtotal   5,250,084    4,680,275 
Less debt discount   -    - 
Total  $5,250,084   $4,680,275 
SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION

The change in fair value of the derivative liabilities of convertible notes outstanding at April 30, 2022 and 2021 was calculated with the following average assumptions, using a Black-Scholes option-pricing model are as follows:

 

Significant Assumptions:       
Risk free interest rate  Ranging from  0.16% to 0.20 
Expected stock price volatility      369%
Expected dividend payout      0 
Expected options life in years  Ranging from   1 year to 2 years 

SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES

Changes in derivative liability during the years ended April 30, 2022 and 2021 were:

 

   April 30, 
   2022   2021 
Balance, beginning of year  $4,252,446   $2,802,125 
Derivative liability reclassified to additional paid in capital   (474,420)   (573,397)
Derivative financial liability arising on the issue of convertible notes and warrants        715,411 
Fair value adjustments   3,728,206    1,310,307 
Balance, end of year  $7,506,232   $4,252,446 
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
EQUITY TRANSACTIONS (Tables)
12 Months Ended
Apr. 30, 2022
Equity [Abstract]  
SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES

As of April 30, 2022, and 2021 the Company had:

  

Preferred stock outstanding shares  2022   2021 
Series A   125    125 
Series B   -    - 
Series C   2,163,000    4,132,269 
Series D   618,411    1,493,962 
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Apr. 30, 2022
Fair Value Disclosures [Abstract]  
SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES

The table below summarizes the fair values of financial liabilities as of April 30, 2022:

 

   Fair Value at   Fair Value Measurement Using 
   April 30, 2022   Level 1   Level 2   Level 3 
Derivative liabilities  $9,549,640    -    -   $9,549,640 

 

Fair values of financial liabilities as of April 30, 2021 are as follows:

 

   Fair Value at   Fair Value Measurement Using 
   April 30, 2021   Level 1   Level 2   Level 3 
Derivative liabilities   $4,252,466    -    -   $4,252,466 
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
PROPERTY AND EQUIPMENT (Tables)
12 Months Ended
Apr. 30, 2022
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT

Major classes of property and equipment at April 30, 2022 and 2021 consist of the followings:

 

           
   2022   2021 
Computer equipment, software and furniture  $213,262   $213,262 
Less: accumulated depreciation   (213,262)   (213,262)
Net property and equipment  $-   $- 
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
NOTE H – WARRANTS: (Tables)
12 Months Ended
Apr. 30, 2022
Note H Warrants  
SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE

The following table summarizes the changes in warrants:

 

    Warrants Outstanding       Warrants Exercisable 
Exercise Prices   Number Outstanding   Weighted
Average
Remaining
Contractual
Life (Years)
   Weighted
Average
Exercise Price
   Number Exercisable   Weighted
Average
Exercise Price
 
$0.3080    1,465,960    3   $0.3080    1,298,738   $0.3080 
$0.2750    1,613,426    3   $0.2750    1,613,426   $0.2750 
$0.0800    4,843,322    3   $0.0800    3,801,657    0.0800 
SCHEDULE OF WARRANTS ACTIVITY

Transactions involving stock warrants issued to non-employees are summarized as follows:

 

   Number
of Shares
   Weighted
Average
Exercise
Price Per Share
 
Outstanding at April 30, 2020   5,310,745   $0.16190 
Granted   2,395,380    0.17097 
Canceled or expired   (400)   0.17000 
           
Outstanding at April 30, 2021   7,705,725    .016190 
Granted   -    - 
Exercised   -    - 
Canceled or expired   (216,983)   0.16010 
Outstanding at April 30, 2022   7,922,708   $0.16190 
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
INCOME TAXES (Tables)
12 Months Ended
Apr. 30, 2022
Income Tax Disclosure [Abstract]  
SCHEDULE OF RECONCILIATION OF INCOME TAX RATE

A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

           
   Years Ended April 30, 
   2022   2021 
Federal statutory income tax rate   (21.0)%   (21.0)%
State income taxes, net of federal benefit   (7.1)   (7.1)
Permanent differences   6.7    6.7 
Change in valuation allowance   21.4    21.4 
           
Provision for income taxes   0.0%   0.0%
SCHEDULE OF DEFERRED TAX ASSETS

Components of deferred tax assets as of April 30, 2022 and estimated 2021 are as follows:

 

           
   April 30, 
   2022   2021 
Noncurrent:          
Net operating loss carry forward  $14,753,877   $13,167,491 
Valuation allowance   (14,753,877)   (13,167,491)
Net deferred tax asset  $-   $- 
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF DISAGGREGATION REVENUE (Details) - USD ($)
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Product Information [Line Items]    
 Revenues $ 245,469 $ 259,731
Information Technology [Member]    
Product Information [Line Items]    
 Revenues 219,404 245,675
New World Health Brands [Member]    
Product Information [Line Items]    
 Revenues $ 26,065 $ 14,056
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT (Details)
12 Months Ended
Apr. 30, 2022
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Computer Equipment 3 years
Furniture and Fixtures [Member]  
Property, Plant and Equipment [Line Items]  
Computer Equipment 7 years
Website Costs [Member]  
Property, Plant and Equipment [Line Items]  
Computer Equipment 3 years
Computer Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Computer Equipment 5 years
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF ACCOUNTING POLICIES (Details Narrative) - shares
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 42,000,000 10,397,258
Shares to be Issued [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 847,866 807,866
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
GOING CONCERN MATTERS (Details Narrative) - USD ($)
Apr. 30, 2022
Apr. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Retained earnings (accumulated deficit) $ 73,984,686 $ 64,993,250
Working capital deficit $ 19,327,286  
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF NOTES PAYABLE (Details) - USD ($)
Apr. 30, 2022
Apr. 30, 2021
Short-Term Debt [Line Items]    
Subtotal $ 5,250,084 $ 4,680,275
Less debt discount
Total 5,250,084 4,680,275
Notes Convertible At Holders Option [Member]    
Short-Term Debt [Line Items]    
Subtotal 2,980,848 2,522,925
Notes Convertible At Companys Option [Member]    
Short-Term Debt [Line Items]    
Subtotal 335,700 335,700
Non Convertible Notes Payable [Member]    
Short-Term Debt [Line Items]    
Subtotal $ 1,933,536 $ 1,821,650
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION (Details)
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]    
Debt Instrument [Line Items]    
Derivative liability, measurement input, percentage 0.16 0.16
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]    
Debt Instrument [Line Items]    
Derivative liability, measurement input, percentage 0.20 0.20
Measurement Input, Price Volatility [Member]    
Debt Instrument [Line Items]    
Derivative liability, measurement input, percentage 369 369
Measurement Input Dividend Payout [Member]    
Debt Instrument [Line Items]    
Derivative liability, measurement input, percentage 0 0
Measurement Input, Expected Term [Member] | Minimum [Member]    
Debt Instrument [Line Items]    
Derivative liability, measurement input, expected life 1 year 1 year
Measurement Input, Expected Term [Member] | Maximum [Member]    
Debt Instrument [Line Items]    
Derivative liability, measurement input, expected life 2 years 2 years
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES (Details) - USD ($)
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Debt Disclosure [Abstract]    
Balance, beginning of year $ 4,252,446 $ 2,802,125
Derivative liability reclassified to additional paid in capital (474,420) (573,397)
Derivative financial liability arising on the issue of convertible notes and warrants   715,411
Fair value adjustments 3,728,206 1,310,307
Balance, end of year $ 7,506,232 $ 4,252,446
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
NOTES PAYABLE AND DERIVATIVES (Details Narrative) - USD ($)
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Apr. 30, 2020
Debt Instrument [Line Items]      
Amortization of debt discount $ 0 $ 0
Minimum [Member]      
Debt Instrument [Line Items]      
Common stock discount rate, percentage 30.00%    
Maximum [Member]      
Debt Instrument [Line Items]      
Common stock discount rate, percentage 48.00%    
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
LOANS PAYABLE TO RELATED PARTIES (Details Narrative) - USD ($)
Apr. 30, 2022
Apr. 30, 2021
Related Party Transactions [Abstract]    
Loans payable to officers and directors $ 432,403 $ 432,403
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES (Details) - shares
Apr. 30, 2022
Apr. 30, 2021
Series A Preferred Stock [Member]    
Class of Stock [Line Items]    
Preferred Stock 125 125
Series B Preferred Stock [Member]    
Class of Stock [Line Items]    
Preferred Stock
Series C Preferred Stock [Member]    
Class of Stock [Line Items]    
Preferred Stock 2,163,000 4,132,269
Series D Preferred Stock [Member]    
Class of Stock [Line Items]    
Preferred Stock 618,411 1,493,962
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
EQUITY TRANSACTIONS (Details Narrative) - USD ($)
12 Months Ended
Jan. 03, 2022
Jul. 30, 2020
Apr. 30, 2022
Apr. 30, 2021
Class of Stock [Line Items]        
Common stock, shares authorized     750,000,000 750,000,000
Common stock, par value     $ 0.001 $ 0.001
Stockholders' equity, reverse stock split   the effective date for the 1 for 100 reverse stock split    
Issuance of shares, reverse stock splits     7,027,930  
Common Stock, Shares, Outstanding     15,128,005 9,809,877
Common Stock, Shares Subscribed but Unissued     8,916,805 1,214,528
Preferred stock, shares designated     10,000,000 10,000,000
Preferred stock, par value     $ 0.001 $ 0.001
Issuance of stock for service, value     $ 159,011 $ 25,319
Convertion of convertible securities, value     $ 25,000 $ 50,000
Common Stock One [Member]        
Class of Stock [Line Items]        
Issuance of stock for service, shares     731,623  
Issuance of stock for service, value     $ 159,010  
Issuance of stock, shares       250,000
Issuance of stock, values       $ 50,000
Common Stock [Member]        
Class of Stock [Line Items]        
Issuance of stock for service, shares     731,623 126,595
Issuance of stock for service, value     $ 732 $ 127
Convertion of convertible securities, shares     125,000 250,000
Convertion of convertible securities, value     $ 125 $ 250
Common Stock [Member] | Havens Stock Option Agreement [Member]        
Class of Stock [Line Items]        
Convertion of deferred salary     $ 137,465.76  
Stock option, grants     1,718,322  
Common Stock [Member] | Ahman Stock Option Agreement [Member]        
Class of Stock [Line Items]        
Convertion of deferred salary     $ 125,000  
Stock option, grants     1,562,500  
Common Stock [Member] | Fourteen Accredited Investors [Member]        
Class of Stock [Line Items]        
Number of stocks sold during period     8,563,531  
Sale of stock     $ 644,968  
Common Stock [Member] | Three Accredited Investors [Member]        
Class of Stock [Line Items]        
Number of stocks sold during period     520,000  
Sale of stock     $ 130,000  
Common Stock [Member] | Two Independent Director [Member]        
Class of Stock [Line Items]        
Stock option, grants 187,500      
Contractual term 5 years      
Share Price $ 0.08      
Share based compensation vesting period 3 years      
Common Stock [Member] | Chief Executive Officer And Vice President [Member]        
Class of Stock [Line Items]        
Stock option, grants 750,000      
Contractual term 5 years      
Share Price $ 0.08      
Share based compensation vesting period 3 years      
Common Stock [Member] | Four Employees [Member]        
Class of Stock [Line Items]        
Stock option, grants 437,500      
Contractual term 5 years      
Share Price $ 0.08      
Share based compensation vesting period 3 years      
Common Stock Two [Member]        
Class of Stock [Line Items]        
Issuance of stock, shares       3,000,000
Issuance of stock, values       $ 6,000
Series A convertible preferred stock [Member]        
Class of Stock [Line Items]        
Preferred stock, shares designated     35,850 35,850
Preferred stock, par value     $ 100 $ 100
Series B convertible preferred stock [Member]        
Class of Stock [Line Items]        
Preferred stock, shares designated     1,000 1,000
Preferred stock, par value     $ 0.001 $ 0.001
Preferred stock, liquidation and redemption value per share     $ 10,000 $ 10,000
Series C Preferred Stock [Member]        
Class of Stock [Line Items]        
Preferred stock, shares designated     4,200,000  
Common shares issued upon conversion     3,305,860  
Converted common shares     1,010,703  
Series C redeemable convertible preferred stock [Member]        
Class of Stock [Line Items]        
Preferred stock, shares designated     200,000 200,000
Preferred stock, par value     $ 0.001 $ 0.001
Preferred stock, liquidation and redemption value per share     $ 10 $ 10
Series D redeemable convertible preferred stock [Member]        
Class of Stock [Line Items]        
Preferred stock, shares designated     2,000,000 2,000,000
Preferred stock, par value     $ 0.001 $ 0.001
Preferred stock, liquidation and redemption value per share     $ 1.00 $ 1.00
Series D Preferred Stock [Member]        
Class of Stock [Line Items]        
Common shares issued upon conversion     650,076  
Converted common shares     162,519  
Series C Convertible Preferred Stock [Member]        
Class of Stock [Line Items]        
Number of stocks sold during period       140,000
Sale of stock       $ 70,000
Convertion of convertible securities, shares     2,086,848  
Convertion of convertible securities, value     $ 231,872  
Series D Convertible Preferred Stock [Member]        
Class of Stock [Line Items]        
Issuance of stock, shares       50,455
Issuance of stock, values       $ 50,455
Convertion of convertible securities, shares     890,540  
Convertion of convertible securities, value     $ 222,635  
Series D Convertible Preferred Stock [Member] | Settlement of Accounts Payable [Member]        
Class of Stock [Line Items]        
Issuance of stock, shares       311,378
Issuance of stock, values       $ 311,378
Post Split [Member]        
Class of Stock [Line Items]        
Common Stock, Shares, Outstanding     15,125,005 9,809,877
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES (Details) - USD ($)
Apr. 30, 2022
Apr. 30, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities $ 9,549,640 $ 3,446,738
Derivative liabilities   4,252,466
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities  
Derivative liabilities  
Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities  
Derivative liabilities  
Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities $ 9,549,640  
Derivative liabilities   $ 4,252,466
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)
Apr. 30, 2022
Apr. 30, 2021
Property, Plant and Equipment [Line Items]    
Less: accumulated depreciation $ (213,262) $ (213,262)
Net property and equipment
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Computer equipment, software and furniture $ 213,262 $ 213,262
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE (Details)
12 Months Ended
Apr. 30, 2022
$ / shares
shares
Warrant One [Member]  
Warrants outstanding, exercise price $ 0.3080
Warrants outstanding, number | shares 1,465,960
Warrants outstanding, weighted average remaining contractual life (years) 3 years
Warrants outstanding, weighted average exercise price $ 0.3080
Warrants exercisable, number exercisable | shares 1,298,738
Warrants exercisable, weighted average exercise price $ 0.3080
Warrant Two [Member]  
Warrants outstanding, exercise price $ 0.2750
Warrants outstanding, number | shares 1,613,426
Warrants outstanding, weighted average remaining contractual life (years) 3 years
Warrants outstanding, weighted average exercise price $ 0.2750
Warrants exercisable, number exercisable | shares 1,613,426
Warrants exercisable, weighted average exercise price $ 0.2750
Warrant Three [Member]  
Warrants outstanding, exercise price $ 0.0800
Warrants outstanding, number | shares 4,843,322
Warrants outstanding, weighted average remaining contractual life (years) 3 years
Warrants outstanding, weighted average exercise price $ 0.0800
Warrants exercisable, number exercisable | shares 3,801,657
Warrants exercisable, weighted average exercise price $ 0.0800
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF WARRANTS ACTIVITY (Details) - Warrant [Member] - Non-Employees [Member] - $ / shares
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Number of shares, warrants outstanding, beginning balance 7,705,725 5,310,745
Weighted average exercise price per share, warrants outstanding, beginning balance $ 0.16190 $ 0.016190
Number of shares, warrants grants 2,395,380
Weighted average exercise price per share, warrants grants $ 0.17097
Number of shares, warrants canceled or expired (216,983) (400)
Weighted average exercise price per share, warrants canceled or expired $ 0.16010 $ 0.17000
Weighted average exercise price per share, warrants outstanding, beginning balance $ 0.016190 $ 0.16190
Number of shares, warrants exercised  
Weighted average exercise price per share, warrants exercised  
Number of shares, warrants outstanding, ending balance 7,922,708 7,705,725
Weighted average exercise price per share, warrants outstanding, ending balance $ 0.16190 $ 0.016190
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
NOTE H – WARRANTS: (Details Narrative) - Warrant [Member]
12 Months Ended
Apr. 30, 2022
USD ($)
$ / shares
shares
Stock issued for services 4,843,322
Stock option price per share | $ / shares $ 0.17
Warrants vested 3,801,657
Fair value adjustment of warrants | $ $ 228,099
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF RECONCILIATION OF INCOME TAX RATE (Details)
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Income Tax Disclosure [Abstract]    
Federal statutory income tax rate (21.00%) (21.00%)
State income taxes, net of federal benefit (7.10%) (7.10%)
Permanent differences 6.70% 6.70%
Change in valuation allowance 21.40% 21.40%
Provision for income taxes 0.00% 0.00%
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Apr. 30, 2022
Apr. 30, 2021
Income Tax Disclosure [Abstract]    
Net operating loss carry forward $ 14,753,877 $ 13,167,491
Valuation allowance (14,753,877) (13,167,491)
Net deferred tax asset
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
INCOME TAXES (Details Narrative)
12 Months Ended
Apr. 30, 2022
USD ($)
Income Tax Disclosure [Abstract]  
Operating loss carry forwards, net $ 65,338,601
Operating loss carryforwards, expiration date 2036
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
12 Months Ended
Sep. 22, 2016
Apr. 30, 2022
Apr. 30, 2021
Feb. 26, 2015
Rent expenses   $ 64,800 $ 70,200  
Promissory Note [Member]        
Aggregate note amount       $ 50,000.00
New York County Kings [Member]        
Loss on contingent $ 102,170.82      
Lender One [Member]        
Debt principal amount   8,365.00    
Aggregate note amount   55,125.00    
Lender Two [Member]        
Debt principal amount   5,000.00    
Aggregate note amount   $ 27,500.00    
Employment Agreement [Member] | Mr. Havens [Member]        
Debt instrument, term   5 years    
Number of shares issued during the period   37,625,574    
Share price   $ 0.00308    
Shares vested term   3 years    
Employment Agreement [Member] | Ms. Ahman [Member]        
Number of shares issued during the period   12,541,858    
Share price   $ 0.00308    
Shares vested term   3 years    
Executive Office Space [Member]        
Lease expiring date   Jul. 31, 2018    
Rent expenses   $ 5,100    
XML 59 form10-k_htm.xml IDEA: XBRL DOCUMENT 0000318299 2021-05-01 2022-04-30 0000318299 2022-04-30 0000318299 2022-08-15 0000318299 2021-04-30 0000318299 SRCO:SeriesAConvertiblePreferredStockMember 2022-04-30 0000318299 SRCO:SeriesAConvertiblePreferredStockMember 2021-04-30 0000318299 SRCO:SeriesBRedeemablePreferredStockMember 2022-04-30 0000318299 SRCO:SeriesBRedeemablePreferredStockMember 2021-04-30 0000318299 SRCO:SeriesCRedeemableConvertiblePreferredStockMember 2022-04-30 0000318299 SRCO:SeriesCRedeemableConvertiblePreferredStockMember 2021-04-30 0000318299 SRCO:SeriesDRedeemableConvertiblePreferredStockMember 2022-04-30 0000318299 SRCO:SeriesDRedeemableConvertiblePreferredStockMember 2021-04-30 0000318299 2020-05-01 2021-04-30 0000318299 SRCO:InformationTechnologyMember 2021-05-01 2022-04-30 0000318299 SRCO:InformationTechnologyMember 2020-05-01 2021-04-30 0000318299 SRCO:NewWorldHealthBrandsMember 2021-05-01 2022-04-30 0000318299 SRCO:NewWorldHealthBrandsMember 2020-05-01 2021-04-30 0000318299 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-04-30 0000318299 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-04-30 0000318299 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2021-04-30 0000318299 us-gaap:CommonStockMember 2021-04-30 0000318299 SRCO:CommonStockToBeIssuedMember 2021-04-30 0000318299 us-gaap:AdditionalPaidInCapitalMember 2021-04-30 0000318299 us-gaap:RetainedEarningsMember 2021-04-30 0000318299 us-gaap:NoncontrollingInterestMember 2021-04-30 0000318299 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-05-01 2022-04-30 0000318299 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-05-01 2022-04-30 0000318299 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2021-05-01 2022-04-30 0000318299 us-gaap:CommonStockMember 2021-05-01 2022-04-30 0000318299 SRCO:CommonStockToBeIssuedMember 2021-05-01 2022-04-30 0000318299 us-gaap:AdditionalPaidInCapitalMember 2021-05-01 2022-04-30 0000318299 us-gaap:RetainedEarningsMember 2021-05-01 2022-04-30 0000318299 us-gaap:NoncontrollingInterestMember 2021-05-01 2022-04-30 0000318299 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-04-30 0000318299 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-04-30 0000318299 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-04-30 0000318299 us-gaap:CommonStockMember 2022-04-30 0000318299 SRCO:CommonStockToBeIssuedMember 2022-04-30 0000318299 us-gaap:AdditionalPaidInCapitalMember 2022-04-30 0000318299 us-gaap:RetainedEarningsMember 2022-04-30 0000318299 us-gaap:NoncontrollingInterestMember 2022-04-30 0000318299 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-04-30 0000318299 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-04-30 0000318299 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2020-04-30 0000318299 us-gaap:CommonStockMember 2020-04-30 0000318299 SRCO:CommonStockToBeIssuedMember 2020-04-30 0000318299 us-gaap:AdditionalPaidInCapitalMember 2020-04-30 0000318299 us-gaap:RetainedEarningsMember 2020-04-30 0000318299 us-gaap:NoncontrollingInterestMember 2020-04-30 0000318299 2020-04-30 0000318299 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-05-01 2021-04-30 0000318299 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-05-01 2021-04-30 0000318299 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2020-05-01 2021-04-30 0000318299 us-gaap:CommonStockMember 2020-05-01 2021-04-30 0000318299 SRCO:CommonStockToBeIssuedMember 2020-05-01 2021-04-30 0000318299 us-gaap:AdditionalPaidInCapitalMember 2020-05-01 2021-04-30 0000318299 us-gaap:RetainedEarningsMember 2020-05-01 2021-04-30 0000318299 us-gaap:NoncontrollingInterestMember 2020-05-01 2021-04-30 0000318299 us-gaap:LeaseholdImprovementsMember 2021-05-01 2022-04-30 0000318299 us-gaap:FurnitureAndFixturesMember 2021-05-01 2022-04-30 0000318299 SRCO:WebsiteCostsMember 2021-05-01 2022-04-30 0000318299 us-gaap:ComputerEquipmentMember 2021-05-01 2022-04-30 0000318299 SRCO:SharesToBeIssuedMember 2021-05-01 2022-04-30 0000318299 SRCO:SharesToBeIssuedMember 2020-05-01 2021-04-30 0000318299 SRCO:NotesConvertibleAtHoldersOptionMember 2022-04-30 0000318299 SRCO:NotesConvertibleAtHoldersOptionMember 2021-04-30 0000318299 SRCO:NotesConvertibleAtCompanysOptionMember 2022-04-30 0000318299 SRCO:NotesConvertibleAtCompanysOptionMember 2021-04-30 0000318299 SRCO:NonConvertibleNotesPayableMember 2022-04-30 0000318299 SRCO:NonConvertibleNotesPayableMember 2021-04-30 0000318299 srt:MinimumMember 2021-05-01 2022-04-30 0000318299 srt:MaximumMember 2021-05-01 2022-04-30 0000318299 2019-05-01 2020-04-30 0000318299 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-04-30 0000318299 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-04-30 0000318299 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-04-30 0000318299 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-04-30 0000318299 us-gaap:MeasurementInputPriceVolatilityMember 2022-04-30 0000318299 us-gaap:MeasurementInputPriceVolatilityMember 2021-04-30 0000318299 SRCO:MeasurementInputDividendPayoutMember 2022-04-30 0000318299 SRCO:MeasurementInputDividendPayoutMember 2021-04-30 0000318299 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2021-05-01 2022-04-30 0000318299 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2020-05-01 2021-04-30 0000318299 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2021-05-01 2022-04-30 0000318299 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2020-05-01 2021-04-30 0000318299 2020-07-25 2020-07-30 0000318299 SRCO:PostSplitMember 2022-04-30 0000318299 SRCO:PostSplitMember 2021-04-30 0000318299 us-gaap:SeriesCPreferredStockMember 2022-04-30 0000318299 SRCO:CommonStockOneMember 2021-05-01 2022-04-30 0000318299 us-gaap:SeriesCPreferredStockMember 2021-05-01 2022-04-30 0000318299 us-gaap:SeriesDPreferredStockMember 2021-05-01 2022-04-30 0000318299 SRCO:FourteenAccreditedInvestorsMember us-gaap:CommonStockMember 2021-05-01 2022-04-30 0000318299 SRCO:ThreeAccreditedInvestorsMember us-gaap:CommonStockMember 2021-05-01 2022-04-30 0000318299 us-gaap:CommonStockMember SRCO:HavensStockOptionAgreementMember 2021-05-01 2022-04-30 0000318299 us-gaap:CommonStockMember SRCO:AhmanStockOptionAgreementMember 2021-05-01 2022-04-30 0000318299 SRCO:TwoIndependentDirectorMember us-gaap:CommonStockMember 2022-01-02 2022-01-03 0000318299 SRCO:TwoIndependentDirectorMember us-gaap:CommonStockMember 2022-01-03 0000318299 SRCO:ChiefExecutiveOfficerAndVicePresidentMember us-gaap:CommonStockMember 2022-01-02 2022-01-03 0000318299 SRCO:ChiefExecutiveOfficerAndVicePresidentMember us-gaap:CommonStockMember 2022-01-03 0000318299 SRCO:FourEmployeesMember us-gaap:CommonStockMember 2022-01-02 2022-01-03 0000318299 SRCO:FourEmployeesMember us-gaap:CommonStockMember 2022-01-03 0000318299 SRCO:SeriesCConvertiblePreferredStockMember 2020-05-01 2021-04-30 0000318299 SRCO:SettlementOfAccountsPayableMember SRCO:SeriesDConvertiblePreferredStockMember 2020-05-01 2021-04-30 0000318299 SRCO:SeriesDConvertiblePreferredStockMember 2020-05-01 2021-04-30 0000318299 SRCO:CommonStockOneMember 2020-05-01 2021-04-30 0000318299 SRCO:SeriesDConvertiblePreferredStockMember 2021-05-01 2022-04-30 0000318299 SRCO:SeriesCConvertiblePreferredStockMember 2021-05-01 2022-04-30 0000318299 SRCO:CommonStockTwoMember 2020-05-01 2021-04-30 0000318299 us-gaap:SeriesAPreferredStockMember 2022-04-30 0000318299 us-gaap:SeriesAPreferredStockMember 2021-04-30 0000318299 us-gaap:SeriesBPreferredStockMember 2022-04-30 0000318299 us-gaap:SeriesBPreferredStockMember 2021-04-30 0000318299 us-gaap:SeriesCPreferredStockMember 2021-04-30 0000318299 us-gaap:SeriesDPreferredStockMember 2022-04-30 0000318299 us-gaap:SeriesDPreferredStockMember 2021-04-30 0000318299 us-gaap:FairValueInputsLevel1Member 2022-04-30 0000318299 us-gaap:FairValueInputsLevel2Member 2022-04-30 0000318299 us-gaap:FairValueInputsLevel3Member 2022-04-30 0000318299 us-gaap:FairValueInputsLevel1Member 2021-04-30 0000318299 us-gaap:FairValueInputsLevel2Member 2021-04-30 0000318299 us-gaap:FairValueInputsLevel3Member 2021-04-30 0000318299 us-gaap:ComputerEquipmentMember 2022-04-30 0000318299 us-gaap:ComputerEquipmentMember 2021-04-30 0000318299 us-gaap:WarrantMember 2021-05-01 2022-04-30 0000318299 us-gaap:WarrantMember 2022-04-30 0000318299 SRCO:WarrantOneMember 2022-04-30 0000318299 SRCO:WarrantOneMember 2021-05-01 2022-04-30 0000318299 SRCO:WarrantTwoMember 2022-04-30 0000318299 SRCO:WarrantTwoMember 2021-05-01 2022-04-30 0000318299 SRCO:WarrantThreeMember 2022-04-30 0000318299 SRCO:WarrantThreeMember 2021-05-01 2022-04-30 0000318299 SRCO:NonEmployeesMember us-gaap:WarrantMember 2020-04-30 0000318299 SRCO:NonEmployeesMember us-gaap:WarrantMember 2020-05-01 2021-04-30 0000318299 SRCO:NonEmployeesMember us-gaap:WarrantMember 2021-04-30 0000318299 SRCO:NonEmployeesMember us-gaap:WarrantMember 2021-05-01 2022-04-30 0000318299 SRCO:NonEmployeesMember us-gaap:WarrantMember 2022-04-30 0000318299 SRCO:ExecutiveOfficeSpaceMember 2021-05-01 2022-04-30 0000318299 SRCO:MrHavensMember SRCO:EmploymentAgreementMember 2021-05-01 2022-04-30 0000318299 SRCO:MrHavensMember SRCO:EmploymentAgreementMember 2022-04-30 0000318299 SRCO:MsAhmanMember SRCO:EmploymentAgreementMember 2021-05-01 2022-04-30 0000318299 SRCO:MsAhmanMember SRCO:EmploymentAgreementMember 2022-04-30 0000318299 SRCO:LenderOneMember 2022-04-30 0000318299 SRCO:LenderTwoMember 2022-04-30 0000318299 SRCO:NewYorkCountyKingsMember 2016-09-21 2016-09-22 0000318299 SRCO:PromissoryNoteMember 2015-02-26 iso4217:USD shares iso4217:USD shares pure 0000318299 false FY 10-K true 2022-04-30 --04-30 2022 false 0-9483 SPARTA COMMERCIAL SERVICES, INC. NV 30-0298178 555 Fifth Avenue 14th Floor New York NY 10017 (212) 239-2666 Common Stock, par value $0.001 SRCO No No Yes Yes Non-accelerated Filer true false false 978241 17501298 None 6285 Boyle CPA, LLC Red Bank, NJ 317 396 469 8422 13823 8739 14688 213262 213262 9628 9000 9000 17739 33316 27202 49041 4354129 3627831 141585 409013 5250084 4680275 13385 13946 9549640 3446738 19336025 12226844 432403 432403 432403 432403 19768428 12659247 0.001 0.001 10000000 10000000 35850 35850 100 100 125 125 125 125 12500 12500 1000 1000 0.001 0.001 10000 10000 0 0 0 0 200000 200000 0.001 0.001 10 10 4145 4145 4145 4145 2363 4145 2000000 2000000 0.001 0.001 1.00 1.00 1494 1494 4494 4494 618 1494 0.001 0.001 750000000 750000000 15128005 15128005 9809877 9809877 15128 9810 8916805 1214528 8292 1215 53210921 51351156 -73984686 -64993250 -20734864 -13612930 984175 986999 -19750689 -12625931 17739 33316 219404 245675 26065 14056 245469 259731 42161 60986 203308 198745 1199416 1394881 217138 1470554 1394881 -1267246 -1196136 11956 7690 -125328 601279 723003 -7132043 -504599 -7721366 -1094584 -8988614 -2290720 -2823 12748 191 -8991437 -2303659 -0.66 -0.37 0.0000 -0.66 -0.37 13686995 6270929 125 12500 4132269 4145 1494962 1494 9809877 9810 1214528 1215 51351156 -64993250 986999 -12625931 -1688269 1501 -467551 467 3194418 -3194 995500 -995 -1656493 -1658714 125000 125 24875 25000 -281000 -281 -409000 -409 -1725176 -2350 -317979 -321019 8916805 8917 501083 510000 731623 732 158279 159011 427235 427 24636 25063 355000 355 59356 59711 484852 485 -484852 -485 -246978 -246978 -8991437 -2823 -8994260 125 12500 2163000 2363 618411 618 15128005 15128 8916805 8292 53210921 -73894687 984176 -19750689 125 12500 4132129 4005 1132962 1132 9433282 9433 847865 848 50120928 -62702339 974251 11591617 125 12500 4132129 4005 1132962 1132 9433282 9433 847865 848 50120928 -62702339 974251 11591617 140 140 366663 367 234995 235502 362000 362 311001 311363 621665 621665 126595 127 25192 25319 250000 250 49750 50000 191 191 -2290720 12748 -2277972 -2290720 12748 -2277972 125 12500 4132269 4145 1494962 1494 9809877 9810 1214528 1215 51351156 -64993250 986999 -12625931 125 12500 4132269 4145 1494962 1494 9809877 9810 1214528 1215 51351156 -64993250 986999 -12625931 -8988614 -2290720 6102902 644613 -312049 59465 723003 786091 382931 159009 464718 -469 -951 -5401 -9508 -9628 -470 695589 -299504 -561 -2308 -1170621 -678387 -21839 34268 890000 235502 302381 409013 1170542 678783 -79 396 396 317 396 <p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zWCdWd938Tc6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE A – <span id="xdx_825_zbyi10jcYefk">SUMMARY OF ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the significant accounting policies applied in the preparation of the accompanying financial statements follows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--BusinessCombinationsPolicy_zWOrfUgaWw07" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_znun3X0Z1oFf">Business</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation serving four markets. Sparta is a technology company that develops, markets and manages business websites and mobile applications (mobile apps) for smartphones and tablets. The Company also owns and manages websites which sell on-demand motorcycle, recreational vehicle, power-sport vehicle and truck title history reports for consumers, retail dealers, auction houses, insurance companies and banks/finance companies. Lastly, since 2007, Sparta has administered leasing programs nationwide for local and/or state agencies seeking to finance municipal vehicles and equipment. The Company also introduced a new business line in the rapidly expanding Hemp-CBD (cannabidiol) market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2016, the Company changed the name of its majority-owned subsidiary Specialty Reports, Inc., to iMobile Solutions, Inc. The new name reflects the Company’s strategic evolution and focus on the growing mobile application market domestically.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sparta’s mobile application (mobile app) offerings have broadened our base beyond our original base of vehicle dealers to include a wide range of businesses including, but not limited to, agriculture dealerships, racetracks, private clubs, country clubs, restaurants and grocery stores. We also offer a private label version of our mobile app framework to enable other businesses to offer custom apps to their customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also designs, launches, maintains, and hosts websites for businesses. We provide specific, tailored action plans for our clients’ websites that include services such as eCommerce, CRM (Customer Relationship Management) development and integration, ordering system creation and integration, SEO (search engine optimization), social media marketing, and online reviews to improve their presence online. In addition, we offer text messaging services which are vital for businesses’ marketing, retention and loyalty strategies. Our text messaging platform allows our clients to easily manage, schedule, and analyze text message performance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s vehicle history reports include Cyclechex (Motorcycle History Reports at <span style="text-decoration: underline">www.cyclechex.com</span>); RVchecks (Recreational Vehicle History Reports at <span style="text-decoration: underline">www.rvchecks.com</span>); and Truckchex (Heavy Duty Truck History Reports at <span style="text-decoration: underline">www.truckchex.com</span>). Our Vehicle History Reports are designed for consumers, retail dealers, auction houses, insurance companies and banks/finance companies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sparta also administers a Municipal Leasing Program for local and/or state agencies throughout the country who are seeking a better and more economical way to finance their essential equipment needs, including police motorcycles, cruisers, buses, fire trucks, and EMS equipment. We are continuing to expand our roster of equipment manufacturers and the types of equipment we lease.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New World Health Brands, Inc. (NWHB) was formed in April 2019 as a subsidiary and new business line of Sparta Commercial Services, Inc. While anticipating, and with the passing of the 2018 Farm Bill, which resulted in the removal of hemp (CBD) from Schedule 1 of the Controlled Substances Act. Sparta’s management recognized a substantial potential business opportunity in the rapidly expanding Industrial Hemp-CBD (Cannabinol) market in the United States. During 2019-2020, management sourced, developed and lab tested 5 CBD product categories totaling 31 products, procured product packaging, labeling, implemented fulfillment and launched an on-line B2C website, <span style="text-decoration: underline">www.newworldhealthcbd.com</span>. The Company has since curated its products and currently offers 15 products with plans to add complementary products to our product line.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Sparta’s newest subsidiary, Sparta Crypto, Inc., <span style="text-decoration: underline">www.SpartaCrypto.com</span>, was established September 25, 2020 and is in the process of completing a proprietary state-of-the-art platform designed to connect users of widely adopted digital currencies with sellers of various goods and services. The platform has not launched and the Company can make no assurances that the described plan will reach implementation. In addition, the Company has completed and tested a cryptocurrency payment gateway called SpartaPayIQ, www.SpartaPayIQ.com, which is functional and was formally announced on March 3, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sparta’s offices are located at 555 Fifth Avenue, 14<sup>th</sup> Floor, New York, NY 10017, (212) 239-2666. The Company maintains a corporate website at <span style="text-decoration: underline">www.spartacommercial.com</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We identify our ongoing information technology business in two reporting groups: mobile apps/websites and vehicle history reports, both of which operate under our wholly owned subsidiary, iMobile Solutions, Inc. The latest product offering, via www.newworldhealthcbd.com, offering a full array of hemp-derived CBD products, is contained in our subsidiary, New World Health Brands, Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_zLlaSvgMJmi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zUgHFpzQyADc">Principles of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of the Company and its majority owned subsidiary. All material intercompany transactions and balances have been eliminated in consolidation. The third party ownership of the Company’s subsidiary is accounted for as noncontrolling interest in the consolidated financial statements. Changes in the noncontrolling interest are reported in the statement of stockholders’ deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--UseOfEstimates_z8U2y9Zvi39d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_863_zZQ7tGOFK8Q1">Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_zJ4td70uAuZ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zrt32Kkqw2Za">Revenue Recognition</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first quarter of 2018, the Company adopted ASU 2014-09, <i>Revenue from Contracts with Customers (Topic 606)</i>, using the cumulative-effect method. The new standard requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The adoption did not have an impact in our consolidated financial statements, other than the enhancement of our disclosures related to our revenue-generating activities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--DisaggregationOfRevenueTableTextBlock_zXBIAp0Icuj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents our revenues disaggregated by revenue source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zavjfFzRnI0e" style="display: none">SCHEDULE OF DISAGGREGATION REVENUE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20210501__20220430_z6a5Bhue9AQ5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20200501__20210430_znHNQvDIzSlc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year Ended April 30,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--InformationTechnologyMember_zT65B9EiSYK3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information Technology</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">219,404</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245,675</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--NewWorldHealthBrandsMember_zhYOkcN7z9B6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New World Health Brands</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,065</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,056</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zXEJaRb7FJU" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Revenues</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245,469</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">259,731</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zZ3GImc4676h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zSwjw7NxgX45" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zWKrAE7QLSEk">Cash Equivalents</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the purpose of the accompanying financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_z0miQwzTN9Bh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zgjoQ59GBG9h">Website Development Costs</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes website development costs in accordance with ASC 350-50, <i>“Accounting for Website Development Costs.” </i>As such, the Company expenses all costs incurred that relate to the planning and post implementation phases of development of its website. Direct costs incurred in the development phase are capitalized and recognized over the estimated useful life. Costs associated with repair or maintenance for the website are included in cost of net revenues in the current period expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z3yakB3h01ga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_z7T4c1HsYcRb">Fair Value Measurements</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASC 820, <i>“Fair Value Measurements</i> (“ASC 820”)<i>.” </i>ASC 820 establishes a three-level fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets the lowest priority to unobservable inputs to fair value measurements of certain assets and Liabilities. The three levels of the fair value hierarchy under ASC 820 are described below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 1 —</i> Quoted prices for identical instruments in active markets. Level 1 assets and liabilities include debt and equity securities and derivative contracts that are traded in an active exchange market, as well as certain securities that are highly liquid and are actively traded in over-the-counter markets.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 2 —</i> Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which all significant inputs and significant value drivers are observable in active markets.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 3 —</i> Unobservable inputs that are supported by little or no market activity and that are significant to the fair value measurements. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques based on significant unobservable inputs, as well as management judgments or estimates that are significant to valuation.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not always be available.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zRzlOd2OnGZk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zTzM11lu95S3">Income Taxes</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We utilize ASC 740 “<i>Income Taxes</i>” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at year-end based on enacted laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zWSXqgWbq5ng" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_zm2nP99Jqhuf">Stock Based Compensation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for our stock based compensation under ASC 718 “<i>Compensation – Stock Compensation</i>” using the fair value based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zaUKbZA1l5Z4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_865_z1mimiLU0cma">Inventories</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health Brands business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zu3JvpIVqlR8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86C_zgYywS90tke6">Property and Equipment</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is calculated using the straight-line method over the estimated useful lives. Estimated useful lives of major depreciable assets are as follows:</span></p> <p id="xdx_896_ecustom--ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentTableTextBlock_zISp0pWdZ2zi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_z5yMYkHPHzgc" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_493_20210501__20220430_zezamGyNMv6d" style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentUsefulLife_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zlkueDnO6hzl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</span></td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentUsefulLife_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z4zOHT25V7Y7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7 years</span></td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentUsefulLife_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteCostsMember_zUNlRZzvRYJj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Website costs</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zWmimPeVmYF1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer Equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr> </table> <p id="xdx_8A6_zwQRA9kkGtJ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zgDfFbAL5ds7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86A_zW5BzurQZ566">Concentrations of Credit Risk</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zcYNO4c4ToF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zGBzoLIB6rP6">Net Loss Per Share</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses ASC 260-10, “<i>Earnings Per Share,</i>” for calculating the basic and diluted loss per share. The Company computes basic loss per share by dividing net loss and net loss attributable to common shareholders by the weighted average number of common shares outstanding. Common equivalent shares are excluded from the computation of net loss per share if their effect is anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At April 30, 2022 and 2021 <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn6n6_c20210501__20220430_z6VOMetlqQha" title="Antidilutive securities excluded from computation of earnings per share, amount">42</span> million potential shares (including <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210501__20220430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SharesToBeIssuedMember_zPN7dyadYWVh" title="Antidilutive securities excluded from computation of earnings per share, amount">847,866</span> shares to be issued included on the balance sheet) and <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200501__20210430_zY1KDTotZXtf" title="Antidilutive securities excluded from computation of earnings per share, amount">10,397,258</span> potential shares (including <span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200501__20210430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SharesToBeIssuedMember_zCtZTlcZ4j13" title="Antidilutive securities excluded from computation of earnings per share, amount">807,866</span> shares to be issued included on the balance sheet), respectively, were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--DerivativesPolicyTextBlock_zh6qyH3lBdZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zlTVatkQdDA">Derivative Liabilities</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assessed the classification of its derivative financial instruments as of April 30, 2022 and 2021 which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_843_eus-gaap--DebtPolicyTextBlock_z5mVBzwWlvth" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zwdNV0vlxfe3">Convertible Instruments</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “<i>Accounting for Derivative Instruments and Hedging Activities</i>”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “<i>Accounting for Convertible Securities with Beneficial Conversion Features</i>,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z13p8Z9HO1La" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zA3SM1N80pj1">Reclassifications</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications have been made to conform to prior periods’ data to the current presentation. These reclassifications had no effect on reported losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zH7WYeq45fp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86B_zRoWg23pDA6k">Recent Accounting Pronouncements</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2019, the FASB issued ASU 2019-09, “<i>Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</i>” (ASU 2018-09). This ASU makes several modifications to Topic 718 related to the accounting for forfeitures, employer tax withholding on share-based compensation, and the financial statement presentation of excess tax benefits or deficiencies. ASU 2018-09 also clarifies the statement of cash flows presentation for certain components of share-based awards. The standard is effective for interim and annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company adopted this guidance on May 1, 2019 and it did not have an impact on the Company’s consolidated financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2014, the FASB issued ASU 2014-15, “<i>Presentation of Financial Statements - Going Concern (Topic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern</i>” (“ASU 2014-15”). This amendment prescribes that an entity should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. The amendments became effective for the Company’s annual and interim reporting periods beginning May 1, 2019. The Company will begin evaluating going concern disclosures based on this guidance upon adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The FASB issued the following accounting standard updates related to Topic 606, Revenue Contracts with Customers:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">● </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU No. 2014-09, <i>Revenue from Contracts with Customers (Topic 606)</i> (“ASU 2014-09”) in May 2014. ASU 2014-09 requires entities to recognize revenue through the application of a five-step model, which includes identification of the contract, identification of the performance obligations, determination of the transaction price, allocation of the transaction price to the performance obligations and recognition of revenue as the entity satisfies the performance obligations.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU No. 2018-08, <i>Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)</i> (“ASU 2018-08”) in March 2018. ASU 2019-08 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on principal versus agent considerations.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU No. 2018-10, <i>Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing</i> (“ASU 2018-10”) in April 2018. ASU 2018-10 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU No. 2018-11, <i>Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates</i> 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2018 EITF Meeting (SEC Update) (“ASU 2018-11”) in May 2018. ASU 2018-11 rescinds SEC paragraphs pursuant to two SEC Staff Announcements at the March 3, 2018 EITF meeting. The SEC Staff is rescinding SEC Staff Observer comments that are codified in Topic 605 and Topic 932, effective upon adoption of Topic 606.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU No. 2018-12, <i>Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients</i> in May 2018. ASU 2018-12 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on a few narrow areas and adds some practical expedients to the guidance.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These ASUs became effective for the Company beginning interim period beginning May 1, 2018. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016, the FASB issued <i>Accounting Standards Update No. 2016-02</i> (Topic 842) “<i>Leases</i>.” Topic 842 supersedes the lease requirements in Accounting Standards Codification (ASC) Topic 840, “<i>Leases</i>.” Under Topic 842, lessees are required to recognize assets and liabilities on the balance sheet for most leases and provide enhanced disclosures. Leases will continue to be classified as either finance or operating. The Company adopted Topic 842 effective May 1, 2019 using a modified retrospective method and elected not to recognize leases with terms of 12 months or less. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, we have not determined whether implementation of such proposed standards would be material to our consolidated financial statements.</span></p> <p id="xdx_85D_zeVr59aNjyBh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--BusinessCombinationsPolicy_zWOrfUgaWw07" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_znun3X0Z1oFf">Business</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation serving four markets. Sparta is a technology company that develops, markets and manages business websites and mobile applications (mobile apps) for smartphones and tablets. The Company also owns and manages websites which sell on-demand motorcycle, recreational vehicle, power-sport vehicle and truck title history reports for consumers, retail dealers, auction houses, insurance companies and banks/finance companies. Lastly, since 2007, Sparta has administered leasing programs nationwide for local and/or state agencies seeking to finance municipal vehicles and equipment. The Company also introduced a new business line in the rapidly expanding Hemp-CBD (cannabidiol) market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2016, the Company changed the name of its majority-owned subsidiary Specialty Reports, Inc., to iMobile Solutions, Inc. The new name reflects the Company’s strategic evolution and focus on the growing mobile application market domestically.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sparta’s mobile application (mobile app) offerings have broadened our base beyond our original base of vehicle dealers to include a wide range of businesses including, but not limited to, agriculture dealerships, racetracks, private clubs, country clubs, restaurants and grocery stores. We also offer a private label version of our mobile app framework to enable other businesses to offer custom apps to their customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also designs, launches, maintains, and hosts websites for businesses. We provide specific, tailored action plans for our clients’ websites that include services such as eCommerce, CRM (Customer Relationship Management) development and integration, ordering system creation and integration, SEO (search engine optimization), social media marketing, and online reviews to improve their presence online. In addition, we offer text messaging services which are vital for businesses’ marketing, retention and loyalty strategies. Our text messaging platform allows our clients to easily manage, schedule, and analyze text message performance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s vehicle history reports include Cyclechex (Motorcycle History Reports at <span style="text-decoration: underline">www.cyclechex.com</span>); RVchecks (Recreational Vehicle History Reports at <span style="text-decoration: underline">www.rvchecks.com</span>); and Truckchex (Heavy Duty Truck History Reports at <span style="text-decoration: underline">www.truckchex.com</span>). Our Vehicle History Reports are designed for consumers, retail dealers, auction houses, insurance companies and banks/finance companies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sparta also administers a Municipal Leasing Program for local and/or state agencies throughout the country who are seeking a better and more economical way to finance their essential equipment needs, including police motorcycles, cruisers, buses, fire trucks, and EMS equipment. We are continuing to expand our roster of equipment manufacturers and the types of equipment we lease.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New World Health Brands, Inc. (NWHB) was formed in April 2019 as a subsidiary and new business line of Sparta Commercial Services, Inc. While anticipating, and with the passing of the 2018 Farm Bill, which resulted in the removal of hemp (CBD) from Schedule 1 of the Controlled Substances Act. Sparta’s management recognized a substantial potential business opportunity in the rapidly expanding Industrial Hemp-CBD (Cannabinol) market in the United States. During 2019-2020, management sourced, developed and lab tested 5 CBD product categories totaling 31 products, procured product packaging, labeling, implemented fulfillment and launched an on-line B2C website, <span style="text-decoration: underline">www.newworldhealthcbd.com</span>. The Company has since curated its products and currently offers 15 products with plans to add complementary products to our product line.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Sparta’s newest subsidiary, Sparta Crypto, Inc., <span style="text-decoration: underline">www.SpartaCrypto.com</span>, was established September 25, 2020 and is in the process of completing a proprietary state-of-the-art platform designed to connect users of widely adopted digital currencies with sellers of various goods and services. The platform has not launched and the Company can make no assurances that the described plan will reach implementation. In addition, the Company has completed and tested a cryptocurrency payment gateway called SpartaPayIQ, www.SpartaPayIQ.com, which is functional and was formally announced on March 3, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sparta’s offices are located at 555 Fifth Avenue, 14<sup>th</sup> Floor, New York, NY 10017, (212) 239-2666. The Company maintains a corporate website at <span style="text-decoration: underline">www.spartacommercial.com</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We identify our ongoing information technology business in two reporting groups: mobile apps/websites and vehicle history reports, both of which operate under our wholly owned subsidiary, iMobile Solutions, Inc. The latest product offering, via www.newworldhealthcbd.com, offering a full array of hemp-derived CBD products, is contained in our subsidiary, New World Health Brands, Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_zLlaSvgMJmi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zUgHFpzQyADc">Principles of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of the Company and its majority owned subsidiary. All material intercompany transactions and balances have been eliminated in consolidation. The third party ownership of the Company’s subsidiary is accounted for as noncontrolling interest in the consolidated financial statements. Changes in the noncontrolling interest are reported in the statement of stockholders’ deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--UseOfEstimates_z8U2y9Zvi39d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_863_zZQ7tGOFK8Q1">Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_zJ4td70uAuZ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zrt32Kkqw2Za">Revenue Recognition</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first quarter of 2018, the Company adopted ASU 2014-09, <i>Revenue from Contracts with Customers (Topic 606)</i>, using the cumulative-effect method. The new standard requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The adoption did not have an impact in our consolidated financial statements, other than the enhancement of our disclosures related to our revenue-generating activities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--DisaggregationOfRevenueTableTextBlock_zXBIAp0Icuj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents our revenues disaggregated by revenue source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zavjfFzRnI0e" style="display: none">SCHEDULE OF DISAGGREGATION REVENUE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20210501__20220430_z6a5Bhue9AQ5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20200501__20210430_znHNQvDIzSlc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year Ended April 30,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--InformationTechnologyMember_zT65B9EiSYK3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information Technology</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">219,404</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245,675</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--NewWorldHealthBrandsMember_zhYOkcN7z9B6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New World Health Brands</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,065</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,056</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zXEJaRb7FJU" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Revenues</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245,469</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">259,731</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zZ3GImc4676h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_899_eus-gaap--DisaggregationOfRevenueTableTextBlock_zXBIAp0Icuj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents our revenues disaggregated by revenue source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zavjfFzRnI0e" style="display: none">SCHEDULE OF DISAGGREGATION REVENUE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20210501__20220430_z6a5Bhue9AQ5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20200501__20210430_znHNQvDIzSlc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year Ended April 30,</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--InformationTechnologyMember_zT65B9EiSYK3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information Technology</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">219,404</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245,675</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--NewWorldHealthBrandsMember_zhYOkcN7z9B6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New World Health Brands</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,065</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,056</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zXEJaRb7FJU" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Revenues</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245,469</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">259,731</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 219404 245675 26065 14056 245469 259731 <p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zSwjw7NxgX45" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zWKrAE7QLSEk">Cash Equivalents</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the purpose of the accompanying financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_z0miQwzTN9Bh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zgjoQ59GBG9h">Website Development Costs</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes website development costs in accordance with ASC 350-50, <i>“Accounting for Website Development Costs.” </i>As such, the Company expenses all costs incurred that relate to the planning and post implementation phases of development of its website. Direct costs incurred in the development phase are capitalized and recognized over the estimated useful life. Costs associated with repair or maintenance for the website are included in cost of net revenues in the current period expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z3yakB3h01ga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_z7T4c1HsYcRb">Fair Value Measurements</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASC 820, <i>“Fair Value Measurements</i> (“ASC 820”)<i>.” </i>ASC 820 establishes a three-level fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets the lowest priority to unobservable inputs to fair value measurements of certain assets and Liabilities. The three levels of the fair value hierarchy under ASC 820 are described below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 1 —</i> Quoted prices for identical instruments in active markets. Level 1 assets and liabilities include debt and equity securities and derivative contracts that are traded in an active exchange market, as well as certain securities that are highly liquid and are actively traded in over-the-counter markets.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 2 —</i> Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which all significant inputs and significant value drivers are observable in active markets.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 3 —</i> Unobservable inputs that are supported by little or no market activity and that are significant to the fair value measurements. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques based on significant unobservable inputs, as well as management judgments or estimates that are significant to valuation.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not always be available.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zRzlOd2OnGZk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zTzM11lu95S3">Income Taxes</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We utilize ASC 740 “<i>Income Taxes</i>” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at year-end based on enacted laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zWSXqgWbq5ng" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_zm2nP99Jqhuf">Stock Based Compensation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for our stock based compensation under ASC 718 “<i>Compensation – Stock Compensation</i>” using the fair value based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zaUKbZA1l5Z4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_865_z1mimiLU0cma">Inventories</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health Brands business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zu3JvpIVqlR8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86C_zgYywS90tke6">Property and Equipment</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is calculated using the straight-line method over the estimated useful lives. Estimated useful lives of major depreciable assets are as follows:</span></p> <p id="xdx_896_ecustom--ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentTableTextBlock_zISp0pWdZ2zi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_z5yMYkHPHzgc" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_493_20210501__20220430_zezamGyNMv6d" style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentUsefulLife_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zlkueDnO6hzl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</span></td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentUsefulLife_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z4zOHT25V7Y7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7 years</span></td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentUsefulLife_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteCostsMember_zUNlRZzvRYJj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Website costs</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zWmimPeVmYF1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer Equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr> </table> <p id="xdx_8A6_zwQRA9kkGtJ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_ecustom--ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentTableTextBlock_zISp0pWdZ2zi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_z5yMYkHPHzgc" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_493_20210501__20220430_zezamGyNMv6d" style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentUsefulLife_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zlkueDnO6hzl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</span></td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentUsefulLife_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z4zOHT25V7Y7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7 years</span></td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentUsefulLife_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteCostsMember_zUNlRZzvRYJj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Website costs</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zWmimPeVmYF1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer Equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr> </table> P3Y P7Y P3Y P5Y <p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zgDfFbAL5ds7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86A_zW5BzurQZ566">Concentrations of Credit Risk</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zcYNO4c4ToF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zGBzoLIB6rP6">Net Loss Per Share</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses ASC 260-10, “<i>Earnings Per Share,</i>” for calculating the basic and diluted loss per share. The Company computes basic loss per share by dividing net loss and net loss attributable to common shareholders by the weighted average number of common shares outstanding. Common equivalent shares are excluded from the computation of net loss per share if their effect is anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At April 30, 2022 and 2021 <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn6n6_c20210501__20220430_z6VOMetlqQha" title="Antidilutive securities excluded from computation of earnings per share, amount">42</span> million potential shares (including <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210501__20220430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SharesToBeIssuedMember_zPN7dyadYWVh" title="Antidilutive securities excluded from computation of earnings per share, amount">847,866</span> shares to be issued included on the balance sheet) and <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200501__20210430_zY1KDTotZXtf" title="Antidilutive securities excluded from computation of earnings per share, amount">10,397,258</span> potential shares (including <span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200501__20210430__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SharesToBeIssuedMember_zCtZTlcZ4j13" title="Antidilutive securities excluded from computation of earnings per share, amount">807,866</span> shares to be issued included on the balance sheet), respectively, were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 42000000 847866 10397258 807866 <p id="xdx_84D_eus-gaap--DerivativesPolicyTextBlock_zh6qyH3lBdZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zlTVatkQdDA">Derivative Liabilities</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assessed the classification of its derivative financial instruments as of April 30, 2022 and 2021 which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_843_eus-gaap--DebtPolicyTextBlock_z5mVBzwWlvth" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zwdNV0vlxfe3">Convertible Instruments</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “<i>Accounting for Derivative Instruments and Hedging Activities</i>”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “<i>Accounting for Convertible Securities with Beneficial Conversion Features</i>,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z13p8Z9HO1La" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zA3SM1N80pj1">Reclassifications</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications have been made to conform to prior periods’ data to the current presentation. These reclassifications had no effect on reported losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zH7WYeq45fp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86B_zRoWg23pDA6k">Recent Accounting Pronouncements</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2019, the FASB issued ASU 2019-09, “<i>Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</i>” (ASU 2018-09). This ASU makes several modifications to Topic 718 related to the accounting for forfeitures, employer tax withholding on share-based compensation, and the financial statement presentation of excess tax benefits or deficiencies. ASU 2018-09 also clarifies the statement of cash flows presentation for certain components of share-based awards. The standard is effective for interim and annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company adopted this guidance on May 1, 2019 and it did not have an impact on the Company’s consolidated financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2014, the FASB issued ASU 2014-15, “<i>Presentation of Financial Statements - Going Concern (Topic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern</i>” (“ASU 2014-15”). This amendment prescribes that an entity should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. The amendments became effective for the Company’s annual and interim reporting periods beginning May 1, 2019. The Company will begin evaluating going concern disclosures based on this guidance upon adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The FASB issued the following accounting standard updates related to Topic 606, Revenue Contracts with Customers:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">● </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU No. 2014-09, <i>Revenue from Contracts with Customers (Topic 606)</i> (“ASU 2014-09”) in May 2014. ASU 2014-09 requires entities to recognize revenue through the application of a five-step model, which includes identification of the contract, identification of the performance obligations, determination of the transaction price, allocation of the transaction price to the performance obligations and recognition of revenue as the entity satisfies the performance obligations.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU No. 2018-08, <i>Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)</i> (“ASU 2018-08”) in March 2018. ASU 2019-08 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on principal versus agent considerations.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU No. 2018-10, <i>Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing</i> (“ASU 2018-10”) in April 2018. ASU 2018-10 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU No. 2018-11, <i>Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates</i> 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2018 EITF Meeting (SEC Update) (“ASU 2018-11”) in May 2018. ASU 2018-11 rescinds SEC paragraphs pursuant to two SEC Staff Announcements at the March 3, 2018 EITF meeting. The SEC Staff is rescinding SEC Staff Observer comments that are codified in Topic 605 and Topic 932, effective upon adoption of Topic 606.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU No. 2018-12, <i>Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients</i> in May 2018. ASU 2018-12 does not change the core principle of revenue recognition in Topic 606 but clarifies the implementation guidance on a few narrow areas and adds some practical expedients to the guidance.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These ASUs became effective for the Company beginning interim period beginning May 1, 2018. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016, the FASB issued <i>Accounting Standards Update No. 2016-02</i> (Topic 842) “<i>Leases</i>.” Topic 842 supersedes the lease requirements in Accounting Standards Codification (ASC) Topic 840, “<i>Leases</i>.” Under Topic 842, lessees are required to recognize assets and liabilities on the balance sheet for most leases and provide enhanced disclosures. Leases will continue to be classified as either finance or operating. The Company adopted Topic 842 effective May 1, 2019 using a modified retrospective method and elected not to recognize leases with terms of 12 months or less. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, we have not determined whether implementation of such proposed standards would be material to our consolidated financial statements.</span></p> <p id="xdx_807_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zEauJJlCYZJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE B – <span id="xdx_82B_zKuRR7nExIz1">GOING CONCERN MATTERS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, the Company has incurred recurring losses and generated negative cash flows from operating activities since inception. As of April 30, 2022, the Company had an accumulated deficit of $<span id="xdx_905_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20220430_zVRX44FoUGM" title="Retained earnings (accumulated deficit)">73,984,686</span> and a working capital deficit (total current liabilities exceeded total current assets) of $<span id="xdx_906_ecustom--WorkingCapitalDeficit_iNI_di_c20220430_z6HplnECSO7h" title="Working capital deficit">19,327,286</span>. The Company’s cash balance and revenues generated are not currently sufficient and cannot be projected to cover its operating expenses for the next twelve months from the filing date of this report. These factors among others raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s existence is dependent upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that the Company’s efforts will be successful. No assurance can be given that management’s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to improve the Company’s liquidity, the Company’s management is actively pursuing additional equity financing through discussions with investment bankers, private equity groups, and private investors. There can be no assurance that the Company will be successful in its effort to secure additional equity financing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> -73984686 -19327286 <p id="xdx_806_eus-gaap--DebtDisclosureTextBlock_zZ46rEhQZDh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE C – <span id="xdx_82F_z5gzDxNF40Vb">NOTES PAYABLE AND DERIVATIVES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfDebtTableTextBlock_z2HnfRcCsYig" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has outstanding numerous notes payable to various parties. The notes bear interest at rates of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220430__srt--RangeAxis__srt--MinimumMember_zpI8YWKfSMWf" title="Debt instrument, interest rate">5</span>% - <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220430__srt--RangeAxis__srt--MaximumMember_z0Ar58WD3CUb" title="Debt instrument, interest rate">20</span>% per year and are summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zUtGFXD1lvn" style="display: none">SCHEDULE OF NOTES PAYABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes Payable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20220430_zXBej3Uasbmc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20210430_zKRA2pQC9uL8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_hus-gaap--DebtInstrumentAxis__custom--NotesConvertibleAtHoldersOptionMember_zZNMgZHjzox1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes convertible at holder’s option</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,980,848</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,522,925</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_hus-gaap--DebtInstrumentAxis__custom--NotesConvertibleAtCompanysOptionMember_z4Ms7yWJa2k5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes convertible at Company’s option</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335,700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335,700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_hus-gaap--DebtInstrumentAxis__custom--NonConvertibleNotesPayableMember_z7lo9ZXRadt1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-convertible notes payable</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,933,536</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,821,650</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_maLTDzyST_z564ud8H4K3e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subtotal</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,250,084</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,680,275</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_zI9ZXXmeklTj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less debt discount</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0925">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzyST_zjWb60hCjeC" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,250,084</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,680,275</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_z8d8IbOW8jl9" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain of the notes payable contain variable conversion rates and the conversion features are classified as derivative liabilities. The conversion prices are based on the market price of the Company’s common stock, at discounts of <span id="xdx_90F_ecustom--CommonStockDiscountRatePercentage_pid_dp_uPure_c20210501__20220430__srt--RangeAxis__srt--MinimumMember_zVksDgwy3V44" title="Common stock discount rate, percentage">30</span>% to <span id="xdx_903_ecustom--CommonStockDiscountRatePercentage_pid_dp_uPure_c20210501__20220430__srt--RangeAxis__srt--MaximumMember_zdCvteF7UGMk" title="Common stock discount rate, percentage">48</span>% to market value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of debt discount for the years ended April 30, 2022 and 2021 was $<span id="xdx_90A_ecustom--AmortizationOfDebtDiscount_c20210501__20220430_znnLqq2q8ssi" title="Amortization of debt discount">0</span> and $<span id="xdx_902_ecustom--AmortizationOfDebtDiscount_c20190501__20200430_zCyUzzDh6KWj" title="Amortization of debt discount">0</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s derivative financial instruments consist of embedded derivatives related to the outstanding short term Convertible Notes Payable. These embedded derivatives include certain conversion features indexed to the Company’s common stock. The accounting treatment of derivative financial instruments requires that the Company record the derivatives and related items at their fair values as of the inception date of the Convertible Notes Payable and at fair value as of each subsequent balance sheet date. In addition, under the provisions of Accounting Standards Codification subtopic 815-40, <i>Derivatives and Hedging; Contracts in Entity’s Own Equity</i> (“ASC 815-40”), as a result of entering into the Convertible Notes Payable, the Company is required to classify all other non-employee stock options and warrants as derivative liabilities and mark them to market at each reporting date. Any change in fair value inclusive of modifications of terms will be recorded as non-operating, non-cash income or expense at each reporting date. If the fair value of the derivatives is higher at the subsequent balance sheet date, the Company will record a non-operating, non-cash charge. If the fair value of the derivatives is lower at the subsequent balance sheet date, the Company will record non-operating, non-cash income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zyPj9inomLaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The change in fair value of the derivative liabilities of convertible notes outstanding at April 30, 2022 and 2021 was calculated with the following average assumptions, using a Black-Scholes option-pricing model are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zQ6QVS3KMPz4" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant Assumptions:</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free interest rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ranging from</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_z9B2383Ptii9" title="Derivative liability, measurement input, percentage"><span id="xdx_900_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20210430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zjNroBiIDc8f">0.16</span></span>% to <span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zMwBvihqc8M4" title="Derivative liability, measurement input, percentage"><span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20210430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_za0Cx9W43rSf">0.20</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 62%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected stock price volatility</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zHJCmi0FRbSk" title="Derivative liability, measurement input, percentage"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20210430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zNJE34RbhYC6">369</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend payout</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_dp_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputDividendPayoutMember_zeosqBzzePal"><span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_dp_uPure_c20210430__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputDividendPayoutMember_zDlGL4EcibQh">0</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected options life in years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ranging from</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--DerivativeLiabilityMeasurementInputExpectedLife_dtY_c20210501__20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zhPLP5wVnjJ" title="Derivative liability, measurement input, expected life"><span id="xdx_908_ecustom--DerivativeLiabilityMeasurementInputExpectedLife_dtY_c20200501__20210430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zEJfQ06LQVu">1</span></span> year to <span id="xdx_90F_ecustom--DerivativeLiabilityMeasurementInputExpectedLife_dtY_c20210501__20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zzA66vKJe6k7" title="Derivative liability, measurement input, expected life"><span id="xdx_902_ecustom--DerivativeLiabilityMeasurementInputExpectedLife_dtY_c20200501__20210430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_ztMk29l9zggj">2</span></span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_8AD_zEA3T6jfXs42" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_z3OScKWJrb6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in derivative liability during the years ended April 30, 2022 and 2021 were:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8B0_zj72HCA6ofv7" style="display: none">SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, beginning of year</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_ecustom--DerivativeLiability_iS_c20210501__20220430_zqt8UiN6goN7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance, beginning of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,252,446</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--DerivativeLiability_iS_c20200501__20210430_zYJJN2kfi5da" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance, beginning of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,802,125</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability reclassified to additional paid in capital</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--DerivativeLiabilityExtinguished_c20210501__20220430_zKKgef7XZESh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative liability reclassified to additional paid in capital"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(474,420</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--DerivativeLiabilityExtinguished_c20200501__20210430_z8Rf8AOqz5J8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative liability reclassified to additional paid in capital"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(573,397</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative financial liability arising on the issue of convertible notes and warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_c20200501__20210430_zZv8JWKQQxp4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liability arising on the issue of convertible notes and warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">715,411</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--AssetsFairValueAdjustment_c20210501__20220430_zZo7z5IO2Wr7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,728,206</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--AssetsFairValueAdjustment_c20200501__20210430_zUIdTFr8vtp8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,310,307</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, end of year</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_ecustom--DerivativeLiability_iE_c20210501__20220430_zyxrXJV6hy9h" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, end of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,506,232</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--DerivativeLiability_iE_c20200501__20210430_z2rFeQwtwA46" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, end of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,252,446</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AE_z1hdkgHBwQvd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_896_eus-gaap--ScheduleOfDebtTableTextBlock_z2HnfRcCsYig" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has outstanding numerous notes payable to various parties. The notes bear interest at rates of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220430__srt--RangeAxis__srt--MinimumMember_zpI8YWKfSMWf" title="Debt instrument, interest rate">5</span>% - <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220430__srt--RangeAxis__srt--MaximumMember_z0Ar58WD3CUb" title="Debt instrument, interest rate">20</span>% per year and are summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zUtGFXD1lvn" style="display: none">SCHEDULE OF NOTES PAYABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes Payable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20220430_zXBej3Uasbmc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20210430_zKRA2pQC9uL8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_hus-gaap--DebtInstrumentAxis__custom--NotesConvertibleAtHoldersOptionMember_zZNMgZHjzox1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes convertible at holder’s option</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,980,848</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,522,925</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_hus-gaap--DebtInstrumentAxis__custom--NotesConvertibleAtCompanysOptionMember_z4Ms7yWJa2k5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes convertible at Company’s option</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335,700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335,700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_hus-gaap--DebtInstrumentAxis__custom--NonConvertibleNotesPayableMember_z7lo9ZXRadt1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-convertible notes payable</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,933,536</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,821,650</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_maLTDzyST_z564ud8H4K3e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subtotal</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,250,084</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,680,275</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_zI9ZXXmeklTj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less debt discount</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0925">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzyST_zjWb60hCjeC" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,250,084</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,680,275</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2980848 2522925 335700 335700 1933536 1821650 5250084 4680275 5250084 4680275 0.30 0.48 0 0 <p id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zyPj9inomLaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The change in fair value of the derivative liabilities of convertible notes outstanding at April 30, 2022 and 2021 was calculated with the following average assumptions, using a Black-Scholes option-pricing model are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zQ6QVS3KMPz4" style="display: none">SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant Assumptions:</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free interest rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ranging from</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_z9B2383Ptii9" title="Derivative liability, measurement input, percentage"><span id="xdx_900_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20210430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zjNroBiIDc8f">0.16</span></span>% to <span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zMwBvihqc8M4" title="Derivative liability, measurement input, percentage"><span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20210430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_za0Cx9W43rSf">0.20</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 62%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected stock price volatility</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zHJCmi0FRbSk" title="Derivative liability, measurement input, percentage"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20210430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zNJE34RbhYC6">369</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend payout</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_dp_uPure_c20220430__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputDividendPayoutMember_zeosqBzzePal"><span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_dp_uPure_c20210430__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputDividendPayoutMember_zDlGL4EcibQh">0</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected options life in years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ranging from</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--DerivativeLiabilityMeasurementInputExpectedLife_dtY_c20210501__20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zhPLP5wVnjJ" title="Derivative liability, measurement input, expected life"><span id="xdx_908_ecustom--DerivativeLiabilityMeasurementInputExpectedLife_dtY_c20200501__20210430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zEJfQ06LQVu">1</span></span> year to <span id="xdx_90F_ecustom--DerivativeLiabilityMeasurementInputExpectedLife_dtY_c20210501__20220430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zzA66vKJe6k7" title="Derivative liability, measurement input, expected life"><span id="xdx_902_ecustom--DerivativeLiabilityMeasurementInputExpectedLife_dtY_c20200501__20210430__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_ztMk29l9zggj">2</span></span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> 0.16 0.16 0.20 0.20 369 369 0 0 P1Y P1Y P2Y P2Y <p id="xdx_892_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_z3OScKWJrb6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in derivative liability during the years ended April 30, 2022 and 2021 were:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8B0_zj72HCA6ofv7" style="display: none">SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, beginning of year</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_ecustom--DerivativeLiability_iS_c20210501__20220430_zqt8UiN6goN7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance, beginning of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,252,446</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--DerivativeLiability_iS_c20200501__20210430_zYJJN2kfi5da" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance, beginning of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,802,125</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability reclassified to additional paid in capital</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--DerivativeLiabilityExtinguished_c20210501__20220430_zKKgef7XZESh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative liability reclassified to additional paid in capital"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(474,420</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--DerivativeLiabilityExtinguished_c20200501__20210430_z8Rf8AOqz5J8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative liability reclassified to additional paid in capital"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(573,397</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative financial liability arising on the issue of convertible notes and warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_c20200501__20210430_zZv8JWKQQxp4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liability arising on the issue of convertible notes and warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">715,411</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--AssetsFairValueAdjustment_c20210501__20220430_zZo7z5IO2Wr7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,728,206</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--AssetsFairValueAdjustment_c20200501__20210430_zUIdTFr8vtp8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,310,307</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, end of year</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_ecustom--DerivativeLiability_iE_c20210501__20220430_zyxrXJV6hy9h" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, end of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,506,232</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--DerivativeLiability_iE_c20200501__20210430_z2rFeQwtwA46" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance, end of year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,252,446</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 4252446 2802125 -474420 -573397 715411 3728206 1310307 7506232 4252446 <p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zMw9u6QQs5C1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE D – <span id="xdx_82E_zxdfwxTKMgb6">LOANS PAYABLE TO RELATED PARTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of April 30, 2022, and 2021, aggregated loans payable, without demand and with no interest, to officers and directors were $<span id="xdx_906_eus-gaap--DueToOfficersOrStockholdersNoncurrent_iI_c20220430_z1l6gGi5UR93" title="Loans payable to officers and directors">432,403</span> and $<span id="xdx_90E_eus-gaap--DueToOfficersOrStockholdersNoncurrent_iI_c20210430_zRLI5qk8acif" title="Loans payable to officers and directors">432,403</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 432403 432403 <p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zt0w5CN1LCX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE E</b> – <b><span id="xdx_82F_z0LcRhvpRiZ">EQUITY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Common Stock</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is authorized to issue <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20220430_zcEMJzQcahv7" title="Common stock, shares authorized">750,000,000</span> shares of common stock, $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210430_zArO7Mjvdr4e" title="Common stock, par value">0.001</span> par value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 30, 2020, Sparta Commercial Services, Inc. (the “Company”) filed with the Secretary of State of the state of Nevada, a Certificate of Amendment to its Articles of Incorporation (the “Amendment”), attached herewith as Exhibit 3.1, and incorporated by reference. The Amendment will be effective as of December 30, 2020. On July 9, 2020, the Board of Directors of the Company declared July 30, 2020 as <span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20200725__20200730_zY8TeTt4iJdl" title="Stockholders' equity, reverse stock split">the effective date for the 1 for 100 reverse stock split</span> (the “Reverse Stock Split”), previously approved by the stockholders of the Company by written consent in accordance with the information contained in the Schedule 14C Information Statement filed with the Securities and Exchange Commission on July 9, 2020. FINRA reviewed and authorized the corporate action changing the effective date to December 30, 2020 (the “Effective Date”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the Reverse Stock Split, every one hundred shares of outstanding common stock will automatically be converted into one shares of the Company’s common stock immediately prior to the opening of trading on the next business day after the Effective Date. If, as a result of the reverse split, a stockholder is left with a fractional share, that stockholder shall receive one full share in lieu of such fractional share. Immediately after the effectiveness of the reverse split, there will be <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_c20210501__20220430_zZk3NInWCd1a" title="Issuance of shares, reverse stock splits">7,027,930</span> shares of the Company’s common stock issued and outstanding. The aggregate number of shares of common stock that the Company is authorized to issue remains the same and was unaffected by the Reverse Stock Split. All outstanding stock options and other contractual rights including the preferred stock entitling the holders of such rights to acquire shares of common stock outstanding at the Effective Date will be appropriately adjusted to give effect to the Reverse Stock Split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had <span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20220430__us-gaap--AwardTypeAxis__custom--PostSplitMember_zCOPWvdNZqYa">15,125,005 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_c20210430__us-gaap--AwardTypeAxis__custom--PostSplitMember_zD8IH2T5Zgvk">9,809,877 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares (post-split) of common stock issued and outstanding as of April 30, 2022 and 2021, respectively. The Company had <span id="xdx_900_eus-gaap--CommonStockSharesSubscribedButUnissued_iI_c20220430_zmrqHqrXF6Ih">8,916,805 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_908_eus-gaap--CommonStockSharesSubscribedButUnissued_iI_c20210430_z9uhUzOWAAY4">1,214,528 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common classified as to be issued at April 30, 2022 and April 30, 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Preferred Stock</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is authorized to issue <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_c20220430_zfFNz544pdR1" title="Preferred stock, shares authorized">10,000,000</span> shares of preferred stock with $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220430_zJ14A4xANK3h" title="Preferred stock, par value">0.001</span> par value per share, of which <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20220430__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zKnwH1MBLcQ3" title="Preferred stock, shares designated">35,850</span> shares have been designated as Series A convertible preferred stock with a $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220430__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zK8Ru2Le3xt2" title="Preferred stock, par value">100</span> stated value per share; <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20220430__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemablePreferredStockMember_zNiyX3DyM7e9" title="Preferred stock, shares designated">1,000</span> shares have been designated as Series B Preferred Stock with a $<span id="xdx_90C_eus-gaap--PreferredStockLiquidationPreference_c20210430__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemablePreferredStockMember_pdd" title="Preferred stock, liquidation and redemption value per share">10,000</span> per share liquidation value; <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20220430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zcTshNoj8H96" title="Preferred stock, shares designated">4,200,000</span> shares have been designated as Series C Preferred Stock with a $<span id="xdx_90C_eus-gaap--PreferredStockLiquidationPreference_iI_pid_c20220430__us-gaap--StatementClassOfStockAxis__custom--SeriesCRedeemableConvertiblePreferredStockMember_zEjXhau0uaIe" title="Preferred stock, liquidation and redemption value per share">10</span> per share liquidation value, and <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20220430__us-gaap--StatementClassOfStockAxis__custom--SeriesDRedeemableConvertiblePreferredStockMember_zskCm5VbLA7i" title="Preferred stock, shares designated">2,000,000</span> shares have been designated as Series D Preferred Stock with a $<span id="xdx_909_eus-gaap--PreferredStockLiquidationPreference_iI_c20220430__us-gaap--StatementClassOfStockAxis__custom--SeriesDRedeemableConvertiblePreferredStockMember_z5EaoKQLiGk1" title="Preferred stock, liquidation and redemption value per share">1</span> per share liquidation value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_ecustom--ScheduleOfPreferredStockOutstandingSharesTableTextBlock_z1FRs31W0v74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of April 30, 2022, and 2021 the Company had:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  <span id="xdx_8BC_z4K6fdDcXldf" style="display: none">SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred stock outstanding shares</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20220430_zWR3BcT0L0n9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20210430_z6GKXMIKvdY5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--PreferredStockSharesOutstanding_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zx12DvB33Ed9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series A</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--PreferredStockSharesOutstanding_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z8WuvXAFquS1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series B</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1022">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1023">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--PreferredStockSharesOutstanding_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zwfd0KPeqdnl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series C</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,163,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,132,269</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--PreferredStockSharesOutstanding_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zey6jgf0g4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series D</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">618,411</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,493,962</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--PreferredStockSharesOutstanding_iI_z3VwIX41cTvb" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Preferred Stock</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zhG5mIYPufYi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Equity Transactions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended April 30, 2022 the Company:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">● </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zB3FjbP1FHAg" title="Issuance of stock for service, shares">731,623</span> common shares for consulting services valued at $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pid_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zaxFgXVrT4g1" title="Issuance of stock for service, value">159,010</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Issued <span id="xdx_901_eus-gaap--ConversionOfStockSharesIssued1_pid_c20210501__20220430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zgIOlRotbf4c" title="Common shares issued upon conversion">3,305,860</span> common shares upon the conversion of <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_pid_c20210501__20220430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zApqxWg41Qs1" title="Converted common shares">1,010,703</span> shares of Series C Convertible Preferred stock.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Issued <span id="xdx_90C_eus-gaap--ConversionOfStockSharesIssued1_pid_c20210501__20220430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zm0FtUJa9eh5" title="Common shares issued upon conversion">650,076</span> common shares upon the conversion of <span id="xdx_901_eus-gaap--ConversionOfStockSharesConverted1_pid_c20210501__20220430__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zoHzIF0cKg3c" title="Converted common shares">162,519</span> shares of Series D Convertible Preferred stock.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sold to fourteen accredited investors <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--FourteenAccreditedInvestorsMember_zy0dQr7RfHGe">8,563,531 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock for cash or conversions of $<span id="xdx_902_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--FourteenAccreditedInvestorsMember_zB8RukJRQUWb">644,968</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">; </span>actual shares were not issued yet and recorded as commons stocks to be issued.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Sold to three accredited investors <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThreeAccreditedInvestorsMember_zeek6ulvVqN5">520,000</span> shares of Sparta Crypto, Inc,’s common stock for cash of $<span id="xdx_902_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThreeAccreditedInvestorsMember_z59OjwoHI6Sk">130,000</span>; actual shares were not issued yet and recorded as commons stocks to be issued.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2022, entered into agreements with Anthony L. Havens, the Company’s Chief Executive Officer (“Havens”) and Sandra L. Ahman, the Company’s Vice-President of Operations (“Ahman”) whereby Havens and Ahman agreed to convert debt owed to them in exchange for non-qualified stock options.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Havens agreed to convert $<span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForDeferredSalary_pp2d_c20210501__20220430__us-gaap--TypeOfArrangementAxis__custom--HavensStockOptionAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUdESEJaJODc" title="Convertion of deferred salary">137,465.76</span> of deferred salary in exchange for a stock option agreement (the “Havens Stock Option Agreement”) to purchase <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210501__20220430__us-gaap--TypeOfArrangementAxis__custom--HavensStockOptionAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zrVHPy8i1uZk" title="Stock options, grants">1,718,322</span> shares of the Company’s common stock.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ahman agreed to convert $<span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForDeferredSalary_c20210501__20220430__us-gaap--TypeOfArrangementAxis__custom--AhmanStockOptionAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkBNMBeEYuoj" title="Convertion of deferred salary">125,000</span> of deferred salary in exchange for a stock option agreement (the “Ahman Stock Option Agreement” and with the Havens Stock Option Agreement, the “Stock Option Agreements”) to purchase <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210501__20220430__us-gaap--TypeOfArrangementAxis__custom--AhmanStockOptionAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zx9YnsNxpgT9" title="Stock options, grants">1,562,500</span> shares of the Company’s common stock.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2022, the Company granted to each of its two independent Directors <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dc_c20220102__20220103__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--TwoIndependentDirectorMember_zOz4fEeNCqff">five year</span> options to purchase <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220102__20220103__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--TwoIndependentDirectorMember_zf5gbbBbAyD3" title="Stock option, grants">187,500</span> shares of the Company’s common stock at $<span id="xdx_90C_eus-gaap--SharePrice_iI_c20220103__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--TwoIndependentDirectorMember_zmHkBwZqCIc1" title="Share Price">0.08</span> per share. The options vest in three equal tranches over <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20220102__20220103__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--TwoIndependentDirectorMember_zlqwpkYRh0fg">three years</span>. These options represent compensation for past service on the board.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2022, the Company granted its CEO, Anthony L Havens and Vice President of Operations, Sandra L Ahman, <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dc_c20220102__20220103__srt--TitleOfIndividualAxis__custom--ChiefExecutiveOfficerAndVicePresidentMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zG6OlCHWQJa6">five year</span> options to purchase an aggregate of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220102__20220103__srt--TitleOfIndividualAxis__custom--ChiefExecutiveOfficerAndVicePresidentMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsjkWzDRENB5" title="Stock option, grants">750,000</span> shares of the Company’s common stock at $<span id="xdx_909_eus-gaap--SharePrice_iI_c20220103__srt--TitleOfIndividualAxis__custom--ChiefExecutiveOfficerAndVicePresidentMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgjFLkzndjs1" title="Share Price">0.08</span> per share. The options vest in three equal tranches over <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20220102__20220103__srt--TitleOfIndividualAxis__custom--ChiefExecutiveOfficerAndVicePresidentMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zenh5bk5ErPc">three years</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2022, the Company granted to four employees, <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dc_c20220102__20220103__srt--TitleOfIndividualAxis__custom--FourEmployeesMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziTHd7ErQ0Bf" title="Contractual term">five year</span> options to purchase an aggregate of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220102__20220103__srt--TitleOfIndividualAxis__custom--FourEmployeesMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzOGw0KH6E3i" title="Stock option, grants">437,500</span> shares of the Company’s common stock at $<span id="xdx_907_eus-gaap--SharePrice_iI_c20220103__srt--TitleOfIndividualAxis__custom--FourEmployeesMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zp3aMSdMssT8" title="Share Price">0.08</span> per share. The options vest in three equal tranches over <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20220102__20220103__srt--TitleOfIndividualAxis__custom--FourEmployeesMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyN3MLPHw24" title="Share based compensation vesting period">three years</span>.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended April 30, 2021, the Company:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sold <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20200501__20210430__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_z3GpWbMPFmu6" title="Number of stocks sold during period">140,000</span> Units of Series C convertible preferred stock for $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20200501__20210430__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_z6WI4LrZBa7c" title="Sale of stock">70,000</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200501__20210430__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__srt--StatementScenarioAxis__custom--SettlementOfAccountsPayableMember_zChlq8PDaMY4" title="Number of shares issued during period, shares">311,378</span> Units of Series D convertible preferred stock upon the conversion of accounts payable aggregating $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200501__20210430__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__srt--StatementScenarioAxis__custom--SettlementOfAccountsPayableMember_z2YfSR3Y4ax9" title="Number of shares issued during period">311,378</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200501__20210430__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_z48ulgZOpqpk" title="Number of shares issued during period, shares">50,455</span> Units of Series D convertible preferred stock upon the conversion of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200501__20210430__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zm7gRBT7dRuf" title="Number of shares issued during period">50,455</span> of the Company’s subsidiary preferred stock</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to agreement, issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_z1cFrbM54HY6" title="Issuance of stock, shares">250,000</span> shares of the Company’s Common Stock, valued at $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__custom--CommonStockOneMember_zY83lNAEoMd9" title="Issuance of stock, values">50,000</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Conversions of Preferred Series D convertible preferred stock, issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20210501__20220430__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_ziy2Jv07dDc" title="Convertion of convertible securities, shares">890,540</span> shares of the Company’s Common Stock, valued at $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20210501__20220430__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zIE7goz6Y9q3" title="Convertion of convertible securities, value">222,635</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Conversions of Preferred Series C convertible preferred stock, issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20210501__20220430__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zKv54tse1aI3" title="Convertion of convertible securities, shares">2,086,848</span> shares of the Company’s Common Stock, valued at $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20210501__20220430__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zbgQYye4a2K1" title="Convertion of convertible securities, value">231,872</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to agreement, issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__custom--CommonStockTwoMember_ze3ZJ92cpHC2" title="Issuance of stock, shares">3,000,000</span> shares of common stock valued at $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__custom--CommonStockTwoMember_zxZUkgcl6o6a" title="Issuance of stock, values">6,000</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 750000000 0.001 the effective date for the 1 for 100 reverse stock split 7027930 15125005 9809877 8916805 1214528 10000000 0.001 35850 100 1000 10000 4200000 10 2000000 1 <p id="xdx_89F_ecustom--ScheduleOfPreferredStockOutstandingSharesTableTextBlock_z1FRs31W0v74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of April 30, 2022, and 2021 the Company had:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  <span id="xdx_8BC_z4K6fdDcXldf" style="display: none">SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred stock outstanding shares</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20220430_zWR3BcT0L0n9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20210430_z6GKXMIKvdY5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--PreferredStockSharesOutstanding_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zx12DvB33Ed9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series A</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--PreferredStockSharesOutstanding_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z8WuvXAFquS1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series B</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1022">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1023">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--PreferredStockSharesOutstanding_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zwfd0KPeqdnl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series C</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,163,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,132,269</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--PreferredStockSharesOutstanding_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zey6jgf0g4c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series D</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">618,411</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,493,962</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--PreferredStockSharesOutstanding_iI_z3VwIX41cTvb" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Preferred Stock</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> 125 125 2163000 4132269 618411 1493962 731623 159010 3305860 1010703 650076 162519 8563531 644968 520000 130000 137465.76 1718322 125000 1562500 P5Y 187500 0.08 P3Y P5Y 750000 0.08 P3Y P5Y 437500 0.08 P3Y 140000 70000 311378 311378 50455 50455 250000 50000 890540 222635 2086848 231872 3000000 6000 <p id="xdx_80C_eus-gaap--FairValueDisclosuresTextBlock_zsS9u7BNMUz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE F – <span id="xdx_828_z0mZeigvUSmk">FAIR VALUE MEASUREMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the guidance established pursuant to ASC 820 which established a framework for measuring fair value and expands disclosure about fair value measurements. ASC 820 defines fair value as the amount that would be received for an asset or paid to transfer a liability (i.e., an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes the following three levels of inputs that may be used:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets and liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Unobservable inputs when there is little or no market data available, thereby requiring an entity to develop its own assumptions. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zjThVU5umbZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below summarizes the fair values of financial liabilities as of April 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zYJsa8KARVr6" style="display: none">SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value at</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value Measurement Using</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20220430_zLrNyHQZeing" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,549,640</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20220430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpf55QFtjfsl" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1112">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20220430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzeampZpLorf" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1114">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20220430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_znwNADzR6sFb" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,549,640</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair values of financial liabilities as of April 30, 2021 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value at</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value Measurement Using</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liabilities </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeLiability_iI_c20210430_zWJ3O3OHKOHc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,252,466</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--DerivativeFairValueOfDerivativeLiability_iI_c20210430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zRwFGtJcqBa4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1120">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--DerivativeFairValueOfDerivativeLiability_iI_c20210430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbPW6Y0jpD19" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1122">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--DerivativeFairValueOfDerivativeLiability_iI_c20210430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMPnvg1J3crc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,252,466</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zomlwKgNVmXg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a description of the valuation methodologies used for these items:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Derivative liabilities </i>— these instruments consist of certain variable conversion features related to notes payable obligations and certain outstanding warrants. These instruments were valued using pricing models which incorporate the Company’s stock price, volatility, U.S. risk free rate, dividend rate and estimated life.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value in accordance with ASC Topic 825 “The Fair Value Option for Financial Issuances”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zjThVU5umbZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below summarizes the fair values of financial liabilities as of April 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zYJsa8KARVr6" style="display: none">SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value at</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value Measurement Using</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20220430_zLrNyHQZeing" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,549,640</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20220430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpf55QFtjfsl" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1112">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20220430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzeampZpLorf" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1114">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20220430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_znwNADzR6sFb" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,549,640</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair values of financial liabilities as of April 30, 2021 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value at</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value Measurement Using</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liabilities </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeLiability_iI_c20210430_zWJ3O3OHKOHc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,252,466</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--DerivativeFairValueOfDerivativeLiability_iI_c20210430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zRwFGtJcqBa4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1120">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--DerivativeFairValueOfDerivativeLiability_iI_c20210430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbPW6Y0jpD19" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1122">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--DerivativeFairValueOfDerivativeLiability_iI_c20210430__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMPnvg1J3crc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,252,466</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 9549640 9549640 4252466 4252466 <p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zEjKi7720Dza" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE G - <span id="xdx_826_zyVQdizgaIKa">PROPERTY AND EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_z94vry3BHMwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major classes of property and equipment at April 30, 2022 and 2021 consist of the followings:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zwFdD1Nx6wHj" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_494_20220430_zT3HdsQNbdw7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_495_20210430_z3aJ2G2Ej5G3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zBVE4c40qS7i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment, software and furniture</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">213,262</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">213,262</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zxUrQyAQNuN6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(213,262</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(213,262</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentNet_iTI_ziSm9iPXF6Ya" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net property and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1136">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1137">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A4_z17eKCnP21d8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All equipment are fully depreciated as of the fiscal year end April 30, 2022 and 2021. No additional investment in equipment for both fiscal year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_z94vry3BHMwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major classes of property and equipment at April 30, 2022 and 2021 consist of the followings:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zwFdD1Nx6wHj" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_494_20220430_zT3HdsQNbdw7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_495_20210430_z3aJ2G2Ej5G3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zBVE4c40qS7i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment, software and furniture</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">213,262</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">213,262</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zxUrQyAQNuN6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(213,262</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(213,262</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentNet_iTI_ziSm9iPXF6Ya" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net property and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1136">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1137">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 213262 213262 213262 213262 <p id="xdx_805_ecustom--WarrantsTextBlock_zyjx79oSNaUh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span id="xdx_82D_zeHgxxP4yca" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE H – WARRANTS:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended April 30, 2022, the company issued a total of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWrpwInGTf2l" title="Stock issued for services">4,843,322</span> warrants to employees and service provider at an average option strike price of $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_c20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9Cr4oBcFBFd" title="Stock option price per share">0.17</span> per share. As of April 30, 2022, <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zqNftnmrgyNf" title="Warrants vested">3,801,657</span> of these warrants were vested. Computed fair value was $<span id="xdx_900_eus-gaap--FairValueAdjustmentOfWarrants_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zchkCkVSXnYg" title="Fair value adjustment of warrants">228,099</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_ecustom--ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeTableTextBlock_zCorMqg73AZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the changes in warrants: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zM1IYE2TrVKd" style="display: none">SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants Outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants Exercisable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Prices</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number Outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted <br/> Average<br/> Remaining<br/> Contractual<br/> Life (Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted<br/> Average<br/> Exercise Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number Exercisable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted<br/> Average<br/> Exercise Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_z6S6i6X3xuOk" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants outstanding, exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.3080</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zR6fEMRM3idc" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants outstanding, number"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,465,960</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_z7M9f8kZLw2b" title="Warrants outstanding, weighted average remaining contractual life (years)">3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zv1MxnyR0qh6" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants outstanding, weighted average exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.3080</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zGOmTfAwKuz6" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants exercisable, number exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,298,738</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zWDpCiGEc1R5" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants exercisable, weighted average exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.3080</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zRDw8r144bkb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding, exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.2750</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zYxY68IdCspb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding, number"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,613,426</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zVxR6sdbGOwk" title="Warrants outstanding, weighted average remaining contractual life (years)">3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zAePv04DkQx5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding, weighted average exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.2750</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_z14e8gyxtBX6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants exercisable, number exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,613,426</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zp8KWUJaNNMc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants exercisable, weighted average exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.2750</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zr8OAudt5ijh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding, exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0800</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_z9IQ86poKNo6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding, number"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,843,322</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zmzCGscLUbY9" title="Warrants outstanding, weighted average remaining contractual life (years)">3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zWObb2zxOmR2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding, weighted average exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0800</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_z5qh1lYJcEsi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants exercisable, number exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,801,657</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zI7UfzGK4xn2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants exercisable, weighted average exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0800</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zPXEOIlBeL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z10rz9wqqoul" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions involving stock warrants issued to non-employees are summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zQ6XbSEYgRsi" style="display: none">SCHEDULE OF WARRANTS ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number<br/> of Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted<br/> Average<br/> Exercise <br/> Price Per Share</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at April 30, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zYoAWDtruTB8" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of shares, warrants outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,310,745</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice_iI_c20200430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zrTLL61iOTp7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted average exercise price per share, warrants outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.16190</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_z4ok0vNlTo62" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants grants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,395,380</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zCfIgY9RA7jk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants grants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.17097</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled or expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zu22H71R1Ze9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants canceled or expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(400</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExpiredWeightedAverageExercisePrice_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zUIEhwQCZAO9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants canceled or expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.17000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at April 30, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zI8RXTdtMSBe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,705,725</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice_iS_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zcv0Ji6qzsS5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.016190</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zJRdmA7P6B81" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants grants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1205">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zIOzDx0pyRV5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants grants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zVmwiZFWBotd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1209">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisedWeightedAverageExercisePrice_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zidiIZhsCl86" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1211">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled or expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zF8XJRbhqlU1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants canceled or expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(216,983</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExpiredWeightedAverageExercisePrice_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zQUAV2FnqVt" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants canceled or expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.16010</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at April 30, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zpYrsTnaHoSi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,922,708</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice_iE_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_z0QH55W8CJzh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.16190</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A0_zwM5yNQK5qw8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 4843322 0.17 3801657 228099 <p id="xdx_899_ecustom--ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeTableTextBlock_zCorMqg73AZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the changes in warrants: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zM1IYE2TrVKd" style="display: none">SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants Outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants Exercisable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Prices</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number Outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted <br/> Average<br/> Remaining<br/> Contractual<br/> Life (Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted<br/> Average<br/> Exercise Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number Exercisable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted<br/> Average<br/> Exercise Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_z6S6i6X3xuOk" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants outstanding, exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.3080</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zR6fEMRM3idc" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants outstanding, number"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,465,960</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_z7M9f8kZLw2b" title="Warrants outstanding, weighted average remaining contractual life (years)">3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zv1MxnyR0qh6" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants outstanding, weighted average exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.3080</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zGOmTfAwKuz6" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants exercisable, number exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,298,738</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zWDpCiGEc1R5" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants exercisable, weighted average exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.3080</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zRDw8r144bkb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding, exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.2750</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zYxY68IdCspb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding, number"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,613,426</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zVxR6sdbGOwk" title="Warrants outstanding, weighted average remaining contractual life (years)">3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zAePv04DkQx5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding, weighted average exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.2750</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_z14e8gyxtBX6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants exercisable, number exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,613,426</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zp8KWUJaNNMc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants exercisable, weighted average exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.2750</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zr8OAudt5ijh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding, exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0800</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_z9IQ86poKNo6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding, number"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,843,322</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zmzCGscLUbY9" title="Warrants outstanding, weighted average remaining contractual life (years)">3</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zWObb2zxOmR2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding, weighted average exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0800</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_z5qh1lYJcEsi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants exercisable, number exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,801,657</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iI_c20220430__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zI7UfzGK4xn2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants exercisable, weighted average exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0800</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 0.3080 1465960 P3Y 0.3080 1298738 0.3080 0.2750 1613426 P3Y 0.2750 1613426 0.2750 0.0800 4843322 P3Y 0.0800 3801657 0.0800 <p id="xdx_89F_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z10rz9wqqoul" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions involving stock warrants issued to non-employees are summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zQ6XbSEYgRsi" style="display: none">SCHEDULE OF WARRANTS ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number<br/> of Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted<br/> Average<br/> Exercise <br/> Price Per Share</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at April 30, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zYoAWDtruTB8" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of shares, warrants outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,310,745</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice_iI_c20200430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zrTLL61iOTp7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted average exercise price per share, warrants outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.16190</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_z4ok0vNlTo62" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants grants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,395,380</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zCfIgY9RA7jk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants grants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.17097</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled or expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zu22H71R1Ze9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants canceled or expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(400</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExpiredWeightedAverageExercisePrice_c20200501__20210430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zUIEhwQCZAO9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants canceled or expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.17000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at April 30, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zI8RXTdtMSBe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,705,725</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice_iS_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zcv0Ji6qzsS5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.016190</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zJRdmA7P6B81" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants grants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1205">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zIOzDx0pyRV5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants grants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zVmwiZFWBotd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1209">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisedWeightedAverageExercisePrice_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zidiIZhsCl86" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1211">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled or expired</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zF8XJRbhqlU1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants canceled or expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(216,983</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExpiredWeightedAverageExercisePrice_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zQUAV2FnqVt" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants canceled or expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.16010</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at April 30, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_zpYrsTnaHoSi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares, warrants outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,922,708</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice_iE_c20210501__20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--NonEmployeesMember_z0QH55W8CJzh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price per share, warrants outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.16190</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 5310745 0.16190 2395380 0.17097 400 0.17000 7705725 0.016190 216983 0.16010 7922708 0.16190 <p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zj0clzDOqypb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE I - <span id="xdx_821_zI8dAvY9tMB5">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At April 30, 2022, the Company has available for federal income tax purposes a net operating loss carry forward of approximately $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_c20220430_zlkJsNATteyk" title="Operating loss carry forwards, net">65,338,601</span> that may be used to offset future taxable income and expiring through the tax year <span id="xdx_909_ecustom--OperatingLossCarryforwardOnExpirationDate_c20210501__20220430_zIrPJLBbnx29" title="Operating loss carryforwards, expiration date">2036</span>, subject to certain limitation pursuant to Internal Revenue Code Section 382. The Company has provided a valuation reserve against the full amount of the net operating loss benefit, since in the opinion of management based upon the earnings history of the Company; it is more likely than not that, the benefits will not be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zNV5YK4gQiOe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zN3AqTowyqb" style="display: none">SCHEDULE OF RECONCILIATION OF INCOME TAX RATE</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20210501__20220430_ztppRUa6IMOe" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20200501__20210430_zEPZYUVAgGPk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended April 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_pid_dpi_uPure_zo5c8xaSgjKg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Federal statutory income tax rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">(21.0</td><td style="width: 1%; text-align: left">)%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">(21.0</td><td style="width: 1%; text-align: left">)%</td></tr> <tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_zsx6cxR8eMI7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State income taxes, net of federal benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7.1</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7.1</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_zWTKHzJDW6X6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Permanent differences</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.7</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_zGS3LzLuyb07" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21.4</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_zn7ahv7f8mBk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Provision for income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8AE_z9Oe59CSN1If" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z8RnQgHvbWU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Components of deferred tax assets as of April 30, 2022 and estimated 2021 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zD7Y5ezKtH49" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_49B_20220430_zFd7TCixYUOg" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_494_20210430_zys6q6ctgfB8" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Noncurrent:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTALNzU93_zGBD8gTDGn76" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: justify">Net operating loss carry forward</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">14,753,877</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">13,167,491</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNzU93_zAS7XSAoL5Hg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(14,753,877</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,167,491</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNzU93_zYhR99ua5VLg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1253">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zAdUZgy4WkK1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 65338601 2036 <p id="xdx_898_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zNV5YK4gQiOe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zN3AqTowyqb" style="display: none">SCHEDULE OF RECONCILIATION OF INCOME TAX RATE</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49B_20210501__20220430_ztppRUa6IMOe" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20200501__20210430_zEPZYUVAgGPk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended April 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_pid_dpi_uPure_zo5c8xaSgjKg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Federal statutory income tax rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">(21.0</td><td style="width: 1%; text-align: left">)%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">(21.0</td><td style="width: 1%; text-align: left">)%</td></tr> <tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_zsx6cxR8eMI7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State income taxes, net of federal benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7.1</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7.1</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_zWTKHzJDW6X6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Permanent differences</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.7</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_zGS3LzLuyb07" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21.4</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_zn7ahv7f8mBk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Provision for income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr> </table> 0.210 0.210 -0.071 -0.071 0.067 0.067 0.214 0.214 0.000 0.000 <p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z8RnQgHvbWU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Components of deferred tax assets as of April 30, 2022 and estimated 2021 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zD7Y5ezKtH49" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_49B_20220430_zFd7TCixYUOg" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_494_20210430_zys6q6ctgfB8" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">April 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Noncurrent:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTALNzU93_zGBD8gTDGn76" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: justify">Net operating loss carry forward</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">14,753,877</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">13,167,491</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNzU93_zAS7XSAoL5Hg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(14,753,877</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,167,491</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNzU93_zYhR99ua5VLg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1253">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 14753877 13167491 14753877 13167491 <p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zxvgTzWOaNAe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE J - <span id="xdx_820_zYHctVsC4zG8">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Operating Lease Commitments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our executive offices are located in New York, NY. We have an agreement for use of office space at this location under a sub-lease which expired on <span id="xdx_90B_eus-gaap--LeaseExpirationDate1_c20210501__20220430__srt--StatementScenarioAxis__custom--ExecutiveOfficeSpaceMember_zUFdbJq4NFD" title="Lease expiring date">July 31, 2018</span>, and continues a month-to-month basis thereafter. The monthly base rent is $<span id="xdx_904_eus-gaap--PaymentsForRent_c20210501__20220430__srt--StatementScenarioAxis__custom--ExecutiveOfficeSpaceMember_zZIEbFZVLRk7" title="Rent expense">5,100</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent expense was $<span id="xdx_902_eus-gaap--PaymentsForRent_c20210501__20220430_zWbGtXRw6277" title="Rent expenses">64,800</span> and $<span id="xdx_900_eus-gaap--PaymentsForRent_c20200501__20210430_zIdMxpshaek3" title="Rent expenses">70,200</span> for the years ended April 30, 2022, and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Employment and Consulting Agreements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not have employment agreements with any of its non-executive employees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has consulting agreements with outside contractors to provide marketing and financial advisory services. The agreements are generally for a term of 12 months from inception and renewable automatically from year to year unless either the Company or consultant terminates such engagement by written notice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into five year employment agreements with its CEO, Anthony L Havens and Vice President of Operations, Sandra L Ahman. As part of their employment agreements, Mr. Havens received <span id="xdx_90D_eus-gaap--DebtInstrumentTerm_dc_c20210501__20220430__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--MrHavensMember_z2ntiS66Xgyf" title="Debt instrument, term">five year</span> options to purchase <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210501__20220430__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--MrHavensMember_zK3n4MU8Vsr8" title="Number of shares issued during the period">37,625,574</span> shares of the Company’s common stock at $<span id="xdx_907_eus-gaap--SharePrice_iI_c20220430__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--MrHavensMember_zkgRDPmIaJ1j" title="Share price">0.00308</span> per share. The options vest in three equal tranches over <span id="xdx_90F_ecustom--SharesVestedTerm_dc_c20210501__20220430__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--MrHavensMember_z0KRxQOCnEgd" title="Shares vested term">three years</span>. Ms. Ahman received five year options to purchase <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210501__20220430__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--MsAhmanMember_z26x6esSCLvf" title="Number of shares issued during the period">12,541,858</span> shares of the Company’s common stock at $<span id="xdx_907_eus-gaap--SharePrice_iI_c20220430__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--MsAhmanMember_zfxjU39bT1ab" title="Share price">0.00308</span> per share. The options vest in three equal tranches over <span id="xdx_900_ecustom--SharesVestedTerm_dc_c20210501__20220430__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--MsAhmanMember_zNLo5PfEZbp4" title="Shares vested term">three years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Litigation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is subject to legal proceedings and claims which arise in the ordinary course of its business. Sparta can make no representations about the potential outcome of such proceedings.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of April 30, 2022, we have not been named as parties to any further legal proceedings except as those disclosed prior and as updated below. From time to time, of course, we may become involved in further legal proceedings, which sometimes arise due to the very nature of and in the ordinary course of this business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By way of background, the Company had received notices dated April 1, 2016, May 13, 2016 and July 22, 2016 from two lenders claiming defaults relating to conversion requests of $<span id="xdx_901_eus-gaap--DebtDefaultLongtermDebtAmount_iI_pp2d_c20220430__srt--TitleOfIndividualAxis__custom--LenderOneMember_z1ExAYL47uOc" title="Debt principal amount">8,365.00</span> in principal plus interest, attorney fees and $<span id="xdx_90B_eus-gaap--DebtDefaultLongtermDebtAmount_iI_pp2d_c20220430__srt--TitleOfIndividualAxis__custom--LenderTwoMember_z48rdICaItG2" title="Debt principal amount">5,000.00</span> in principal plus interest also seeking stock conversions aside from the stated principal and interest with regard to notes in the total amounts of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pp2d_c20220430__srt--TitleOfIndividualAxis__custom--LenderOneMember_zGTEQ8fhZtNb" title="Aggregate note amount">55,125.00</span> and $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp2d_c20220430__srt--TitleOfIndividualAxis__custom--LenderTwoMember_zKQhVfxgSNka" title="Aggregate note amount">27,500.00</span>, respectively, which the Company has declined to process and believes it has valid, meritorious defenses in that regard. The Company believes these claims are contingent, unliquidated and disputes same. While there can be no assurances that the Company would prevail in any potential litigation with regard to claims brought against the Company, these potential liabilities have been recorded in the unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to the above claims, on September 22, 2016, a motion for summary judgment in lieu of complaint was filed in the Supreme Court in the State of New York: County of Kings, against the Company by a lender for the amount of $<span id="xdx_908_eus-gaap--LossContingencyLossInPeriod_pp2d_c20160921__20160922__dei--LegalEntityAxis__custom--NewYorkCountyKingsMember_zYpdGTUyUst3" title="Loss on contingent">102,170.82</span> in principal and stock conversion interest, plus fees and costs. The Plaintiff’s motion for summary judgment in lieu of complaint was denied on May 5, 2017. On August 22, 2018, Plaintiff thereafter brought a second motion seeking summary judgment on the issue of liability which was, again, denied by the Court on March 14, 2019. The most recent appearance in this matter had been scheduled for March 13, 2020, at which time, the Court marked the case “adjourned without a date”, due to the restrictions imposed on the Courts arising from the COVID-19 pandemic. No further Court appearances have been scheduled, to date, in this matter. However, most notably, a favorable decision from the New York State Court of Appeals regarding the very same types of transactions have since been determined to be criminally usurious and, therefore, unenforceable. These were the very same defenses raised on behalf of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 26, 2018, a second lender commenced an action in the Supreme Court of the State of New York: New York County alleging damages from unpaid principal arising from a promissory note dated February 26, 2015 in the amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp2d_c20150226__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zDpAzyPd1kY1" title="Aggregate note amount">50,000.00</span> plus damages including interest and stock conversions, costs and fees. There are cross dispositive motions pending which are scheduled to be heard in September, 2022. The Company disputes the enforceability of such claims for the similar reasons, as stated above, based on the Court of Appeals ruling as to the unenforceable nature of such claims demanding usurious interest rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2018-07-31 5100 64800 70200 P5Y 37625574 0.00308 P3Y 12541858 0.00308 P3Y 8365.00 5000.00 55125.00 27500.00 102170.82 50000.00 <p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_z6mrbyLju6Z7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE K – <span id="xdx_829_zKVizsw9OxJk">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has evaluated subsequent events for recognition and disclosure as of <span style="background-color: white">August 15,</span> 2022 which is the date the financial statements were available to be issued. No other matters were identified affecting the accompanying financial statements and related disclosures.</span></p> EXCEL 60 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 62 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 63 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 146 245 1 false 59 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://spartacommercial.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://spartacommercial.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://spartacommercial.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://spartacommercial.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Deficit Sheet http://spartacommercial.com/role/StatementsOfDeficit Consolidated Statements of Deficit Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://spartacommercial.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - SUMMARY OF ACCOUNTING POLICIES Sheet http://spartacommercial.com/role/SummaryOfAccountingPolicies SUMMARY OF ACCOUNTING POLICIES Notes 7 false false R8.htm 00000008 - Disclosure - GOING CONCERN MATTERS Sheet http://spartacommercial.com/role/GoingConcernMatters GOING CONCERN MATTERS Notes 8 false false R9.htm 00000009 - Disclosure - NOTES PAYABLE AND DERIVATIVES Notes http://spartacommercial.com/role/NotesPayableAndDerivatives NOTES PAYABLE AND DERIVATIVES Notes 9 false false R10.htm 00000010 - Disclosure - LOANS PAYABLE TO RELATED PARTIES Sheet http://spartacommercial.com/role/LoansPayableToRelatedParties LOANS PAYABLE TO RELATED PARTIES Notes 10 false false R11.htm 00000011 - Disclosure - EQUITY TRANSACTIONS Sheet http://spartacommercial.com/role/EquityTransactions EQUITY TRANSACTIONS Notes 11 false false R12.htm 00000012 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://spartacommercial.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 12 false false R13.htm 00000013 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://spartacommercial.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT Notes 13 false false R14.htm 00000014 - Disclosure - NOTE H ??? WARRANTS: Sheet http://spartacommercial.com/role/NoteHWarrants NOTE H ??? WARRANTS: Notes 14 false false R15.htm 00000015 - Disclosure - INCOME TAXES Sheet http://spartacommercial.com/role/IncomeTaxes INCOME TAXES Notes 15 false false R16.htm 00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://spartacommercial.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 16 false false R17.htm 00000017 - Disclosure - SUBSEQUENT EVENTS Sheet http://spartacommercial.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 00000018 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Policies) Sheet http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies SUMMARY OF ACCOUNTING POLICIES (Policies) Policies 18 false false R19.htm 00000019 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Tables) Sheet http://spartacommercial.com/role/SummaryOfAccountingPoliciesTables SUMMARY OF ACCOUNTING POLICIES (Tables) Tables http://spartacommercial.com/role/SummaryOfAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - NOTES PAYABLE AND DERIVATIVES (Tables) Notes http://spartacommercial.com/role/NotesPayableAndDerivativesTables NOTES PAYABLE AND DERIVATIVES (Tables) Tables http://spartacommercial.com/role/NotesPayableAndDerivatives 20 false false R21.htm 00000021 - Disclosure - EQUITY TRANSACTIONS (Tables) Sheet http://spartacommercial.com/role/EquityTransactionsTables EQUITY TRANSACTIONS (Tables) Tables http://spartacommercial.com/role/EquityTransactions 21 false false R22.htm 00000022 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://spartacommercial.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://spartacommercial.com/role/FairValueMeasurements 22 false false R23.htm 00000023 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://spartacommercial.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://spartacommercial.com/role/PropertyAndEquipment 23 false false R24.htm 00000024 - Disclosure - NOTE H ??? WARRANTS: (Tables) Sheet http://spartacommercial.com/role/NoteHWarrantsTables NOTE H ??? WARRANTS: (Tables) Tables http://spartacommercial.com/role/NoteHWarrants 24 false false R25.htm 00000025 - Disclosure - INCOME TAXES (Tables) Sheet http://spartacommercial.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://spartacommercial.com/role/IncomeTaxes 25 false false R26.htm 00000026 - Disclosure - SCHEDULE OF DISAGGREGATION REVENUE (Details) Sheet http://spartacommercial.com/role/ScheduleOfDisaggregationRevenueDetails SCHEDULE OF DISAGGREGATION REVENUE (Details) Details 26 false false R27.htm 00000027 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT (Details) Sheet http://spartacommercial.com/role/ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentDetails SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT (Details) Details 27 false false R28.htm 00000028 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details Narrative) Sheet http://spartacommercial.com/role/SummaryOfAccountingPoliciesDetailsNarrative SUMMARY OF ACCOUNTING POLICIES (Details Narrative) Details http://spartacommercial.com/role/SummaryOfAccountingPoliciesTables 28 false false R29.htm 00000029 - Disclosure - GOING CONCERN MATTERS (Details Narrative) Sheet http://spartacommercial.com/role/GoingConcernMattersDetailsNarrative GOING CONCERN MATTERS (Details Narrative) Details http://spartacommercial.com/role/GoingConcernMatters 29 false false R30.htm 00000030 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) Notes http://spartacommercial.com/role/ScheduleOfNotesPayableDetails SCHEDULE OF NOTES PAYABLE (Details) Details 30 false false R31.htm 00000031 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION (Details) Sheet http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION (Details) Details 31 false false R32.htm 00000032 - Disclosure - SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES (Details) Sheet http://spartacommercial.com/role/ScheduleOfChangesInDerivativeLiabilitiesDetails SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES (Details) Details 32 false false R33.htm 00000033 - Disclosure - NOTES PAYABLE AND DERIVATIVES (Details Narrative) Notes http://spartacommercial.com/role/NotesPayableAndDerivativesDetailsNarrative NOTES PAYABLE AND DERIVATIVES (Details Narrative) Details http://spartacommercial.com/role/NotesPayableAndDerivativesTables 33 false false R34.htm 00000034 - Disclosure - LOANS PAYABLE TO RELATED PARTIES (Details Narrative) Sheet http://spartacommercial.com/role/LoansPayableToRelatedPartiesDetailsNarrative LOANS PAYABLE TO RELATED PARTIES (Details Narrative) Details http://spartacommercial.com/role/LoansPayableToRelatedParties 34 false false R35.htm 00000035 - Disclosure - SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES (Details) Sheet http://spartacommercial.com/role/ScheduleOfPreferredStockOutstandingSharesDetails SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES (Details) Details 35 false false R36.htm 00000036 - Disclosure - EQUITY TRANSACTIONS (Details Narrative) Sheet http://spartacommercial.com/role/EquityTransactionsDetailsNarrative EQUITY TRANSACTIONS (Details Narrative) Details http://spartacommercial.com/role/EquityTransactionsTables 36 false false R37.htm 00000037 - Disclosure - SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES (Details) Sheet http://spartacommercial.com/role/ScheduleOfFairValuesOfFinancialLiabilitiesDetails SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES (Details) Details 37 false false R38.htm 00000038 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Sheet http://spartacommercial.com/role/ScheduleOfPropertyAndEquipmentDetails SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Details 38 false false R39.htm 00000039 - Disclosure - SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE (Details) Sheet http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE (Details) Details 39 false false R40.htm 00000040 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details) Sheet http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails SCHEDULE OF WARRANTS ACTIVITY (Details) Details 40 false false R41.htm 00000041 - Disclosure - NOTE H ??? WARRANTS: (Details Narrative) Sheet http://spartacommercial.com/role/NoteHWarrantsDetailsNarrative NOTE H ??? WARRANTS: (Details Narrative) Details http://spartacommercial.com/role/NoteHWarrantsTables 41 false false R42.htm 00000042 - Disclosure - SCHEDULE OF RECONCILIATION OF INCOME TAX RATE (Details) Sheet http://spartacommercial.com/role/ScheduleOfReconciliationOfIncomeTaxRateDetails SCHEDULE OF RECONCILIATION OF INCOME TAX RATE (Details) Details 42 false false R43.htm 00000043 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) Sheet http://spartacommercial.com/role/ScheduleOfDeferredTaxAssetsDetails SCHEDULE OF DEFERRED TAX ASSETS (Details) Details 43 false false R44.htm 00000044 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://spartacommercial.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://spartacommercial.com/role/IncomeTaxesTables 44 false false R45.htm 00000045 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://spartacommercial.com/role/CommitmentsAndContingencies 45 false false All Reports Book All Reports form10-k.htm ex21-1.htm ex23-1.htm ex31-1.htm ex31-2.htm ex32-1.htm srco-20220430.xsd srco-20220430_cal.xml srco-20220430_def.xml srco-20220430_lab.xml srco-20220430_pre.xml form10-k_002.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 65 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-k.htm": { "axisCustom": 0, "axisStandard": 14, "contextCount": 146, "dts": { "calculationLink": { "local": [ "srco-20220430_cal.xml" ] }, "definitionLink": { "local": [ "srco-20220430_def.xml" ] }, "inline": { "local": [ "form10-k.htm" ] }, "labelLink": { "local": [ "srco-20220430_lab.xml" ] }, "presentationLink": { "local": [ "srco-20220430_pre.xml" ] }, "schema": { "local": [ "srco-20220430.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 406, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 58, "http://spartacommercial.com/20220430": 3, "http://xbrl.sec.gov/dei/2022": 3, "total": 64 }, "keyCustom": 39, "keyStandard": 206, "memberCustom": 38, "memberStandard": 21, "nsprefix": "SRCO", "nsuri": "http://spartacommercial.com/20220430", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://spartacommercial.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - LOANS PAYABLE TO RELATED PARTIES", "role": "http://spartacommercial.com/role/LoansPayableToRelatedParties", "shortName": "LOANS PAYABLE TO RELATED PARTIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - EQUITY TRANSACTIONS", "role": "http://spartacommercial.com/role/EquityTransactions", "shortName": "EQUITY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - FAIR VALUE MEASUREMENTS", "role": "http://spartacommercial.com/role/FairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - PROPERTY AND EQUIPMENT", "role": "http://spartacommercial.com/role/PropertyAndEquipment", "shortName": "PROPERTY AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "SRCO:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - NOTE H \u2013 WARRANTS:", "role": "http://spartacommercial.com/role/NoteHWarrants", "shortName": "NOTE H \u2013 WARRANTS:", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "SRCO:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - INCOME TAXES", "role": "http://spartacommercial.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://spartacommercial.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - SUBSEQUENT EVENTS", "role": "http://spartacommercial.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationsPolicy", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Policies)", "role": "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies", "shortName": "SUMMARY OF ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationsPolicy", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Tables)", "role": "http://spartacommercial.com/role/SummaryOfAccountingPoliciesTables", "shortName": "SUMMARY OF ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "role": "http://spartacommercial.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - NOTES PAYABLE AND DERIVATIVES (Tables)", "role": "http://spartacommercial.com/role/NotesPayableAndDerivativesTables", "shortName": "NOTES PAYABLE AND DERIVATIVES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "SRCO:ScheduleOfPreferredStockOutstandingSharesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - EQUITY TRANSACTIONS (Tables)", "role": "http://spartacommercial.com/role/EquityTransactionsTables", "shortName": "EQUITY TRANSACTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "SRCO:ScheduleOfPreferredStockOutstandingSharesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "role": "http://spartacommercial.com/role/FairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "role": "http://spartacommercial.com/role/PropertyAndEquipmentTables", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "SRCO:WarrantsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "SRCO:ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - NOTE H \u2013 WARRANTS: (Tables)", "role": "http://spartacommercial.com/role/NoteHWarrantsTables", "shortName": "NOTE H \u2013 WARRANTS: (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "SRCO:WarrantsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "SRCO:ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - INCOME TAXES (Tables)", "role": "http://spartacommercial.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - SCHEDULE OF DISAGGREGATION REVENUE (Details)", "role": "http://spartacommercial.com/role/ScheduleOfDisaggregationRevenueDetails", "shortName": "SCHEDULE OF DISAGGREGATION REVENUE (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R27": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRCO:ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-012022-04-30_us-gaap_LeaseholdImprovementsMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT (Details)", "role": "http://spartacommercial.com/role/ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentDetails", "shortName": "SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRCO:ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-012022-04-30_us-gaap_LeaseholdImprovementsMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details Narrative)", "role": "http://spartacommercial.com/role/SummaryOfAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - GOING CONCERN MATTERS (Details Narrative)", "role": "http://spartacommercial.com/role/GoingConcernMattersDetailsNarrative", "shortName": "GOING CONCERN MATTERS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "lang": null, "name": "SRCO:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://spartacommercial.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details)", "role": "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails", "shortName": "SCHEDULE OF NOTES PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION (Details)", "role": "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails", "shortName": "SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-04-30", "decimals": "0", "first": true, "lang": null, "name": "SRCO:DerivativeLiability", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES (Details)", "role": "http://spartacommercial.com/role/ScheduleOfChangesInDerivativeLiabilitiesDetails", "shortName": "SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-04-30", "decimals": "0", "lang": null, "name": "SRCO:DerivativeLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "SRCO:AmortizationOfDebtDiscount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - NOTES PAYABLE AND DERIVATIVES (Details Narrative)", "role": "http://spartacommercial.com/role/NotesPayableAndDerivativesDetailsNarrative", "shortName": "NOTES PAYABLE AND DERIVATIVES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2019-05-012020-04-30", "decimals": "0", "lang": null, "name": "SRCO:AmortizationOfDebtDiscount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToOfficersOrStockholdersNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - LOANS PAYABLE TO RELATED PARTIES (Details Narrative)", "role": "http://spartacommercial.com/role/LoansPayableToRelatedPartiesDetailsNarrative", "shortName": "LOANS PAYABLE TO RELATED PARTIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToOfficersOrStockholdersNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRCO:ScheduleOfPreferredStockOutstandingSharesTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30_us-gaap_SeriesAPreferredStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES (Details)", "role": "http://spartacommercial.com/role/ScheduleOfPreferredStockOutstandingSharesDetails", "shortName": "SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRCO:ScheduleOfPreferredStockOutstandingSharesTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30_us-gaap_SeriesAPreferredStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - EQUITY TRANSACTIONS (Details Narrative)", "role": "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "shortName": "EQUITY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-07-252020-07-30", "decimals": null, "lang": "en-US", "name": "us-gaap:StockholdersEquityReverseStockSplit", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilitiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES (Details)", "role": "http://spartacommercial.com/role/ScheduleOfFairValuesOfFinancialLiabilitiesDetails", "shortName": "SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-04-30", "decimals": "0", "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "role": "http://spartacommercial.com/role/ScheduleOfPropertyAndEquipmentDetails", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30_us-gaap_ComputerEquipmentMember", "decimals": "0", "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRCO:ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeTableTextBlock", "SRCO:WarrantsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30_custom_WarrantOneMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE (Details)", "role": "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails", "shortName": "SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRCO:ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeTableTextBlock", "SRCO:WarrantsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30_custom_WarrantOneMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "role": "http://spartacommercial.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": "0", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "SRCO:WarrantsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-04-30_us-gaap_WarrantMember_custom_NonEmployeesMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details)", "role": "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails", "shortName": "SCHEDULE OF WARRANTS ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "SRCO:WarrantsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-04-30_us-gaap_WarrantMember_custom_NonEmployeesMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "p", "SRCO:WarrantsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-012022-04-30_us-gaap_WarrantMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - NOTE H \u2013 WARRANTS: (Details Narrative)", "role": "http://spartacommercial.com/role/NoteHWarrantsDetailsNarrative", "shortName": "NOTE H \u2013 WARRANTS: (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "SRCO:WarrantsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-012022-04-30_us-gaap_WarrantMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - SCHEDULE OF RECONCILIATION OF INCOME TAX RATE (Details)", "role": "http://spartacommercial.com/role/ScheduleOfReconciliationOfIncomeTaxRateDetails", "shortName": "SCHEDULE OF RECONCILIATION OF INCOME TAX RATE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)", "role": "http://spartacommercial.com/role/ScheduleOfDeferredTaxAssetsDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - INCOME TAXES (Details Narrative)", "role": "http://spartacommercial.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForRent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "role": "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForRent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Deficit", "role": "http://spartacommercial.com/role/StatementsOfDeficit", "shortName": "Consolidated Statements of Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-04-30", "decimals": "0", "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "role": "http://spartacommercial.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": "0", "lang": null, "name": "SRCO:DerivativeGainLossOnDerivative", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - SUMMARY OF ACCOUNTING POLICIES", "role": "http://spartacommercial.com/role/SummaryOfAccountingPolicies", "shortName": "SUMMARY OF ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - GOING CONCERN MATTERS", "role": "http://spartacommercial.com/role/GoingConcernMatters", "shortName": "GOING CONCERN MATTERS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - NOTES PAYABLE AND DERIVATIVES", "role": "http://spartacommercial.com/role/NotesPayableAndDerivatives", "shortName": "NOTES PAYABLE AND DERIVATIVES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-01to2022-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 59, "tag": { "SRCO_AhmanStockOptionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ahman Stock Option Agreement [Member]", "label": "Ahman Stock Option Agreement [Member]" } } }, "localname": "AhmanStockOptionAgreementMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_AmortizationOfDebtDiscount": { "auth_ref": [], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of debt discount.", "label": "AmortizationOfDebtDiscount", "negatedLabel": "Amortization of debt discount", "verboseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscount", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/NotesPayableAndDerivativesDetailsNarrative", "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "SRCO_BankOverdraft": { "auth_ref": [], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Bank overdraft.", "label": "Bank overdraft" } } }, "localname": "BankOverdraft", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "SRCO_ChiefExecutiveOfficerAndVicePresidentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chief Executive Officer And Vice President [Member]", "label": "Chief Executive Officer And Vice President [Member]" } } }, "localname": "ChiefExecutiveOfficerAndVicePresidentMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_CommonSharesIssuedForCashStockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares issued for cash stock issued during period shares new issues.", "label": "Issuance of common shares for cash, shares" } } }, "localname": "CommonSharesIssuedForCashStockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "sharesItemType" }, "SRCO_CommonSharesIssuedForCashStockIssuedDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common shares issued for cash", "label": "Issuance of common shares for cash" } } }, "localname": "CommonSharesIssuedForCashStockIssuedDuringPeriodValueNewIssues", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "SRCO_CommonStockDiscountRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock discount rate, percentage.", "label": "Common stock discount rate, percentage" } } }, "localname": "CommonStockDiscountRatePercentage", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/NotesPayableAndDerivativesDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRCO_CommonStockOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock One [Member]", "label": "Common Stock One [Member]" } } }, "localname": "CommonStockOneMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_CommonStockToBeIssuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock to be Issued [Member]", "label": "Common Stock to be Issued [Member]" } } }, "localname": "CommonStockToBeIssuedMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "domainItemType" }, "SRCO_CommonStockTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock Two [Member]", "label": "Common Stock Two [Member]" } } }, "localname": "CommonStockTwoMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_ConversionOfAccruedCompensationToSeriesDPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of accrued compensation to series D preferred stock.", "label": "Conversion of Accrued Compensation to Series D Preferred Stock" } } }, "localname": "ConversionOfAccruedCompensationToSeriesDPreferredStock", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "SRCO_ConversionOfAccruedCompensationToSeriesDPreferredStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of accrued compensation to series d preferred stock shares.", "label": "Conversion of Accrued Compensation to Series D Preferred Stock, shares" } } }, "localname": "ConversionOfAccruedCompensationToSeriesDPreferredStockShares", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "sharesItemType" }, "SRCO_DebtForgiveness": { "auth_ref": [], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt forgiveness.", "label": "Forgiveness of debt" } } }, "localname": "DebtForgiveness", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "SRCO_DerivativeGainLossOnDerivative": { "auth_ref": [], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Derivative gain loss on derivative.", "label": "Loss (Gain) from change in fair value of derivative liabilities" } } }, "localname": "DerivativeGainLossOnDerivative", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRCO_DerivativeLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Derivative liability.", "label": "DerivativeLiability", "periodEndLabel": "Balance, end of year", "periodStartLabel": "Balance, beginning of year" } } }, "localname": "DerivativeLiability", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfChangesInDerivativeLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "SRCO_DerivativeLiabilityExtinguished": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Derivative liability extinguished.", "label": "Derivative liability reclassified to additional paid in capital" } } }, "localname": "DerivativeLiabilityExtinguished", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfChangesInDerivativeLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "SRCO_DerivativeLiabilityMeasurementInputExpectedLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative liability, measurement input, expected life.", "label": "Derivative liability, measurement input, expected life" } } }, "localname": "DerivativeLiabilityMeasurementInputExpectedLife", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "durationItemType" }, "SRCO_DisclosureNoteHWarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note H Warrants" } } }, "localname": "DisclosureNoteHWarrantsAbstract", "nsuri": "http://spartacommercial.com/20220430", "xbrltype": "stringItemType" }, "SRCO_EmploymentAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employment Agreement [Member]", "label": "Employment Agreement [Member]" } } }, "localname": "EmploymentAgreementMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_ExecutiveOfficeSpaceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Executive Office Space [Member]", "label": "Executive Office Space [Member]" } } }, "localname": "ExecutiveOfficeSpaceMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_FinancingCost": { "auth_ref": [], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing cost.", "label": "Financing cost" } } }, "localname": "FinancingCost", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "SRCO_FourEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Four Employees [Member]", "label": "Four Employees [Member]" } } }, "localname": "FourEmployeesMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_FourteenAccreditedInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fourteen Accredited Investors [Member]" } } }, "localname": "FourteenAccreditedInvestorsMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_HavensStockOptionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Havens Stock Option Agreement [Member]", "label": "Havens Stock Option Agreement [Member]" } } }, "localname": "HavensStockOptionAgreementMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_InformationTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information Technology [Member]", "label": "Information Technology [Member]" } } }, "localname": "InformationTechnologyMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDisaggregationRevenueDetails", "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "SRCO_LenderOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lender One [Member]", "label": "Lender One [Member]" } } }, "localname": "LenderOneMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_LenderTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Common Stock Four [Member]", "label": "Lender Two [Member]" } } }, "localname": "LenderTwoMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_MeasurementInputDividendPayoutMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Input Dividend Payout [Member]", "label": "Measurement Input Dividend Payout [Member]" } } }, "localname": "MeasurementInputDividendPayoutMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "domainItemType" }, "SRCO_MrHavensMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mr. Havens [Member]", "label": "Mr. Havens [Member]" } } }, "localname": "MrHavensMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_MsAhmanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ms. Ahman [Member]", "label": "Ms. Ahman [Member]" } } }, "localname": "MsAhmanMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_NetIncomeLossAvailableToCommonStockholders": { "auth_ref": [], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net income loss available to common stock holders.", "label": "NetIncomeLossAvailableToCommonStockholders", "totalLabel": "Net income (loss) attributed to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholders", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "SRCO_NewWorldHealthBrandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New World Health Brands [Member]", "label": "New World Health Brands [Member]" } } }, "localname": "NewWorldHealthBrandsMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDisaggregationRevenueDetails", "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "SRCO_NewYorkCountyKingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New York County Kings [Member]", "label": "New York County Kings [Member]" } } }, "localname": "NewYorkCountyKingsMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_NonConvertibleNotesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Convertible Notes Payable [Member]" } } }, "localname": "NonConvertibleNotesPayableMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "domainItemType" }, "SRCO_NonEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-Employees [Member]", "label": "Non-Employees [Member]" } } }, "localname": "NonEmployeesMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "domainItemType" }, "SRCO_NotesConvertibleAtCompanysOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Convertible At Companys Option [Member]" } } }, "localname": "NotesConvertibleAtCompanysOptionMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "domainItemType" }, "SRCO_NotesConvertibleAtHoldersOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Convertible At Holders Option [Member]" } } }, "localname": "NotesConvertibleAtHoldersOptionMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "domainItemType" }, "SRCO_OperatingLossCarryforwardOnExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating loss carryforwards, expiration date.", "label": "Operating loss carryforwards, expiration date" } } }, "localname": "OperatingLossCarryforwardOnExpirationDate", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "gYearItemType" }, "SRCO_PostSplitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post Split [Member]", "label": "Post Split [Member]" } } }, "localname": "PostSplitMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory Note [Member]", "label": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Estimated Useful Life Of Property And Equipment [Table Text Block]", "label": "SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT" } } }, "localname": "ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentTableTextBlock", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "SRCO_ScheduleOfPreferredStockOutstandingSharesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Preferred Stock Outstanding Shares [Table Text Block]", "label": "SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES" } } }, "localname": "ScheduleOfPreferredStockOutstandingSharesTableTextBlock", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsTables" ], "xbrltype": "textBlockItemType" }, "SRCO_ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Warrants Or Rights Shares Authorized By Exercise Price Range [Table Text Block]", "label": "SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE" } } }, "localname": "ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeTableTextBlock", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/NoteHWarrantsTables" ], "xbrltype": "textBlockItemType" }, "SRCO_SeriesAConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A convertible preferred stock [Member]", "label": "Series A convertible preferred stock [Member]" } } }, "localname": "SeriesAConvertiblePreferredStockMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/BalanceSheets", "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_SeriesBRedeemablePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series B convertible preferred stock [Member]", "label": "Series B convertible preferred stock [Member]" } } }, "localname": "SeriesBRedeemablePreferredStockMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/BalanceSheets", "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_SeriesCConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series C Convertible Preferred Stock [Member]", "label": "Series C Convertible Preferred Stock [Member]" } } }, "localname": "SeriesCConvertiblePreferredStockMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_SeriesCRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series C redeemable convertible preferred stock [Member]", "label": "Series C redeemable convertible preferred stock [Member]" } } }, "localname": "SeriesCRedeemableConvertiblePreferredStockMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/BalanceSheets", "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_SeriesDConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series D Convertible Preferred Stock [Member]", "label": "Series D Convertible Preferred Stock [Member]" } } }, "localname": "SeriesDConvertiblePreferredStockMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_SeriesDRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series D redeemable convertible preferred stock [Member]", "label": "Series D redeemable convertible preferred stock [Member]" } } }, "localname": "SeriesDRedeemableConvertiblePreferredStockMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/BalanceSheets", "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_SettlementOfAccountsPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Settlement of Accounts Payable [Member]", "label": "Settlement of Accounts Payable [Member]" } } }, "localname": "SettlementOfAccountsPayableMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number warrants exercisable.", "label": "Warrants exercisable, number exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "sharesItemType" }, "SRCO_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price, warrants exercised.", "label": "Weighted average exercise price per share, warrants exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisedWeightedAverageExercisePrice", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "SRCO_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExpiredWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price, warrants canceled or expired.", "label": "Weighted average exercise price per share, warrants canceled or expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExpiredWeightedAverageExercisePrice", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "SRCO_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants outstanding, weighted average exercise price of warrants.", "label": "Warrants outstanding, weighted average exercise price", "periodEndLabel": "Weighted average exercise price per share, warrants outstanding, ending balance", "periodStartLabel": "Weighted average exercise price per share, warrants outstanding, beginning balance", "verboseLabel": "Weighted average exercise price per share, warrants outstanding, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails", "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "perShareItemType" }, "SRCO_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price of warrants on exercisable.", "label": "Warrants exercisable, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "perShareItemType" }, "SRCO_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForDeferredSalary": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options for deferred salary.", "label": "Convertion of deferred salary" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForDeferredSalary", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRCO_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price, warrants grants.", "label": "Weighted average exercise price per share, warrants grants" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "SRCO_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual life (years)", "label": "Warrants outstanding, weighted average remaining contractual life (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "durationItemType" }, "SRCO_SharesIssuedDuringPeriodSharesForSettlementOfAccountsPayable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued during period shares for settlement of accounts payable.", "label": "Stocks issued for settlement of payables, shares" } } }, "localname": "SharesIssuedDuringPeriodSharesForSettlementOfAccountsPayable", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "sharesItemType" }, "SRCO_SharesIssuedDuringPeriodValueForSettlementOfAccountsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued for settlement of accounts payable.", "label": "Stocks issued for settlement of payables" } } }, "localname": "SharesIssuedDuringPeriodValueForSettlementOfAccountsPayable", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "SRCO_SharesIssuedForConversionOfPreferredShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for conversion of preferred shares.", "label": "Conversion of Preferred to common, shares" } } }, "localname": "SharesIssuedForConversionOfPreferredShares", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "sharesItemType" }, "SRCO_SharesIssuedForConversionOfPreferredValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares Issued For Conversion Of Preferred Value.", "label": "SharesIssuedForConversionOfPreferredValue", "negatedLabel": "Conversion of Preferred to common shares" } } }, "localname": "SharesIssuedForConversionOfPreferredValue", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "SRCO_SharesToBeIssuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares to be Issued [Member]", "label": "Shares to be Issued [Member]" } } }, "localname": "SharesToBeIssuedMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_SharesVestedTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares vested term.", "label": "Shares vested term" } } }, "localname": "SharesVestedTerm", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "SRCO_StockIssuedDuringPeriodSharesIssuanceOfPreferredAndCommonStockForCash": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares issuance of preferred and common stock for cash.", "label": "Issuance of Preferred and Common Stock for Cash, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuanceOfPreferredAndCommonStockForCash", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "sharesItemType" }, "SRCO_StockIssuedDuringPeriodValueIssuanceOfPreferredAndCommonStockForCash": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value issuance of preferred and common stock for cash.", "label": "Issuance of Preferred and Common Stock for Cash" } } }, "localname": "StockIssuedDuringPeriodValueIssuanceOfPreferredAndCommonStockForCash", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "SRCO_StocksIssuedForEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stocks issued for equity.", "label": "Stocks issued for equity" } } }, "localname": "StocksIssuedForEquity", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "SRCO_StocksIssuedForEquityShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stocks issued for equity shares.", "label": "Stocks issued for equity, shares" } } }, "localname": "StocksIssuedForEquityShares", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "sharesItemType" }, "SRCO_StocksIssuedFromTobeIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stocks issued from to be issued.", "label": "Stocks issued from to be issued" } } }, "localname": "StocksIssuedFromTobeIssued", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "SRCO_StocksIssuedFromTobeIssuedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stocks issued from to be issued shares.", "label": "Stocks issued from tobe issued, shares" } } }, "localname": "StocksIssuedFromTobeIssuedShares", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "sharesItemType" }, "SRCO_ThreeAccreditedInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Three Accredited Investors [Member]" } } }, "localname": "ThreeAccreditedInvestorsMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_TwoIndependentDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Independent Director [Member]", "label": "Two Independent Director [Member]" } } }, "localname": "TwoIndependentDirectorMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRCO_WarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant One [Member]", "label": "Warrant One [Member]" } } }, "localname": "WarrantOneMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "domainItemType" }, "SRCO_WarrantThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Three [Member]", "label": "Warrant Three [Member]" } } }, "localname": "WarrantThreeMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "domainItemType" }, "SRCO_WarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Two [Member]", "label": "Warrant Two [Member]" } } }, "localname": "WarrantTwoMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "domainItemType" }, "SRCO_WarrantsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants [Text Block]", "label": "NOTE H \u2013 WARRANTS:" } } }, "localname": "WarrantsTextBlock", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/NoteHWarrants" ], "xbrltype": "textBlockItemType" }, "SRCO_WebsiteCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Website Costs [Member]", "label": "Website Costs [Member]" } } }, "localname": "WebsiteCostsMember", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "SRCO_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital deficit.", "label": "WorkingCapitalDeficit", "negatedLabel": "Working capital deficit" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://spartacommercial.com/20220430", "presentation": [ "http://spartacommercial.com/role/GoingConcernMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r468", "r470", "r471" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r468", "r470", "r471" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r468", "r470", "r471" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r468", "r470", "r471" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r476" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://spartacommercial.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MaximumMember": { "auth_ref": [ "r176", "r177", "r178", "r179", "r196", "r234", "r271", "r273", "r401", "r402", "r403", "r404", "r405", "r406", "r408", "r441", "r443", "r454", "r455" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://spartacommercial.com/role/NotesPayableAndDerivativesDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r176", "r177", "r178", "r179", "r196", "r234", "r271", "r273", "r401", "r402", "r403", "r404", "r405", "r406", "r408", "r441", "r443", "r454", "r455" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://spartacommercial.com/role/NotesPayableAndDerivativesDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r154", "r177", "r178", "r260", "r261", "r411", "r440", "r442" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDisaggregationRevenueDetails", "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r154", "r177", "r178", "r260", "r261", "r411", "r440", "r442" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDisaggregationRevenueDetails", "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r170", "r176", "r177", "r178", "r179", "r196", "r234", "r262", "r271", "r273", "r303", "r304", "r305", "r401", "r402", "r403", "r404", "r405", "r406", "r408", "r441", "r443", "r454", "r455" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://spartacommercial.com/role/NotesPayableAndDerivativesDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r170", "r176", "r177", "r178", "r179", "r196", "r234", "r262", "r271", "r273", "r303", "r304", "r305", "r401", "r402", "r403", "r404", "r405", "r406", "r408", "r441", "r443", "r454", "r455" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://spartacommercial.com/role/NotesPayableAndDerivativesDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r109", "r114", "r175", "r272" ], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r109", "r114", "r175", "r272", "r396" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r157", "r389" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r158", "r159" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r15", "r167" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated depreciation and amortization", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r26", "r394" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r101", "r102", "r103", "r308", "r309", "r310", "r360" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "Options issued for compensation and accrued compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r307" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Stock based compensation" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r63", "r76", "r216", "r380" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r58", "r76", "r216", "r382" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Non-cash financing cost" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r17", "r95", "r143", "r146", "r152", "r161", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r341", "r347", "r372", "r392", "r394", "r412", "r428" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r34", "r95", "r161", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r341", "r347", "r372", "r392", "r394" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of addition (reduction) to the amount at which an asset could be incurred (settled) in a current transaction between willing parties.", "label": "Fair value adjustments" } } }, "localname": "AssetsFairValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfChangesInDerivativeLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r275", "r276", "r277", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r302", "r303", "r304", "r305", "r306" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r13", "r78" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r71", "r78", "r85" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents , end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r71", "r373" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease) increase in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r23", "r24", "r25", "r92", "r95", "r116", "r117", "r118", "r120", "r122", "r129", "r130", "r131", "r161", "r182", "r186", "r187", "r188", "r191", "r192", "r232", "r233", "r237", "r241", "r248", "r372", "r473" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets", "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfPreferredStockOutstandingSharesDetails", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfPreferredStockOutstandingSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Warrants outstanding, exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Warrants outstanding, number" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r171", "r172", "r173", "r180", "r450" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r101", "r102", "r360" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r25", "r248" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock shares outstanding", "verboseLabel": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscribedButUnissued": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common stock to be issued", "verboseLabel": "Common Stock, Shares Subscribed but Unissued" } } }, "localname": "CommonStockSharesSubscribedButUnissued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscriptions": { "auth_ref": [ "r25", "r230" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common stock to be issued 8,916,805 and 1,214,528 respectively" } } }, "localname": "CommonStockSharesSubscriptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r25", "r394" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value; 750,000,000 shares authorized, and 15,128,005 and 9,809,877 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentDetails", "http://spartacommercial.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r134", "r425" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r87", "r343" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r82", "r83", "r84" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Converted common shares" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r82", "r83", "r84" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Common shares issued upon conversion" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r60", "r411" ], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Less Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDefaultLongtermDebtAmount": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured.", "label": "Debt principal amount" } } }, "localname": "DebtDefaultLongtermDebtAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r91", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r210", "r217", "r218", "r220", "r227" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "NOTES PAYABLE AND DERIVATIVES" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/NotesPayableAndDerivatives" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r19", "r20", "r21", "r94", "r99", "r193", "r194", "r195", "r196", "r197", "r198", "r200", "r206", "r207", "r208", "r209", "r211", "r212", "r213", "r214", "r215", "r216", "r223", "r224", "r225", "r226", "r383", "r413", "r414", "r426" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r21", "r221", "r414", "r426" ], "calculation": { "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Subtotal" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentDecreaseForgiveness": { "auth_ref": [ "r94" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.", "label": "Debt Instrument, Decrease, Forgiveness", "verboseLabel": "Forgiveness of debt" } } }, "localname": "DebtInstrumentDecreaseForgiveness", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r193", "r223", "r224", "r381", "r383", "r384" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Aggregate note amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/NotesPayableAndDerivativesDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r39", "r94", "r99", "r193", "r194", "r195", "r196", "r197", "r198", "r200", "r206", "r207", "r208", "r209", "r211", "r212", "r213", "r214", "r215", "r216", "r223", "r224", "r225", "r226", "r383" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r39", "r94", "r99", "r193", "r194", "r195", "r196", "r197", "r198", "r200", "r206", "r207", "r208", "r209", "r211", "r212", "r213", "r214", "r215", "r216", "r219", "r223", "r224", "r225", "r226", "r249", "r252", "r253", "r254", "r380", "r381", "r383", "r384", "r424" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/NotesPayableAndDerivativesDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r206", "r380", "r384" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Less debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Convertible Instruments" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r321" ], "calculation": { "http://spartacommercial.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred tax asset" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r325", "r326" ], "calculation": { "http://spartacommercial.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carry forward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r320" ], "calculation": { "http://spartacommercial.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssetsNoncurrent": { "auth_ref": [ "r16" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.", "label": "Deposits" } } }, "localname": "DepositsAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r76", "r142" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r44", "r46", "r47", "r357", "r407" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "verboseLabel": "Derivative liabilities" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfFairValuesOfFinancialLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r356" ], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "negatedLabel": "Loss (gain) in changes in fair value of derivative liability" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r45" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative liabilities" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets", "http://spartacommercial.com/role/ScheduleOfFairValuesOfFinancialLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityMeasurementInput": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure derivative liability.", "label": "Derivative liability, measurement input, percentage" } } }, "localname": "DerivativeLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r98", "r352", "r353", "r354", "r355", "r358" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivative Liabilities" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "SCHEDULE OF DISAGGREGATION REVENUE" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r255", "r423" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Preferred Stock", "negatedLabel": "Preferred dividend" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToOfficersOrStockholdersNoncurrent": { "auth_ref": [ "r22", "r388", "r427", "r449" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company, which are due after one year (or one business cycle).", "label": "Loans payable to officers and directors" } } }, "localname": "DueToOfficersOrStockholdersNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/LoansPayableToRelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r57", "r106", "r107", "r108", "r109", "r110", "r115", "r116", "r120", "r121", "r122", "r125", "r126", "r361", "r362", "r420", "r439" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net loss attributable to Sparta Commercial Services, Inc. common stockholders" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted loss per share:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r123", "r124" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Loss Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Provision for income taxes" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfReconciliationOfIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r96", "r316", "r331" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "negatedLabel": "Federal statutory income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfReconciliationOfIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r316", "r331" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfReconciliationOfIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r316", "r331" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Permanent differences" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfReconciliationOfIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r316", "r331" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "State income taxes, net of federal benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfReconciliationOfIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r51", "r52", "r53", "r101", "r102", "r103", "r105", "r111", "r113", "r128", "r162", "r248", "r255", "r308", "r309", "r310", "r328", "r329", "r360", "r374", "r375", "r376", "r377", "r378", "r379", "r385", "r444", "r445", "r446" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/NoteHWarrantsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails", "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r76", "r228" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair value adjustment of warrants" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/NoteHWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfFairValuesOfFinancialLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r363", "r364", "r371" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfFairValuesOfFinancialLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/NotesPayableAndDerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r208", "r223", "r224", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r364", "r398", "r399", "r400" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfFairValuesOfFinancialLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r208", "r263", "r264", "r269", "r270", "r364", "r398" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfFairValuesOfFinancialLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r208", "r223", "r224", "r263", "r264", "r269", "r270", "r364", "r399" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfFairValuesOfFinancialLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r208", "r223", "r224", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r364", "r400" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfFairValuesOfFinancialLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.", "label": "SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r208", "r223", "r224", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r398", "r399", "r400" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfFairValuesOfFinancialLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": { "auth_ref": [ "r367", "r370" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/NotesPayableAndDerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues": { "auth_ref": [ "r368", "r370" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Derivative financial liability arising on the issue of convertible notes and warrants" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfChangesInDerivativeLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r61" ], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r59", "r95", "r143", "r145", "r148", "r151", "r153", "r161", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r372" ], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r54", "r57", "r104", "r106", "r107", "r108", "r109", "r116", "r120", "r121", "r362", "r417", "r418", "r420", "r435" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Loss from continuing operations attributable to Sparta Commercial Services, Inc. common stockholders" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": { "auth_ref": [ "r55", "r57", "r117", "r120", "r121", "r420", "r436", "r438", "r439" ], "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.", "label": "Loss from discontinued operations attributable to Sparta Commercial Services, Inc. common stockholders" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r96", "r317", "r318", "r323", "r330", "r332", "r333", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r50", "r314", "r315", "r318", "r319", "r322", "r327" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r81" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r75" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r75" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r75" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "verboseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r75" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r75" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r69", "r72", "r81" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r6", "r32", "r394" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r9", "r31", "r88", "r127", "r163", "r164", "r165", "r409" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseExpirationDate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.", "label": "Lease expiring date" } } }, "localname": "LeaseExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r37", "r95", "r147", "r161", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r342", "r347", "r348", "r372", "r392", "r393" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r30", "r95", "r161", "r372", "r394", "r416", "r433" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r8", "r38", "r95", "r161", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r342", "r347", "r348", "r372", "r392", "r393", "r394" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r10", "r11", "r12", "r21", "r22", "r95", "r161", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r342", "r347", "r348", "r372", "r392", "r393" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Long Term Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r21", "r207", "r222", "r223", "r224", "r414", "r430" ], "calculation": { "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "totalLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyLossInPeriod": { "auth_ref": [ "r174" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.", "label": "Loss on contingent" } } }, "localname": "LossContingencyLossInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDerivativeLiabilitiesAssumptionsUsingBlack-scholesOptionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r43", "r95", "r161", "r182", "r186", "r187", "r188", "r191", "r192", "r372", "r415", "r432" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Non-controlling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r71" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r71" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r71", "r74", "r77" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r3", "r48", "r49", "r53", "r56", "r77", "r95", "r104", "r106", "r107", "r108", "r109", "r112", "r113", "r119", "r143", "r145", "r148", "r151", "r153", "r161", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r362", "r372", "r419", "r437" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r48", "r49", "r53", "r112", "r113", "r345", "r350" ], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "SRCO_NetIncomeLossAvailableToCommonStockholders", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net loss (income) attributed to non-controlling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r101", "r102", "r103", "r255", "r338" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r62" ], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "negatedTotalLabel": "Total other (income) expense" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other (income) expense:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Current portion notes payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesNoncurrent": { "auth_ref": [ "r40", "r97", "r388" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).", "label": "Loans payable-related parties" } } }, "localname": "NotesPayableRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r143", "r145", "r148", "r151", "r153" ], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r324" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating loss carry forwards, net" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r33", "r394" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r16" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r64" ], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedLabel": "Other income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r73" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Rent expenses" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMachineryAndEquipment": { "auth_ref": [ "r65" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for acquisition of machinery and equipment.", "label": "Purchase of equipment" } } }, "localname": "PaymentsToAcquireMachineryAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "auth_ref": [], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "SRCO_NetIncomeLossAvailableToCommonStockholders", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.", "label": "Preferred Stock Dividends, Income Statement Impact", "negatedLabel": "Preferred dividend" } } }, "localname": "PreferredStockDividendsIncomeStatementImpact", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockLiquidationPreference": { "auth_ref": [ "r24", "r92", "r237", "r249", "r250" ], "lang": { "en-us": { "role": { "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.", "label": "Preferred stock, liquidation and redemption value per share" } } }, "localname": "PreferredStockLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r24", "r232" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares designated" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r24", "r232" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding", "verboseLabel": "Preferred Stock" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/ScheduleOfPreferredStockOutstandingSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r24", "r394" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassifications" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r66" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from sale of stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r67" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Net Proceeds from notes payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r67" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from related party notes" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfBankOverdrafts": { "auth_ref": [ "r67", "r68", "r79" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow from the excess drawing from an existing cash balance, which will be honored by the bank but reflected as a loan to the drawer.", "label": "Proceeds from (Repayments of) Bank Overdrafts", "verboseLabel": "Bank overdraft" } } }, "localname": "ProceedsFromRepaymentsOfBankOverdrafts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "Payments on related party notes" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDisaggregationRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r3", "r48", "r49", "r53", "r70", "r95", "r104", "r112", "r113", "r143", "r145", "r148", "r151", "r153", "r161", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r340", "r344", "r346", "r350", "r351", "r362", "r372", "r421" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://spartacommercial.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "SRCO_NetIncomeLossAvailableToCommonStockholders", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net loss", "totalLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows", "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentDetails", "http://spartacommercial.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r169", "r451", "r452", "r453" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r14", "r166" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Computer equipment, software and furniture" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentDetails", "http://spartacommercial.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r168", "r394", "r422", "r434" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net of accumulated depreciation and amortization of $213,262 and $213,262, respectively", "totalLabel": "Net property and equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets", "http://spartacommercial.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r168", "r451", "r452" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentDetails", "http://spartacommercial.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Computer Equipment" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r386", "r387", "r388", "r390", "r391" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "LOANS PAYABLE TO RELATED PARTIES" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/LoansPayableToRelatedParties" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r68" ], "calculation": { "http://spartacommercial.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Payments on notes payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r313", "r410", "r456" ], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Website Development Costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r27", "r255", "r394", "r431", "r447", "r448" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Retained earnings (accumulated deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets", "http://spartacommercial.com/role/GoingConcernMattersDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r101", "r102", "r103", "r105", "r111", "r113", "r162", "r308", "r309", "r310", "r328", "r329", "r360", "r444", "r446" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r140", "r141", "r144", "r149", "r150", "r154", "r155", "r156", "r259", "r260", "r411" ], "calculation": { "http://spartacommercial.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Total Revenue", "verboseLabel": "Revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDisaggregationRevenueDetails", "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r89", "r90" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of stock" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Number of stocks sold during period" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Stock option price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/NoteHWarrantsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "SCHEDULE OF NOTES PAYABLE" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/NotesPayableAndDerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX ASSETS" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "SCHEDULE OF RECONCILIATION OF INCOME TAX RATE" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfDisaggregationRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfEstimatedUsefulLifeOfPropertyAndEquipmentDetails", "http://spartacommercial.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r23", "r24", "r25", "r92", "r129", "r130", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r237", "r241", "r246", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfPreferredStockOutstandingSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r257", "r274" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "SCHEDULE OF WARRANTS ACTIVITY" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/NoteHWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r23", "r24", "r248" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfPreferredStockOutstandingSharesDetails", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r23", "r24", "r248" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfPreferredStockOutstandingSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesCPreferredStockMember": { "auth_ref": [ "r23", "r24", "r248" ], "lang": { "en-us": { "role": { "documentation": "Series C preferred stock.", "label": "Series C Preferred Stock [Member]" } } }, "localname": "SeriesCPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfPreferredStockOutstandingSharesDetails", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesDPreferredStockMember": { "auth_ref": [ "r23", "r24", "r248" ], "lang": { "en-us": { "role": { "documentation": "Series D preferred stock.", "label": "Series D Preferred Stock [Member]" } } }, "localname": "SeriesDPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfPreferredStockOutstandingSharesDetails", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share based compensation vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Warrants vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/NoteHWarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r288" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Number of shares, warrants exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations", "negatedLabel": "Number of shares, warrants canceled or expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r287" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number of shares, warrants grants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r279", "r280" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Number of shares, warrants outstanding, ending balance", "periodStartLabel": "Number of shares, warrants outstanding, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Stock option, grants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r275", "r276", "r277", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r302", "r303", "r304", "r305", "r306" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r278", "r300", "r301", "r302", "r303", "r306", "r311", "r312" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "verboseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r18", "r394", "r413", "r429" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short Term Loan" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r86", "r100" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r23", "r24", "r25", "r92", "r95", "r116", "r117", "r118", "r120", "r122", "r129", "r130", "r131", "r161", "r182", "r186", "r187", "r188", "r191", "r192", "r232", "r233", "r237", "r241", "r248", "r372", "r473" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets", "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfPreferredStockOutstandingSharesDetails", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r42", "r51", "r52", "r53", "r101", "r102", "r103", "r105", "r111", "r113", "r128", "r162", "r248", "r255", "r308", "r309", "r310", "r328", "r329", "r360", "r374", "r375", "r376", "r377", "r378", "r379", "r385", "r444", "r445", "r446" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/NoteHWarrantsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails", "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets", "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://spartacommercial.com/role/NoteHWarrantsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails", "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails", "http://spartacommercial.com/role/StatementsOfDeficit", "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r101", "r102", "r103", "r128", "r411" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets", "http://spartacommercial.com/role/BalanceSheetsParenthetical", "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://spartacommercial.com/role/NoteHWarrantsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails", "http://spartacommercial.com/role/ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeDetails", "http://spartacommercial.com/role/StatementsOfDeficit", "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r41", "r211", "r248", "r249", "r255" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Conversion of convertible notes, shares", "verboseLabel": "Convertion of convertible securities, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Shares issued for services, shares", "terseLabel": "Stock issued for services", "verboseLabel": "Issuance of stock for service, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/NoteHWarrantsDetailsNarrative", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r24", "r25", "r248", "r255" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of stock, shares", "verboseLabel": "Number of shares issued during the period" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Issuance of preferred, shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split.", "label": "Issuance of shares, reverse stock splits" } } }, "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r42", "r248", "r255" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Conversion of convertible notes", "verboseLabel": "Convertion of convertible securities, value" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Shares issued for services", "verboseLabel": "Issuance of stock for service, value" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r24", "r25", "r248", "r255" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Issuance of stock, values" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Issuance of preferred shares" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r25", "r28", "r29", "r95", "r160", "r161", "r372", "r394" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total deficiency in stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Deficit:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r52", "r95", "r101", "r102", "r103", "r105", "r111", "r161", "r162", "r255", "r308", "r309", "r310", "r328", "r329", "r338", "r339", "r349", "r360", "r372", "r374", "r375", "r379", "r385", "r445", "r446" ], "calculation": { "http://spartacommercial.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "alance value", "periodStartLabel": "Balance value", "totalLabel": "Total Deficit" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/BalanceSheets", "http://spartacommercial.com/role/StatementsOfDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r93", "r233", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r247", "r255", "r258", "r359" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "EQUITY TRANSACTIONS" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Stockholders' equity, reverse stock split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r395", "r397" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "GOING CONCERN MATTERS" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/GoingConcernMatters" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://spartacommercial.com/role/EquityTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r132", "r133", "r135", "r136", "r137", "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/SummaryOfAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/NoteHWarrantsDetailsNarrative", "http://spartacommercial.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r115", "r122" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://spartacommercial.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r169": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r173": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r227": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r258": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r312": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r335": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r391": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r397": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(17))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r457": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r458": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r459": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r460": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r461": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r462": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r463": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r464": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r465": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r466": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r467": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r468": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r469": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r470": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r471": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r472": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r473": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r474": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r475": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r476": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r477": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(14))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" } }, "version": "2.1" } ZIP 66 0001493152-22-023055-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-22-023055-xbrl.zip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�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�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end